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ABSTRACT 
 
 
A working hypothesis within the Laboratory of Vascular Research is that 
mechanical loading on vascular smooth muscle cells (VSMCs), especially due to solid 
contact from endovascular devices, contributes to the development of restenosis.  In order 
to better understand the role of mechanical loading on VSMCs in vascular disease 
development, it is imperative to understand the mechanical properties of VSMCs 
themselves.  To measure the viscoelastic and frictional properties of living VSMCs in an 
in vitro setting, an atomic force microscope (AFM) was utilized, thereby allowing for 
mechanical testing of living cells in a fluid environment.  In the first phase of research, it 
was found that proliferative VSMCs, similar to those commonly found in atherosclerotic 
lesions, had lower stiffness and higher hysteresis values than quiescent VSMCs.  
Furthermore, measured stiffness values did not appear to deviate greatly within the 
central region of adherent cells.  As VSMCs are viscoelastic, rather than purely elastic in 
their mechanical behavior, phase two involved the development of an AFM-based stress 
relaxation technique, in order to quantify VSMC viscoelastic behavior.  Suitable 
mechanical models, including the QLV reduced relaxation function and a simple power-
law model, were identified and applied to accurately describe VSMC stress relaxation.  In 
addition, the roles of two major cytoskeletal components, actin and microtubules, in 
governing stress relaxation behavior, were quantified via the aforementioned mechanical 
models.   In phase three, the surface frictional properties of VSMCs were focused upon, 
and a novel method to quantify surface shear forces on VSMCs using lateral force 
microscopy was developed.  It was determined that VSMC frictional properties are 
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greatly influenced by cell stiffness, and elastohydrodynamic lubrication was proposed as 
a possible cellular lubricating mechanism.   During research phase four, each of the 
techniques developed during the preceding phases was employed to test the effects of a 
clinically relevant biomolecule, oxidized low-density lipoprotein (oxLDL) on VSMC 
mechanical properties.  It was concluded that oxLDL is associated with decreased cell 
stiffness, and decreased viscosity, as measured by stress relaxation and indentation tests.  
Furthermore, frictional coefficients were found to correlate positively with more fluid-
like cells.  This research project has led to a better understanding of VSMC mechanical 
behavior, as well as the development of AFM-based techniques and models that will be 
useful in determining cellular mechanical and frictional effects of various stimuli in an in 
vitro environment. 
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CHAPTER ONE 
 
LITERATURE REVIEW 
 
 
 The current doctoral research project addresses vascular restenosis following stent 
implantation. It is hypothesized that one of the key factors in restenosis is a shift in 
vascular smooth muscle cell mechanical properties, caused in part by the associated  
inflammatory response.  Overall this research is intended to help understand this 
relationship both from a basic science perspective, and with a long-term goal of finding 
novel preventative treatments for vascular disease.   
Vascular diseases, including atherosclerosis and restenosis, are among the world’s 
most widespread, costly, and lethal medical conditions [1].  This remains true, despite 
recent advances in treatment, including the advent of drug eluting stents, as well as 
pharmaceutical treatments such as statins.  At their core, atherosclerosis and restenosis 
are both inflammatory diseases with significant biomechanical components [2, 3]. A 
highly complex inflammatory process coupled with cellular mechanical environment 
both play crucial roles in the development and duration of vascular disease.  Recent 
evidence has begun to demonstrate that cellular mechanical behavior, inflammation, and 
disease progression are inextricably linked [2, 3] .  With the rapid development of the 
fields of bioengineering, biochemistry, and molecular biology, it is now possible to study 
these phenomena at the single cell or even single molecule level.  It is this link between 
vascular disease as an inflammatory disease and a biomechanical disorder that serves as 
the primary motivation for this research.  The literature review that follows is a summary 
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of current knowledge regarding vascular diseases as inflammatory and mechanical 
disorders, as well as cell mechanics theory and experimentation.  
 
Atherosclerosis: An Inflammatory Disease 
 
Atherosclerosis is the leading cause of mortality in the Western world, accounting 
for approximately 55% of all deaths [4]. This mortality rate remains staggeringly high, 
despite recent advances in treatments such as the introduction of drug eluting stents, as 
well as an increased understanding of preventative measures relating to diet and exercise.  
Atherosclerosis refers to a vascular disease characterized by accumulation of lipids and 
fibrous components in medium and large sized arteries, although the word itself means 
hardening of the arteries.  It is a complex, multi-stage disease process that is associated 
with a number of risk factors, including elevated blood pressure (hypertension), obesity, 
diabetes mellitus, smoking, elevated low-density lipoprotein (LDL) cholesterol levels, 
family history and advanced age [2].  Many of the aforementioned factors have a strong 
genetic component, while others are environmental in origin [1].  In general, 
atherosclerosis can be thought of as a multi-stage inflammatory disease.  Among the most 
significant phenomena observed during the pathogenesis of atherosclerosis, are 
endothelial dysfunction, a significant and prolonged inflammatory response, alterations in 
the extracellular matrix (ECM) of the affected region, and vascular cell proliferation [5, 
6]. Interestingly, many dangerous lesions are often non-occlusive and therefore difficult 
to diagnose by angiography.  However, active inflammation is evident in these non-
occlusive lesions.  Plaque inflammation can be detected through various screening 
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methods, as it is generally associated with increased plasma concentrations of fibrinogen 
and C-reactive protein (CRP) [6].   Local inflammation is also associated with increased 
temperature and lower pH levels, which can thus be used to measure inflammatory 
response in the plaque [6].  The information contained here regarding the progression of 
atherosclerosis is by no means complete.  Given the complexity of the disease, such an 
undertaking would require a far lengthier discussion.  For the purposes of this literature 
review, the information is meant to give a basic background and to support the idea that 
atherosclerosis is both an inflammatory disease and a biomechanical disorder, caused by 
an immune response gone awry.  In addition, some, but not all, of the major biochemical 
players in atherosclerosis are discussed.  Much remains to be learned regarding the 
disease’s pathology, which is why there is a vast amount of ongoing research dedicated to 
further elucidating these disease mechanisms.  The current research was motivated both 
by the idea of gaining a greater understanding of atherosclerosis from a basic science 
perspective, and by the search for more effective and targeted treatments.        
    
Endothelial Dysfunction 
 
The disease process is believed to begin with endothelial dysfunction, which can 
be the result of numerous stimuli, including smoking, hypertension, diabetes, genetic 
alterations, elevated homocysteine concentrations, and infectious microorganisms [6].  
The vascular endothelium secretes a wide variety of active molecules (vasoactive 
substances, matrix products, procoaguluant factors, antithrombotic factors, growth 
factors, inflammatory mediators), and performs a myriad of functions including: acting as 
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a barrier to free passage of molecules and cells, mediating endothelium-dependent 
vasodilation, inhibiting leukocyte adhesion, migration, platelet adhesion, and 
aggregation, inhibiting VSMC migration and proliferation; inhibiting coagulation, 
promoting fibrinolysis, and participating in immune and inflammatory reactions [6].   An 
early marker of endothelial dysfunction is the reduction of nitric oxide (NO) activity, a 
regulator of vessel tone [6].  In animal models, an atherogenic diet causes endothelial 
cells (ECs) to express surface adhesion molecules (intracellular adhesion molecules 
(ICAMs) and vascular adhesion molecules (VCAMs)) that act as receptors for 
glycoconjugates and integrins present on monocytes and T-cells [6].  
 
Onset of the Inflammatory Response 
 
Following the changes that occur to the endothelial layer, monocytes are recruited 
to the affected area, and subsequently they migrate through the irregularly functioning 
endothelial layer with the help of chemoattractants (MCP-1 is responsible for migration 
of monocytes) [6, 7].  Monocytes may initially play a protective role, however, their 
continued accumulation is ultimately one of the key factors in the development of an 
atherosclerotic lesion [1].  The monocytes differentiate into macrophages under the 
influence of macrophage-colony stimulating factor (M-CSF) [6], take up accumulated 
lipids (forming foam cells, Figure 1.1), and eventually form fatty streaks, which can be 
found in the human aorta in the first decade of life [1].   
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Figure 1.1.  Diagram of the various components of an atherosclerotic lesion, including the 
necrotic core, foam cells, and fibrous regions. Figure from Jerome (2006)[8]   
 
 
Foam cells eventually die, contributing their contents to what is known as the 
necrotic core (Figure 1.1).  If the initial inflammatory response resulting from endothelial 
dysfunction fails, the inflammatory process continues, which leads to VSMC migration 
and proliferation [6].    VSMCs migrate to the intima from the media, secreting ECM 
components such as collagen and various proteoglycans.  Lesions initially grow towards 
the adventitia, until a critical point is reached, when they begin to expand towards the 
lumen [1].  As the disease progresses, continued recruitment of inflammatory cells and 
lipids, and proliferation of SMCs, leads to the development of a mature atherosclerotic 
plaque.  A fibrous cap separates this underlying conglomeration of lipids, SMCs, and 
ECM constituents from the luminal blood flow (Figure 1.2).   
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Figure 1.2.  Schematic representation of a healthy artery wall (a) and an atherosclerotic 
lesion (b) with plaque and fibrous cap formation.  Figure from Steffens and Mach 
(2004)[7]. 
 
 
The fibrous cap is most likely formed by migration of SMCs from the media, and 
their collagen production [6].   Thinning of this fibrous cap may lead to rupture of the 
plaque, and an acute ischemic event such as a cardiac infarction or stroke, depending on 
the origin of the lesion.  Plaque rupture, which typically occurs in regions of high 
tangential stress and collagen depletion, sustained inflammation, macrophage 
accumulation, and apoptosis, (often at the shoulders of the lesion) is responsible for 80% 
of fatal myocardial infarctions (MI) in men [6].  Half of all infarctions occur in arteries 
that have < 50% stenosis, and the presence of inflammation seems to be a key 
characteristic.  It has been found that the occurrence of acute coronary events is more 
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heavily dependent on the composition of the plaque, rather than the degree of stenosis 
caused by the lesion [1].   Additionally, the stability of atherosclerotic lesions may 
depend upon the degree of calcification [1]. 
Numerous signaling molecules and immune cells interact with one another during 
lesion formation.  All of these components contribute to the formation of a vicious cycle, 
characterized by increased lesion thickening and growth (Figure 1.3) [6].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3.  Major events occurring during development of an atherosclerotic lesion, 
beginning with endothelial dysfunction, and leading to a vicious cycle of ECM 
production, VSMC migration/proliferation, and intimal thickening. Figure from 
Kaperonis, et al. (2006)[6]. 
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Among the biomolecules that play roles in atherosclerotic lesion development and 
inflammtion are lipoproteins, cytokines, and adhesion molecules.  A brief overview of the 
interaction among some of these key players is given here.   
 
Lipoproteins 
 
One of the main culprits in the development of atherosclerosis is LDL cholesterol 
[9], which is present in blood plasma.  Low-density lipoprotein is responsible for 
transport of lipids to peripheral tissues such as arteries, while high-density lipoprotein 
(HDL) is responsible for the removal of lipids from these tissues.  Hence, HDL has an 
anti-atherogenic effect, while high LDL levels can be detrimental to one’s health.  Native 
LDL, is not taken up by macrophages rapidly enough to form foam cells, however 
oxidized LDL does contribute to foam cell formation [1].   Oxidation of the LDL takes 
place from a reactive oxygen species (oxidative waste) produced by endothelial cells, 
macrophages, and SMCs.  Nitric oxide (NO) is an oxidizing agent produced by 
endothelial cells and macrophages, and evidence suggests that it can have either 
atherogenic or atheroprotective effects, depending on its source [7]. Oxidized LDL can 
inhibit the production of NO, possibly leading to increased lesion development due to the 
potential anti-atherogenic properties of NO [10].   Oxidized LDL can also penetrate the 
endothelium, upregulate adhesions molecules on endothelial cells, as well as induce the 
expression of monocyte chemoattractant protein (MCP)-1, and a number of growth 
factors [11, 12].   Areas of the endothelium subject to disturbed flow patterns such as 
bifurcated or curved regions, are susceptible to increased LDL permeability and 
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atherosclerotic lesion development [13].  The atheroprotective effects of HDL may be in 
part due to to its anti-inflammatory and anti-oxidant properties, as HDL particles can 
carry anti-oxidant enzymes [6].   
 
Adhesion Molecules 
 
As mentioned above, various adhesion molecules mediate the adherence and 
migration of leukocytes across the endothelial layer (Figure 1.4) [7].   A group of 
adhesion molecules known as selectins (including E-selectin and P-selectin) mediate the 
rolling of inflammatory leukocytes across the endothelial layer during the early stages of 
atherogenesis [14].   Intracellular adhesion molecules (ICAM-1) and vascular adhesion 
molecule (VCAM-1), along with integrins, play similar roles in the attachment, arrest,  
and subsequent migration of leukocytes [15, 16].  Macrophages and endothelial cells 
produce ICAM-1 in response to a number of inflammatory cytokines, including IL-6, IL-
1, Tumor Necrosis Factor (TNF)-α, and interferon (IFN).  On the other hand, VCAM-1 is 
only expressed by endothelial cells [14], and its expression precedes macrophage and T-
lymphocyte recruitment [17].  
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Figure 1.4.  The role of various adhesion molecules in endothelial-leukocyte interactions.  
Figure from Blankenberg, et al. (2003)[15]. 
 
 
Gap Junctions 
 
Important ion and metabolite exchange channels known as gap junctions have 
also been found to contribute to leukocyte migration and the development of 
atherosclerosis [18].  Gap junctions are formed by the connexin (Cx) family of proteins, 
with changes in Cx37, 40, and 43 expression all having been implicated in the 
development of atherosclerosis [18].   
Cytokines 
 
The elevation and modification of lipoproteins associated with atherosclerotic 
lesion development leads to the release of cytokines and attraction of cells expressing 
receptors for these cytokines [19].  Cytokines can in turn promote lesion development or 
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block it, depending upon which ones are involved.  Opposing effects can be exerted by 
pro- and anti-inflammatory cytokines during the course of lesion development [20].  
Some of the proinflammatory cytokines, such as TNF-α, are inducers of other cytokines 
and chemokines, which results in an autoamplification system that makes it difficult to 
distinguish the effects of each particular cytokine in the atherosclerotic process [19].  
Proinflammatory cytokines can be produced by, and act on, numerous cell and tissue 
types (Figure 1.5) [20].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5.  Action of the proinflammatory cytokines IL-1b, IL-6 and TNF-α on various 
cells and tissues. Figure from Tousoulis, et al. (2006)[20]. 
 
 
It has been shown that certain cytokines can alter SMC phenotype and modulate 
the nature of matrix synthesis and secretion [21]. The proinflammatory cytokines MCP-1, 
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SDF1alpha, and CCL11 have been implicated in the promotion of SMC migration and 
proliferation following acute injury from a balloon or wire [22].  Other injury models 
have found that IL-1 and TNF-α both appear to promote SMC accumulation after injury 
[23].  Some murine models have suggested that neither IL-1β nor TNF- α, two cytokines 
associated with atherosclerotic lesions, appear to strongly affect the accumulation of 
SMCs within those lesions.  It is however, believed that TNF-α plays a significant role in 
the induction of SMC adhesion molecule expression [19].  Thus, discrepancies are often 
noted among different atherosclerotic models [19].  The cytokine MIF (macrophage 
migration inhibitory factor) induces disease progression as a potent stimulant of SMC 
accumulation and matrix deposition following vascular injury and in atherosclerosis [24].  
Adipose tissue can synthesize cytokines, including TNF-α and IL-6, meaning that obesity 
can promote inflammation and advance atherogenesis, independently of its effect on 
insulin resistance and lipoprotein metabolism.  Both TNF-α and IL-6 have been found to 
be associated with 1-year mortality in patients with critical limb ischemia [25].  In terms 
of negative regulation of VSMC proliferation, both IL-10 and IL-18 appear to play that 
role in vivo, with the majority of other involved cytokines leading to enhanced 
proliferation [26, 27].  Similarly, it should be noted that IL-10 and TGF- β are potent 
inhibitors of the pleiotropic (controlling several distinct and unrelated phenotypes) NF-κβ 
signaling pathway, which has been linked to atherosclerosis [19].  Transforming growth 
factor (TGF)-β is a cytokine that plays a significant role in the inflammatory component 
of atherosclerosis.  Studies conducted under various experimental conditions have found 
conflicting results, but the most recent data indicate that TGF- β plays a protective role.  
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Other cytokines, such as M-CSF, which stimulates the proliferation and differentiation of 
macrophages, have been shown to play an atherogenic role and contribute to lesion 
formation [28].  Taken together, this suggests that certain anti-inflammatory cytokines 
may limit SMC modulation during the atherosclerotic and restenotic disease processes.  
Given the vast number of cytokines involved in vascular disease, along with their 
complex interactions and conflicting data regarding their roles, it is clear the further 
research in this area is needed.   
   
VSMC Physiology and Phenotypic Modulation 
 
One significant result of the physiologic action of lipoproteins, adhesion 
molecules, and immune cells, is an alteration in smooth muscle cell function and 
phenotype.  In fact, the phenotypic state of VSMCs can be affected by numerous different 
stimuli, including humoral factors, cell-cell interactions, and mechanical forces (Figure 
1.6).   
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Figure 1.6.  Phenotypic state of SMCs can vary greatly from fully differentiated (right) to 
synthetic (left) based on influence of numerous stimuli.  Figure from Owens, et al. 
(2004)[4]. 
 
 
Smooth muscle cells are unique among the three major types of muscle cells (skeletal, 
cardiac, smooth) in their retention of phenotypic plasticity, where as both skeletal and 
cardiac muscle cells are terminally differentiated [4, 29].   It is likely that the plasticity of 
VSMCs evolved as a means of repairing damaged blood vessels and remodeling for 
blood pressure regulation [4].   However, with the increasing life-expectancy of humans, 
this reparative mechanism can often give rise to the development of atherosclerotic 
lesions. In the adult blood vessel, SMCs exhibit extremely low proliferation and 
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migration rates, and express a unique set of contractile proteins, including smooth muscle 
α-actin, smooth muscle γ-actin, sm-MHC (myosin heavy chain), calponin, h-caldesmon, 
SM22, smoothelin, and metavinculin [4, 29].   The principal function of SMCs in their 
healthy contractile state is the regulation of blood vessel tone, blood pressure, and blood 
distribution [4].   In certain cases, such as during vascular development, and in disease 
states such as atherosclerosis and restenosis, a shift from a contractile to a synthetic 
phenotypic takes place.  This shift from the normal contractile state to a synthetic state is 
known as modulation, and is associated with a decrease in contractile protein content, as 
well as increased rates of proliferation, migration, and matrix production [29].  In 
addition to atherosclerosis, changes in SMC phenotype and function have been observed 
in numerous other diseases, including asthma [30] and cancer [31],  as all types of SMCs 
can undergo modulation. According to Owens, et al. [4], the key points regarding 
phenotypic modulation of SMCs are that; changes in phenotype of SMC vary as a 
function of disease stage and location within lesion; it is difficult to identify whether 
lesion cells were or were not derived from preexisting SMC; environmental cues that 
exist within atherosclerotic lesions are different from those of a healthy vessel; and 
phenotypically modified SMCs contribute to alterations in ECM.  These key points will 
now be discussed further.  
Intimal SMCs found in atherosclerotic lesions are often characterized by 
increased DNA synthesis, decreased protein expression, alterations in contractility, and 
loss of myofilaments [4].  There are several protein markers expressed by SMCs that are 
indicative of their relative state of differentiation, including SM-α-actin, SM-MHC, h1-
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calponin, SM22 α, ACLP, desmin, metavinculin, h-caldesmon, metavinculin, telokin, and 
smoothelin, but it must be noted that no single marker is exclusively unique to SMCs.  It 
is also important to recognize that SMC phenotype is a continuum, with no set contractile 
or synthetic cells [32].  Additionally, it has been found that even within a single blood 
vessel, there is a great deal of heterogeneity among resident SMCs, as evidenced by 
differing levels of protein expression [33].  The most commonly utilized marker of SMC 
differentiation is SM-α-actin, due to its abundance, crucial role in SMC contraction, and 
the availability of its antibodies.  Identification of SMC lineage on the other hand 
however, requires a more SMC specific marker, for which SM-MHC is suitable, due to 
the fact that it is not expressed in any other cell types, as is SM-α-actin [4].   A positive 
marker of modulated synthetic phenotype SMCs is SMemb (SM MHC embryonic), 
which is relatively specific for synthetic and embryonic SMCs [4].  Despite the vast 
amount of research in the area, very little is actually known regarding the regulation of 
SMC differentiation and maturation in vivo.  Among the important factors that play a role 
however, are mechanical forces, contractile agonists, ECM components, neuronal factors, 
reactive oxygen species, endothelial-SMC interactions, and various cytokines [4].  The 
only factor thus far positively identified that directly promotes phenotypic modulation of 
SMCs is platelet derived growth factor-BB (PDGF-BB), a chemoattractant produced by 
activated platelets and macrophages [34] which induces proliferation and downregulation 
of SMC marker genes in vitro [35].  Other factors thought to play a role in phenotypic 
regulation of SMCs include TGF-β, which promotes SMC differentiation in cell culture 
by upregulating SM-selective markers such as SM-alpha actin and SM MHC [36], and 
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MMPs, which contribute to degradation and remodeling of plaque ECM, and in turn can 
cause SMC phenotypic switching [37].  Current understanding of the in vivo effects of 
these factors is poor, as most of our information is based on in vitro studies.  Despite the 
ever-increasing library of knowledge regarding SMC physiology and its relationship to 
atherosclerosis, it is still not yet known if phenotypic modulation is a cause or an effect of 
atherosclerosis.     
 
VSMCs and ECM Components 
 
Some of the most noticeable changes that occur during the progression of vascular 
disease involve the ECM and its components.  Interaction of VSMCs with surrounding 
ECM is mediated by several types of transmembrane receptors.  The principal receptors 
for ECM components on vascular cells include integrins, CD44, and RHAMM [38].   
There is a great deal of evidence to suggest that different ECM constituents have varying 
effects on vascular cell function [32, 38, 39].  A healthy artery will generally by 
composed of an intima (endothelial cells, minimal subendothelial ECM enriched in 
proteoglycans and hyaluronan ); media (SMCs embedded in ECM comprising elastin, 
collagen, proteoglycans); and adventitia  (fibrillar collagen, fibroblasts, vaso vasora) [38]. 
One of the main ECM constituents, collagen, is composed of a triple helix of 3 
polypeptide α chains, each having a gly-x-y repeating sequence [40].  The predominant 
forms of collagen found in arteries are types I and III, providing tensile strength to the 
vessel wall [38].  While collagen provides tensile strength, it is also exhibits elastic 
behavior, which provides the recoil necessary in an environment with cylic pressure 
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pulses [41].  Elastic fibers that are synthesized by VSMCs are arranged in concentric 
lamellae that separate the different layers of the artery.  Following balloon injury of a 
health artery, a neointima forms that is composed mainly of SMCs that migrate from the 
media to the intima.  Injury of an already atherosclerotic vessel however, leads to 
neointimal accumulation of monocytes and lymphocytes, followed by SMC migration 
and proliferation [42, 43].  Lesions that are rich in lipids and macrophages typically 
contain less collagen, while fibrous plaques contain areas rich in collagen I and III [44].  
In situ fibronectin assembly by neointimal SMCs has been observed 12 days after injury 
in rats.  Fibronectin also assembled a fibrillar network associated with the surface of 
synthetic SMCs during early atherosclerotic and restenotic lesion development [45, 46].  
Using 2D monolayers in vitro, fibronectin and collagen I have been found to induce shifts 
towards a synthetic state, while laminin and collagen IV induce the opposite [32, 39].  
Proteoglycans and hyaluronan are hydrophilic molecules that represent another 
main ECM constituent.  These proteoglycans consist of a core protein linked to one or 
more polysaccharides that have diverse roles in regulating connective tissue structure and 
permeability.  Hyaluronan is a large molecule consisting of many repeats of a simple 
disaccharide stretched end to end, which binds a large amount of water forming a viscous 
hydrate gel.  This allows the ECM to resist compressive forces.  In addition, 
proteoglycans and HA are known to interact with vascular cells [38]. 
The adhesive glycoproteins fibronectin and laminin form connections between 
other ECM and cells via specific integrin receptors.  Fibronectin is a multifunctional 
adhesive protein present in plasma and synthesized by vascular cells.  It is a large 
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disulphide-linked, glycoprotein dimer that binds collagen, fibrin, and proteoglycans via 
specific domains as well as vascular cells through specific integrins.  Laminin is the most 
abundant glycoprotein in endothelial and SMC basement membranes.  Cells are bound to 
laminin through specific integrins and interacts with other ECM, such as collagen IV and 
heparin sulphate [38].   
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Atherosclerosis: Biomechanical Phenomena 
 
Vascular smooth muscle cells are continuously exposed to cyclic mechanical 
stretch from arterial blood pressure [3].  When the mechanical environment acting on 
VSMCs changes, a number of contractile proteins are downregulated, including SM-
MHC isoforms, α -actin, h-caldesmon, and calponin [3].  Increased stresses resulting 
from hypertension lead to myofilament loss, the development of extensive endoplasmic 
reticulum, and large Golgi complexes, which are all events indicative of the shift towards 
a synthetic phenotype.  In addition, contractile ability is lost, protein secretion is 
increased, and the cells become more responsive to autocrine and paracrine growth 
factors that are produced in response to mechanical stress.  These growth factors can then 
lead to further hypertrophy and/or hyperplasia [42].  Biomechanical stress on arterial 
walls can be increased as much as 30% in cases of severe hypertension, leading to 
significant changes in the arterial tissue structure [47].  Evidence of the important role of 
stress states in the development of atherosclerosis is also provided by the fact that lesions 
occur most frequently in areas of bifurcation or otherwise disturbed stress states [48].  
Given the abundant evidence implicating altered stress states in the development of 
atherosclerosis and restenosis, it has been hypothesized that physical forces can initiate 
signaling pathways which in turn lead to cell death, an inflammatory response, and 
VSMC proliferation.  A proposed mechanism for this sequence of events is the altering of 
receptor conformation that may be cause by mechanical stresses [3].   
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VSMC Mechanosensors 
 
A number of different types of mechanosensors exist on the surface of SMCs.  
Perhaps the most important in terms of mechanical signal transduction are integrins.  
These are a family of transmembrane receptors that mediate cell attachment to the ECM 
at focal contact sites [49].  Integrins are heterodimeric, and consist of non-covalently 
bound transmembrane α and β subunits, of which there are at least 15 α and 8 β that can 
heterodimerise to produce more than 20 different receptors (Figure 1.7).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7.  Involvement of different of α / β integrin pairings in forming adhesions to 
various ECM components, and regulating phenotype.  Figure from Moiseeva (2001)[50]. 
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Importantly, integrins also transmit extracellular mechanical stimuli to intracellular 
signaling events [42],  in turn activating numerous downstream signals potentially 
leading to phenomena such as cell migration and cytoskeletal reorganization [3].  In 
cultured VSMCs, mechanical stress has been shown to increase DNA synthesis when the 
substrate is collagen, fibronectin, or vitronectin, but not laminin or elastin.  This suggests 
some level of specificity in the cell-ECM interactions that lead to biochemical responses 
when external stresses are applied [3].  Integrin signaling is also associated with the 
formation of new focal adhesion complexes consisting of clustered integrins with various 
cytoskeletal proteins, such as talin and paxillin [3].  It has been shown that focal adhesion 
kinase (FAK) binds both to the cytoplasmic regions of integrins and to cytoskeletal 
proteins, providing a direct linkage for signal transduction leading to MAPK activation 
[51].  Integrin mediated autophosphorylation of FAK can lead to subsequent tyrosine 
phosphorylation of various cytoskeletal proteins and cytoskeletal remodeling, as a result 
of mechanical stimuli [3].   
Mechanical stresses have been shown to alter the structure and organization of 
intracellular actin (Figure 1.8) [52]. Vascular SMCs contain a reservoir of unpolymerized 
globular (G) actin, which their skeletal and cardiac counterparts do not possess.  
Intravascular pressure leads to a decrease in G-actin concentration, and in increase in 
filamentous (F) actin [53].  Depolymerization of F-actin with substances such as 
cytochalasin D leads to an increase in G-actin content, and cell relaxation, while 
polymerization of F-actin causes cell contraction and decreased G-actin content [52].  
Such formation of F-actin could very well be involved in mechanical signal transduction 
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and increased force production.  The exact mechanism by which mechanical forces 
induce actin polymerization is not known, but it most likely involves integrin-mediated 
signal transduction.     
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8.  Increased intravascular pressure leads to activation of numerous cross-talking 
signaling pathways, along with an increased F/G-actin ration, formation of stress fibers, 
and greater force production.  Figure from Cipolla, et al. (2002)[52]. 
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Platelet derived growth factors (PDGF) are homo- or heterodimers of A and B 
polypeptide chains that can combine to form form three different dimers, PDGF-AA, BB, 
and AB.  Thus far, two distinct PDGF receptors have been described, PDGF receptor-α, 
which binds all PDGF forms, and PDGF receptor-β, which binds PDGF-BB and AB [54].  
It has been shown that PDGF receptor-MAPK signaling pathways can be directly 
activated by mechanical forces [55], suggesting a role in modulation of VSMCs.  
Vascular endothelial growth factor (VEGF) is also upregulated by VSMCs in response to 
mechanical stress.  It is possible that normal physiological levels of stress are necessary 
to produce sufficient levels of VEGF, and therefore maintain a healthy endothelium [4].   
Another significant phenomenon observed with regard to VSMC response to 
mechanical force is the opening of mechanically gaited ion channels, which leads to a 
transient influx of calcium and sodium.  This cause depolarization of the membrane and a 
subsequent myogenic response [56].  It is likely that this calcium influx, along with 
increased levels of angiotensin leads to increased MAPK activation in cases of 
hypertension.  Mechanical stress has also been shown to increase protein kinase C (PKC) 
activity in VSMCs, leading to formation of PKC particulates and subsequent VSMC 
proliferation in the case of cyclic strain [57].  It is likely that PKC is involved in a 
number of signaling pathways, due to the many signaling molecules that it can activate.  
Mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated 
kinases (ERKs), p38, and c-Jun N-terminal kinases (JNKs), are also activated in response 
to mechanical stress.  This is significant because MAPKs regulate such important cellular 
processes is DNA synthesis, proliferation, mitosis, and apoptosis [4].  Some kinases, such 
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as MAPK phosphatase-1 and PKA (cyclic AMP-dependent protein kinase), may actually 
serve as negative feedback regulators by blocking mechanical signal transduction [58, 
59].   
Smooth muscle cell apoptosis often occurs in atherosclerotic lesions, and is in part 
affected by mechanical stresses.  In restenosis, VSMC apoptosis is an acute event that 
occurs in response to vascular injury induced by balloon-catheter or angioplasty.  This 
medial VSMC cell death has been demonstrated in vivo using animal models [60]. 
Apoptosis after cell injury is governed by activation of MAPK signaling pathway and 
expression level of antiapoptotic genes.  Among the factors relating SMC apoptosis in 
response to mechanical stress are endothelin receptor expression, p38, p53, and DNA 
oxidation [61-63].  Mechanical stresses play a significant role in the mediation of the 
VSMC inflammatory response during atherosclerosis.  Increased mechanical stresses lead 
to increased production of leukocyte adhesion molecules and promote VSMCs to produce 
proteglycans.  These proteoglycans bind and retain LDL particles, leading to their 
oxidative modification which promotes inflammatory responses within atherosclerotic 
lesions [64].  Production of ICAM-1 by VSMCs has also been shown to be induced by 
mechanical stresses in animal models [65].      
 
Atherosclerosis Summary 
 
It can be seen that atherosclerosis and the abnormal physiologic behavior of 
VSMCs associated with it, are affected by numerous stimuli working in conjunction with 
one another. This complexity makes understanding and treating vascular disease all the 
more formidable of a task.  However, at its core, it is now beginning to be understood that 
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atherosclerosis is essentially a chronic inflammatory disease, which is greatly affected by 
the mechanical state of the cells and tissues involved.  Therefore a better understanding 
of the link between atherosclerosis as an inflammatory disease and a biomechanical 
disorder, may yield important information to aid in the development of novel treatments.     
 
 
Treatment of Atherosclerosis  
Stents and Restenosis 
 
In recent years, stenting has become the preferred method for percutaneous 
treatment of coronary artery disease, due to its advantages of preventing elastic recoil of 
the artery, preventing acute vessel closure, and improving long-term patency [66].  In the 
year 2000, over one million percutaneous coronary procedures were performed in the US, 
almost half of which included placement of intracoronary stents [66].  One of the most 
frequent difficulties encountered following stent implantation is that of restenosis, which 
is a re-occlusion of the treated vessel region.  Restenosis is generally caused by vascular 
elastic recoil and negative remodeling of the vessel wall (Figure 1.9) [67].  Stents reduce 
the level of recoil, but also stimulate the formation of neointimal tissue, especially in 
smaller caliber arteries [67].  
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Figure 1.9.  Restenosis after angioplasty (a-b) and after stenting (c-d).  Figure from 
Kivela, et al. (2006)[68]. 
 
 
Stent deployment is a traumatic event that can alter local vessel conditions in a 
number of ways.  Stainless steel stents are placed via balloon-driven expansion, often 
requiring a second dilation, leading to overexpansion of the vessel [69].  This initial 
injury caused by balloon inflation and the stent itself, leads to the migration of 
macrophages and polymorphonuclear neutrophils to the damaged region [70-72].  These 
immune cells then release chemokines, increasing the amount matrix metalloproteinase 
(MMP), and subsequently leading to remodeling of the ECM and SMC migration.[73, 
74].   Mitogenic SMC genes are stimulated as well [75].  Furthermore, stenting has been 
shown to raise systemic levels of inflammatory markers such as IL-6 and C-reactive 
protein (Figure 1.10) [76].   
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Figure 1.10.  Interaction of local (cytokine release) and systemic (CRP production) 
inflammatory responses in the onset of restenosis.  Figure from Gaspardone, et al. 
(2005)[77]. 
 
 
Improper stent deployment can alter the normally athero-protective local blood 
flow conditions, leading to a greater risk of restenosis [78].  The presence of the stent 
itself can lead to an overexpansion of the artery, as well as decreased compliance and 
extendibility, all of which increase stresses on the vessel wall [67, 79].  These stresses, in 
turn, lead to proliferation of SMCs and the formation of neointimal tissue [80].  
Formation of the neointima following stent placement is associated with the action of 
numerous leukocytes, as well as platelets and growth factors (Figure 1.11) [68].  Taking 
all of these factors into account, it is the expansion of the stent which is one of the most 
important factors contributing to restenosis, as the stent not only causes tissue damage, 
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but is itself a foreign body which will itself illicit an immune response and impair healing 
[67].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11.   Role of cytokines, leukocytes, platelets, and growth factors in the 
development of restenosis.  Figure from Kivela, et al. (2006)[68] . 
 
 
Histological analyses have revealed that the degree of penetration of stent struts is 
directly related to the thickness of neointimal tissue [81].   When strut penetration is less 
severe, there is only a moderate layer of new SMC-rich tissue.  In the first days following 
stent implantation, stent struts are typically surrounded by fibrin and neutrophils.  Within 
two to three weeks however, these are replaced by the presence of macrophages and 
SMCs [81].   After 3-18 months post-implantation, there is typically a restenotic tissue 
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extremely rich with proteoglycans (including versican and hyaluronan) that is infiltrated 
with α-actin positive SMCs.  Towards the end of the first 18 months post-implantation, 
type I collagen begins to prevail.  After 18 months, SMC density and stent stenosis are 
reduced [82, 83].  These observed patterns of ECM constituents and phenomena are 
typical of a tissue that is incompletely healed. 
The intial clotting response following stent implantation may play a significant 
role in restenosis, as platelet derived growth factor (PDGF) is one of the most potent 
stimulators of SMCs and macrophages [84].  However, at later stages following stent 
placement, there is little or no sign of markers suggesting an active inflammatory 
response or of replication SMCs [85, 86].  Star-shaped SMCs dispersed in a loose 
proteoglycan-based ECM is the most frequent finding in studies of later stage tissue, with 
the cellularity of the neointima decreasing with time after stenting.  Furthermore, SMCs 
in late stage neointimal tissue are typically not in a synthetic state.  This has led some 
authors to suggest that it is primarily the ECM which the main culprit in restenosis, rather 
than the cells themselves [85, 86].  The pattern that is emerging suggests that neointimal 
tissue changes from inflammatory, to proliferative, to secreting as time passes [67].  From 
this progression, one can divide the process of restenosis into two main phases.  The first 
is the wound healing process, including clotting, followed by inflammation, and 
infiltration by myofibroblasts derived from SMCs, macrophages, and other progenitor 
cells.  The second phase is that of neointimal hyperplasia, where myofibroblasts reduce 
their proliferation rate and enter a synthetic phenotype which secretes abundant ECM 
[67].   Mechanical and chemical stimuli working in conjunction are likely responsible for 
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the phenotypic changes in VSMCs during restenosis.  Numerous studies have been 
conducted examining the effects of mechanical stresses on SMCs [67],  with no clear 
consensus.  It is speculated that in cases with greater intimal penetration of struts, a 
higher mechanical forces may be applied to the VSMCSs, resulting in the phenotypic 
shift to a proliferative state [67].  The shift to a synthetic phenotype may explain an early 
triggering of SMCs to participate in neointimal formation, but it does not explain the lack 
of proliferative cells in later stages [67].   
A number of strategies have been employed to reduced restenosis rates and 
improve the overall performance of stents.  Initial attempts to reduce restenosis rates 
involved the use of various systemic anti-platelet and anti-thrombus drugs.  On the whole 
however, these efforts have not been very successful [87].   Some researchers have taken 
the approach of decreasing the stresses applied to the vessel wall with different stent 
designs, including using self-expandable stents [88], low-pressure deployment [89], and 
varying strut thickness [90].  There are data indicating that increased strut thickness cause 
excessive damage and thereby lead to higher restenosis rates [91].   A number of factors 
relating to the stent material itself play a significant role in host tissue response.  Stainless 
steel, for instance, has excellent mechanical performance but possesses significant 
disadvantages relating to its biocompatibility[92, 93].  The corrosion resistance of 
stainless steel has been improved by adding more chromium to the alloy, but there is still 
the problem that nickel is one of the ions that can potentially be released [94].  Nitinol is 
currently the main alternative stent material to stainless steel.  Its largest advantage is that 
deployment does not require balloon, due to its shape memory properties.  Unfortunately, 
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analyses have demonstrated that nitinol has not brought any significant advantage in 
reducing restenosis rates thus far [67].  Improvements in nitinol biocompatibility can be 
achieved by inducing a titanium oxide surface, which can increase clotting time, reduce 
fibrinogen absorption and platelet activation, and allow for SMCs to retain their 
contractile phenotype, therefore reducing SMC proliferation when compared to stainless 
steel [95, 96].  
Various coatings have been applied to stents in order to improve performance as 
well.  Initially, researchers applied carbon or gold to alter material surface properties.  
Carbon coating does appear to have some beneficial attributes, most likely due to reduced 
thromobgenicity, although the studies were not randomized or controlled [97].   Gold 
coatings on the other hand have yielded discouraging results on the whole, actually 
resulting in increased neointimal tissue proliferation compared to bare metal stents [98].  
Silicone-carbide [99],  phosphorylcholine [100],  and heparin coatings [101],  have also 
exhibited little or no beneficial effects with regard to restenosis.  The most success thus 
far has come from anti-proliferative agents, which are usually contained within polymeric 
stent coatings.  Two of these, rapamycin and paclitaxel, have reduced restenosis rates to 
single digits since their introduction [102, 103].  Rapamycin (trade name Sirolimus) is an 
antibiotic discovered in a microbe on Easter island.  It acts as an anti-proliferative agent 
on SMCs by inhibiting growth factor and cytokine-induced cell division and migration 
[104, 105].  Paclitaxel (trade name TAXUS) is a derivative of Taxol with anti-mitotic 
properties.  It works by inhibiting microtubule depolymerization, therefore arresting the 
cell cycle, and halting cell proliferation [66].   Despite the success of these anti-
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proliferative agents, there are still a number of concerns relating to the long term success 
of drug-eluting stents.  For example, some evidence suggests that localized drug delivery 
may lead to hypersensitivity reactions and SMC drug resistance [106, 107].  Other 
complications from drug-eluting stents include inflammation at the stent extremities, 
delayed endothelialization, and a relatively high cost to the healthcare system [106-108]. 
Furthermore, several meta-analyses have thus far failed to yield any strong evidence that 
drug-eluting stents significantly reduce the risk of mortality or myocardial infarction (MI) 
[108].   In fact, there have actually been non-statistically significant increases in these 
two endpoints (mortality and MI) with drug eluting stents [109].  Currently, more than 
85% of all coronary interventions in the U.S. are performed with drug eluting stents, 
many of which are cases for which they are not approved [109].  The major clinical trials 
which are often touted as evidence for the superiority of drug eluting stents have several 
methodological flaws, including the use of inferior thick-strutted stents as controls, 
biased protocol-mandated angiography, questionable clinical relevance of angiographic 
outcomes such as binary restenosis, and a lack of data from high risk patients [109]. 
These trials may have also relied too heavily on “soft outcomes” such as restenosis and 
revascularization, as opposed to “hard outcomes” such as MI or death.  In addition there 
is recent evidence suggesting the drug eluting stents may result in higher levels of 
thrombosis, especially in cases where anti-platelet therapy is discontinued prematurely 
[109].   Lastly, relative costs associated with drug eluting stents may have been 
underestimated [109].  Some general goals with regard to stent implantation and design 
that should be considered are reducing excessive dilation of the stent (possible through 
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better self-expandable stents), and gaining a better understanding of the host response 
[67].   Despite all the knowledge that has been gathered, and the technological advances 
that have been made, there is still much to be discovered regarding the underlying causes 
of restenosis in terms of an immune response, and the effects of mechanical stresses on 
underlying tissue.  It is clear that restenosis exhibits histological features distinct from 
those of atherosclerosis, yet increasing evidence shows that both result from 
inflammatory responses.  Essentially, restenosis is an incomplete healing process 
resulting from an inflammatory response, and the presence of the implant is clearly 
associated with its formation, as the stent challenges vessel wall tissue by threatening its 
integrity, subjecting it to elevated mechanical forces, and exposing it to a foreign surface. 
 
Cell Mechanics 
 
The mechanical properties of cells reflect cytoskeletal state and health. Any 
deviation in cellular structural and mechanical properties can result in the breakdown of 
physiological functions [110].  Furthermore, the structural integrity of individual cells 
can affect overall tissue mechanics, due to cell-ECM interactions [110].   Most soft 
materials will exhibit a combination of solid- and fluid-like mechanical characteristics, 
and cells are no exception [111].  The cytoplasmic fluid component of a cell is distinct, as 
it depends on the rate at which force is applied as opposed to the magnitude.  The 
viscoelasticity of cytoplasm is about 10-100 times that of water, reflecting high 
concentration of proteins in the fluid [111].  Overall however, a cell’s behavior is that of 
a solid, as it will not flow without limit as a true liquid does [111].   A cell’s mechanical 
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properties are largely determined by its cytoskeleton, which is an interconnected structure 
composed of three main types of filamentous biopolymers [112].   The first type is actin 
filaments, which carry tensile forces that are actively generated by the cell’s contractile 
apparatus and passively through attachments to its substrate [112].   The diameter of 
these filaments is typically in the range of 5-10 nm, with elastic moduli on the order of 
GPa.  Actin filaments can also be found in bundles known as actin stress fibers, which 
carry both tensile and compressive forces.  Actin filaments are crosslinked by specific 
proteins such as alpha-actinin and filamin [111].   Due to their small size, actin filaments 
undergo thermal fluctuations, which are overcome when force is applied, after which the 
intrinsic elastic modulus dominates mechanical behavior.  The magnitude of this elastic 
response is determined by the concentration of actin and the concentration of crosslinks 
[111].  The second major type of cytoskeletal element is the microtubule.  Microtubules 
are tubule biopolymers (o.d. ~ 24 nm, ~ i.d. 12 nm) that carry compressive forces in order 
to resist contraction of the cytoskeletal network.  It has been proposed that the 
contribution of microtubules to balancing prestress depends inversely on the extent of cell 
spreading [113].  The third type of cytoskeletal filament is the intermediate filament, 
which have a diameter of ~ 10 nm.  Their role in cytoskeletal mechanics is less well 
understood than actin or microtubules, but it is believed that they carry tension at large 
strains of greater than 20% [112].  Microtubules tend to have the highest bending 
stiffness, while actin filaments have greater tensile strength at short extensions, although 
a shorter elongation to break (Figure 1.12) [114]. 
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Figure 1.12.  Tensile properties of the three main cytoskeletal constituents; actin, 
microtubules, and intermediate filaments.  Figure from Humphrey (2002)[114]. 
 
 
An increase in contractile stress from this cytoskeletal network corresponds to an increase 
in cell stiffness.  Adherent cells also exhibit several distinct mechanical features, 
including viscoelasticity, creep, stress relaxation, strain hardening, and hysteresis [112].   
 
Mechanotransduction 
 
In recent years, it has become recognized that mechanical factors are equally 
important as chemical events in terms of physiological regulation and response [115]. 
Mechanical forces can influence both chemical equilibria and molecular polymerization 
events [116].  Cellular mechanotransduction is the process by which mechanical stimuli  
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are converted into biochemical signals.  This process is mediated by numerous elements, 
including cell-cell-adhesion, cytoskeletal properties, and the cell membrane, among 
others (Figure 1.13).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13.  The various mediators of cellular mechanotransduction.  Figure from Ingber 
(2006)[116]. 
 
 
It is believed that mechanotransduction involves structural hierarchies that span 
several size scales from whole organs and tissues, down to individual molecules within 
cells [116].  Therefore, the mechanical properties and level of prestress that exist at each 
level along this pathway can have significant effects on the eventual response [116].   
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Processes as varied as cell growth, differentiation, polarity, motility, contractility, ECM 
synthesis, and apoptosis are all influenced by physical deformation of cells of all types 
[115, 117, 118].  When a whole tissue is deformed, the forces are transmitted to cells via 
adhesions to the ECM [115].  Furthermore, the mechanical properties of the ECM itself 
also contribute significantly to the cellular mechanotransduction response.  Different cell 
types respond to different force magnitudes.  Chondrocytes and osteocytes, for example, 
show a biological response to forces of ~20 MPa, while endothelial cells respond to small 
force of < 1 Pa [111].  And within single phenotypes, it is likely that different structures 
are responsible for different forms of mechanical sensing.  Cellular response to 
mechanical stimulation requires both an element that is directly altered by the applied 
force, and second element that transmits this information to the desired target.  Currently 
however, knowledge regarding these mechanosensors is scarce.   The most well 
characterized and probably most important class of receptor in terms of force 
transmission are integrins, as they have been shown to provide greater mechanical force 
transmission than other types of receptors [119].  Integrins are clustered at focal adhesion 
sites [120] containing multiple actin-associated proteins such as talin, vinculin, paxillin, 
and zyxin [116], and act to distribute externally applied stresses through the cytoskeleton.  
The mechanical coupling that exists between integrin and cell nucleus is largely mediated 
by intermediate filaments, but also to a lesser extent by actin filaments, and the efficiency 
of this intracellular mechanotransduction is greatly affected by cytoskeletal prestress 
[116].   Applying mechanical stress to integrins results in recruitment of proteins to the 
site in order to strengthen itself [119].   Application of mechanical forces to bound 
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integrins promotes focal adhesion assembly by activating small GTPase Rho and 
stimulating its downstream targets mDia1 and ROCK, which promote actin filament 
polymerization and cytoskeletal contraction respectively [121, 122].  Other 
transmembrane molecules such as cadherins and selectins can transmit mechanical forces 
across the cell membrane, but in a much less significant manner [116].   Another type of 
membrane protein involved in mechanotransduction are G proteins, which are localized 
at focal adhesion sites.  Application of mechanical force causes a conformational change 
to G proteins, initiating a signal cascade, generation of second messengers, and eventual 
cell growth [118].  Receptor tyrosine kinases (RTKs) also play a significant role in 
integrin-mediate mechanical signal transduction, as do mitogen-activated protein kinases 
(MAPKs), which transduce mechanical forces into gene expression and protein synthesis 
through their complex pathways [118].  Because only certain molecular and structural 
channels within a cell transmit mechanotransductive signals, other intracellular molecules 
are left unaffected by mechanical stimulation [116].   In addition to protein-mediated 
signal transduction, the lipid bilayer may also play a role, although this hypothesis is 
more controversial [111].         
The importance of a cell’s intrinsic mechanical properties (prestress) in regulating 
response to stimuli has also been demonstrated in several studies [123].  Hence it is 
important to understand how cellular mechanical properties are altered under different 
conditions.  Biological responses of cells to mechanical loading vary greatly, and are 
largely dependent on the strength and type of loading (i.e. cyclic, static, biaxial, uniaxial, 
etc.), the time of exposure to the mechanical forces, cell type, and the ECM or substrate 
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constituents [118].  When mechanical stresses are applied to a cell, the cytoskeletal 
filaments will distort, thus altering the shape of some the molecules that make up the 
filaments.  Changing the shape of a molecule can alter its biophysical and biochemical 
properties.  As many signaling molecules are located on the cytoskeleton near focal 
adhesion sites, this provides a mechanism for the alteration of signal transduction through 
the application of mechanical force [115].  In addition, all cells contain mechanically 
gaited ion channels that can increase or decrease the level of ion flux through a 
membrane upon the application of mechanical stresses [124].   Abnormal stress states and 
abnormal responses to mechanical forces may both contribute to the development of a 
very large number of diseases. 
 
Vascular Smooth Muscle Cell Mechanics 
 
A handful of studies have been performed examining the tensile properties of 
vascular smooth cells [125-127].   All of these studies have examined non-adherent 
vascular smooth muscle cells which were stretched using a custom-built dual micro-
pipette system.  Consistently, it has been observed that synthetic VSMCs have a lower 
tensile modulus than contractile VSMCs.  For example, Nagayama and co-workers [127] 
found that freshly isolated contractile VSMCs had an average tensile modulus of 11 kPa, 
while cultured synthetic VSMCs had an average modulus of 2.6 kPa.  Another study 
found that the tensile elastic moduli of cultured bovine VSMCs were about 1/5 that of 
freshly isolated rat VSMCs [125].  Miyazaki and co-workers found that both VSMC 
phenotypes showed almost the same load-elongation relations in small elongation ranges, 
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however tensile load was higher in contractile VSMCs at elongations greater than 20 um, 
and there were significant differences at 25 and 30 um elongation [126].  One major 
cytoskeletal difference that has been noted is that actin filaments in cultured cells were 
less abundant and almost uniform in direction, while actin content in fresh SMC was so 
abundant as to look uniformly stained [127].  Actin bundles much thicker in contractile 
cells than synthetic ones.  The tensile modulus of cultured SMCs was also reduced by 
approximately 50% upon disruption with cytochalasin D, and it was observed that the 
cellular tensile properties were affected not only by the amount of actin filaments, but 
also by their organization and distribution [127].  Furthermore, SM-MHC are SM-α-actin 
are typically observed in contractile, but not synthetic VSMCs [4, 126].   Smooth muscle 
α-actin is found in the contractile apparatus of the cell, while β- and γ-actin are found in 
the cytoskeleton [126] .   During phenotypic modulation, smooth muscle α-actin is 
downregulated by, while β- and γ-actin are upregulated, and non-muscle β-actin is found 
heavily in synthetic SMCs [126].  Intact arterial medial sections, which are largely 
composed of smooth muscle cells, have also been examined using atomic force 
microscopy[128].   In that study, Engler and co-workers found a medial apparent elastic 
modulus of 5.7 ± 0.3 kPa.   
 
Cellular Mechanical Models 
 
Measurements of cellular mechanical properties have now advanced to the point 
where forces smaller than a piconewton and displacements smaller than a nanometer can 
be induced and/or measured [129].   Cellular deformation can be studied in any number 
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of ways, including uniaxial and biaxial tension or compression, pure shear, hydrostatic 
pressure, bending, twisting, or a combination of these methods (Figure 1.14).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14.  The various methods of studying cellular deformation: a) AFM b) magnetic 
beads c) micropipette aspiration d) optical trap e) shear flow f) membrane stretching.  
Figure from Bao and Suresh (2003)[129]. 
 
 
One can study cellular mechanical behavior with local probes deforming the cell, whole 
cell loading, or simultaneous stressing of a larger population of cells.  Measurements of 
cellular apparent elastic modulus have yielded values between 102 and 105 Pa, with much 
of the deformability being determined by the cytoskeleton [129].  However, an important 
concept to take into account is that cellular mechanical properties are dynamic in nature.  
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That is, cells alter their cytoskeletal structures actively in response to applied forces, and 
during physiologic processes including cell division, crawling, spreading, rounding, and 
actin-based motility [129].   
Given the advancements made in cellular mechanical measurement technologies, 
it has become necessary to develop appropriate mechanical models. Mechanical models 
for cells can be broadly categorized as either continuum models or micro/nanostructural 
models [110]. Micro/nanostructural models consider the cytoskeleton to be the prevailing 
structural component.  The prevailing micro/nanostructural model for adherent cell 
mechanical behavior is that of a tensed cable network, or more specifically, the tensegrity 
model (Figure 1.15) [115, 130]. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15.  Illustration of the tensegrity model, showing the force balance achieved 
through actin microfilament (MF) and intermediate filament (IF) tension and compressed 
microtubules (MT).   
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The tensegrity model suggests that the cytoskeleton is composed of tensile elements 
(actin and intermediate filaments) that are balanced by compressive elements or struts 
(microtubules and actin bundles).  The ECM also balances some of this tension through 
integrin-ECM connections.  When compression reaches a critical level, the microtubules 
will buckle, allowing cellular deformation.  The actin network carries “prestress”, giving 
the cell shape stability.  The strain hardening phenomenon observed in cells is explained 
by the tensegrity model to be a result of reorientation and change in spacing of 
cytoskeletal components in the direction of applied load.  The tensegrity model is the best 
current model of cellular mechanical behavior in a 3D in vivo environment.  One 
significant drawback however, is that structurally based models such as the tensegrity 
model are static and therefore not sufficient in describing the dynamic properties of a 
cell.  For example, it has been observed that elastic and frictional moduli of cells increase 
with frequency according to a weak power law, and that at a given frequency these 
moduli increase linearly with increasing cytoskeletal prestress.  All of this information 
underscores the complex and dynamic behavior of living cells, and the difficulty in 
characterization of this behavior. 
The continuum approach to cellular mechanical modeling treats cells as being 
comprised of materials with certain continuum material properties.  Appropriate 
constitutive material models and parameters are derived through experimental 
observations [110].   This method gives less detail into specific molecular events that take 
place, but is easier for interpreting mechanical responses at the whole-cell level.  
Continuum models can be further divided into liquid drop models and solid models [110].  
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Liquid drop models can be yet again divided into Newtonian, compound Newtonian, 
shear thinning, and Maxwell sub-categories.  Liquid models such as these are most 
suitable certain mechanical characteristics of non-adherent cells, such as erythrocytes and 
neutrophils.  Solid models generally assume the cell to be homogeneous, modeling it as 
either an incompressible elastic solid or a viscoelastic solid [110].   Assumption of 
homogeneity allows for simplification of analysis and fewer parameters.  The 
experimental basis for such models is that an equilibrium state can be achieved after a 
certain amount of loading [110].  The linear elastic and viscoelastic models differ in 
neglect and use of a time factor, respectively.  With linear elastic solid models, the 
apparent elastic modulus that is found does however depend on loading rate and history.  
Cells must maintain sufficient structural integrity to behave like a solid under mechanical 
stresses, but most also exhibit more fluid-like behavior for processes such as crawling 
and spreading [131].   The linear elastic and viscoelastic models are suitable for transient 
loading conditions, including the understanding of creep and stress relaxation.  However, 
for dynamic loading, power law structural damping models have been developed.  
Cellular power law behavior suggests that under an applied stress, cells deform 
continuously and that this process is timescale invariant (does not depend on loading 
frequency) [131].  Often, this is accomplished through oscillatory indentation with an 
AFM, through which a storage modulus (G’) and a loss modulus (G”) are found.  The 
loss modulus is dependent on a weak power-law with an exponent 0 < α < 1 below ~ 10 
Hz, but viscous components become more significant at higher frequencies.  Dynamic 
rheological properties of adherent cells are related to contractile stress, with larger 
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stresses corresponding with high dynamic moduli.  The power law exponent α decreases 
with increasing prestress (α is an index of deformability, with 0 corresponding to elastic 
solid, and 1 corresponding to flowing liquids).  So, fact that alpha changes with prestress 
suggests that this regulates the transition between solid and fluid-like behavior [131].  
Power-law structural damping has been said to suggest behavior like that of a soft-glassy 
material (such as slurries of foams) close to its glass transition temperature [110].   On 
the macroscale, this results in slow cell deformation over a wide range of timescales 
[131].           
Whole tissues have often been  modeled using Fung’s theory of quasilinear 
viscoelasticity (QLV) [132],  in which it is assumed that the reduced relaxation function 
G(t) is independent of initial strain [133].  Stress is normalized by the peak stress at the 
completion of a step strain.  Strain independence is an essential feature necessary for 
QLV modeling.  While the QLV model has been applied to numerous soft tissues, it has 
to data never been used for describing the viscoelastic behavior of individual cells. 
 
Mechanical Measurements Using Atomic Force Microscopy 
 
As discussed above, there are many physiologic processes and disease states that 
can alter cellular mechanical properties, and such differences have been detected in cells 
including myocytes, chondrocytes, and hepatocytes, among others. Establishing both the 
normal and abnormal properties of the cells affected by disease could aid in the in vitro 
identification of effective treatments [134].  Information including detailed knowledge of 
stress/strain relationships, viscoelasticity, and hysteresis, could all be of benefit [134].   It 
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is theoretically possible that any disease altering the composition, organization, kinetics, 
or crosslinking of the cytoskeleton may be detectable using cell mechanics measuring 
techniques [134].  Cytoskeletal properties, particularly those relating to actin, have been 
found to have the greatest effect on measured cell stiffness [135] .  Cell morphology, 
height, and degree of attachment also play significant roles [135].  Viscous properties 
and/or elastic properties may be altered in diseased cells, so it is important to take both 
into account when performing cellular mechanical measurements [134, 136] .   In 
addition to soft tissue, mechanics of mineralized tissues have also been investigated using 
nano-indentation [137].   At present however, there is a lack of information regarding 
tissue mechanics in disease progression, tissue repair, and remodeling mechanisms 
associated with medical treatments [137].   
There are a number of techniques for measuring cellular mechanics, including 
magnetic twisting cytometry, magnetic tweezers, optical stretching, and atomic force 
microscopy (AFM), among others [134].  Among these, the AFM has emerged as one of 
the most effective and useful tools in the field of mechanobiology [134, 138, 139].  The 
AFM is a member of the scanning probe microscope family, and was originally 
developed to overcome the limitations of the scanning tunneling microscope (STM) in 
imaging non-conducting materials [140].  In terms of cell biology, AFM usage can be 
divided into several categories, including imaging, micromanipulation, material property 
investigation, and binding force investigation [140].  Several advantages that the AFM 
possesses over other mechanical measurement techniques are the ability to combine high-
resolution scanning with nano-indentation, the direct mechanical interaction between 
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probe and sample, high sensitivity, high spatial resolution, the capability of being used 
for real-time measurements in a physiologic aqueous environment, and commercial 
availability [134].  An aqueous environment has also been found to be important due to 
the fact that sample drying increases elastic modulus [137].  The small probe size of an 
AFM allows for testing of smaller samples, such as biopsy specimens or tissue samples 
from small animal models [137].  Other emerging capabilities of the AFM for biological 
research include the ability to monitor dynamic processes, study molecular and adhesion 
forces (such as between RGD and integrins), and elucidate intracellular force 
transduction [140].    
The basic operating principles of the AFM are as follows.  The deflection of a 
silicon-nitride cantilever probe, usually 100 to 300 microns long and approximately 0.5 
micron thick, is measured by reflecting a laser off the probe’s topside onto a photodiode 
(Figure 1.16).   
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Figure 1.16.  Schematic representation  of the basic operating components of the atomic 
force microscope. Adapted from Alessandrini and Facci (2005)[140]. 
 
 
The photodiode can detect movements on the order of 0.1 nm.  A cantilever spring 
constant, k, (N/m, either the nominal value or experimentally determined) is used to 
convert deflection into force.  Cantilever deflection leads to a shift of the reflected laser 
spot, and thus a reduced signal on one segment of the photodiode, and an increased signal 
on the other.  The size and shape of this spot size can also influence sensitivity [141]. 
Typically values for k range from 0.01 N/m to 1.0 N/m.  The cantilever’s mechanical 
properties have a significant effect on the AFM’s performance [141].   Methods of 
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experimentally determining the cantilever spring constant include using cantilever 
geometrical factors, measurement of static deflection applying known force to cantilever, 
measuring dynamic properties with different masses on cantilever, and thermal noise (the 
most common method, cantilever is treated as a simple harmonic oscillator excited by 
thermal noise, 15-20% accuracy) [140].  Cantilevers with higher resonant frequencies, a 
property related to thickness, length, density, and modulus, are less subject to 
disturbances from external vibrations [141].  Contact mode cantilevers are usually V-
shaped, in order to increase lateral stiffness and prevent fracture [141].  On the underside 
of the cantilever is the tip, which is usually pyramid-shaped with a blunted point of radius 
of 50-100 nanometers.  For biological applications, the probe is typically moved relative 
to a stationary sample, which can be heated to the desired temperature and kept in an 
aqueous environment.  Movement in the z-direction is accomplished using a piezoelectric 
actuator and has a range on the order of 6 microns, while maximum x-y movement is 
usually 100 x 100 microns [134].  The piezoelectric crystal itself is subject to both 
hysteresis and creep behavior, which can affect measurement accuracy [141].  Sample 
cells are typically adhered to a hard underlying substrate via an ECM component protein, 
such as collagen or fibronectin, or through the use of a positively charged material such 
as poly-l-lysine [135].  Glass or polymer microspheres can be attached to the underside of 
the cantilever, for the purposes of creating an easier to characterize contact geometry, 
increasing contact area, or attaching any number of biologically relevant molecules [134].  
AFM tips can also be functionalized, for what is commonly referred to as chemical force 
spectroscopy.  The most commonly used method, and the one with the best reliability, is 
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the attachment of thiol groups (-SH) to gold coated AFM tips [141].  Thiols will form a 
close-packed monolayer on the gold, simply by immersing the AFM probe into a thiol 
solution (with ethanol or dichloromethane) [141].   Other functional groups, such as 
carboxyl, hydroxyl, methyl, or amine, can then be added as needed.       
There are two primary modes of AFM imaging, tapping and contact mode.  
Tapping mode involves oscillating the probe near its resonant frequency, and maintaining 
the height baseline, frequency, and amplitude of oscillation as the probe encounter 
different sample features [134, 139].  This mode is best for use with fragile samples that 
would be damaged with direct contact.  Contact mode on the other hand, involves 
scanning the tip over the sample and using a feedback system to maintain constant 
cantilever deflection, and is best suited for obtaining mechanical properties of the sample.  
Both height and deflection images can be yielded using the AFM in imaging mode 
(Figure 1.17).  The height image represents the z-distance between the substrate surface 
and each point on the sample, while the deflection image represents a more detailed 
topographical view of the sample. 
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Figure 1.17. Height (left) and deflection (right) images of a human fibroblast.  Figure 
from Alessandrini and Facci (2005)[140]. 
 
 
The amount of indentation into a sample is calculated using the equation D=(Z-Zo)-h, 
where D is sample indentation, Zo is the contact point between probe and sample, (Z-Zo) 
is the extension of the probe from the contact point, and h is probe deflection [134]. 
Varying the rate of indentation can also be used to measure viscoelastic properties, as the 
level of hysteresis has been shown to vary with different probe speeds [142].  
Measurements such as these can be taken in separately, or in combination with imaging, 
which is known as force mapping.  This allows for determining intracellular variation in 
mechanical properties.  When a sample is probed, both and indentation and a retraction 
curve are curve, with the difference in area between the two representing the level of 
hysteresis [143] . Adherence of the probe to the sample can lead to negative deflections, 
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which is useful for measuring such things as receptor-ligand and cell-cell interactions 
[134, 140].   
Once the force curves have been obtained, the AFM data must be analyzed, which 
is typically done using the Hertz model of contact between two elastic bodies [142-144] . 
The Hertz model is  based on a number of simplifying material assumptions, including 
homogeneity, isotropicity, linear elasticity, axisymmetry, infinitesimal deformation, 
infinite sample thickness and dimensions, and a smooth sample surface.  The equations 
relating force and depth for AFM probe indentation are: F = (2/π)(E/1-υ2) tan (α)D2  and F 
= (4/3)(E/1-υ2)(RD3)1/2 for a cone and sphere respectively [134].  In the preceding 
equations, α is the semi-included angle of the cone tip, R is the sphere radius, and υ is the 
Poisson’s ratio, which is typically taken to be 0.5 for cells due to their high water content.  
Correlation between micro- and macroscale properties using the Hertz model is largely 
dependent on the satisfaction of key assumptions listed earlier.  Several recent studies 
have examined alternative methods of AFM force curve analysis [145, 146].  Among the 
other important procedures in AFM force curve analysis are the accurate identification of 
the contact point (which is particularly difficult with soft samples), calibration of the 
probe spring constant, and representation of tip geometry.  Furthermore, mechanical 
properties of cells are substrate dependent, and have been shown to vary with difference 
ECM constituents [147].  Cells are also known to exert greater forces on stiffer surfaces, 
although the mechanism by which they do so is unknown [111].  All of these variables 
can have significant effects on the final data.     
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Several methods have been developed to directly measure and account for the 
viscoelastic properties of cells using the AFM.  Among them are the “force modulation 
method” whereby sinusoidal loading is applied on the cell surface via AFM indentation 
and the phase and amplitude of the tip response is measured for probing the cell 
viscoelasticity, and the “force mapping method” in which the AFM tip touches and 
dwells over a period of time on the cell surfaces, and then indents slowly into the cell 
body [148].   Others have used closed-loop feedback to apply constant deflection and 
measure stress relaxation [149].   Standard viscoelastic testing methods such as creep and 
stress relaxation have recently become more feasible with advances in AFM technology 
[149].  The most easily observed viscoelastic material behavior is creep (sinking of 
indenter into material under constant load).  When loading is followed by unloading 
without a hold at peak load, displacement increases slightly in the initial portion of the 
unloading phase, because creep rate is initially higher than the imposed unloading rate.  A 
hold period can be used prior to unloading to allow the material to reach equilibrium.  
Appropriate hold time selected based on creep and unloading rates used in experiments 
vary from ~ 3 to 120 seconds [137] . Darling and coworkers recently developed a 
mathematical model for AFM stress relaxation experiments based off of the commonly 
used Hertz models, by employing LaPlace transformations [149]. 
The effect of drugs and naturally occurring soluble biomolecules on cell 
mechanics is another area of study possible using AFM force measurements.  This can 
lead to information such as cell morphology and mechanical compliance, furthering our 
knowledge of how cells move, generate, and respond to force, as well as how drugs affect 
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cell behavior at the functional level [150].   Receptor-ligand binding at the cell surface 
can be visualized and quantified, yielding a binding force FR (Figure 1.18)  [151]. 
 
 
 
 
 
 
 
 
 
 
Figure 1.18.  Illustration of receptor-ligand interaction measured using biomolecues 
bound to an AFM tip via a biofunctional linker.  Figure from Van Vliet and Hinterdorfer 
(2006) [150]. 
 
 
Receptor distribution can be mapped with nanometer spatial resolution superior to that 
afforded by immunocytochemical staining, and can be directly correlated with structural 
and mechanical subcellular features such as cytoskeletal filament association [150, 151]. 
Unbinding or rupture force FR (on order of 50 to 1000 pN for cells on rigid substrates) is 
measured directly through bending of the cantilever and can be related to binding 
affinities that characterize ligand-binding kinetics [151]. This allows comparisons of 
binding affinities among different ligands and possibly indentification of previously 
unknown receptors.  This approach is well suited for ligands that are not compatible with 
conventional methods (fluorophore or radioactive isotope labeling) and receptors with 
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low spatial density and mobility.  Typically, one or more ligand molecules are 
permanently tethered to the AFM tip, usually by covalent linking with a flexible linker 
molecule [151].  Use of a linker allows the ligand to freely move over the volume area 
allowed by the linker’s length.  The dissociation process of the receptor-ligand process is 
followed over time.  Force-time profiles allow the monitoring of conformational changes 
during receptor-ligand dissociation.  It is possible to detect energy barriers that are 
difficult to detect by conventional, near-equilibrium assays and also to probe the free 
energy surface of proteins and molecular complexes [151].   Rates of lateral diffusion and 
internalization of receptors within the cell membrane must be considered with respect to 
experimentally attainable scanning rates and resolutions [150].  Validation of probe 
functionalization is necessary, in order to ensure that molecule is tethered and oriented so 
that it can bind to its receptor.  Accurate characterization of the cantilever spring 
constant, as well as demonstration of binding specificity through competitive binding that 
eliminates measurable FR with the soluble ligand or ion-dependent disruption of receptor 
binding are also necessary [150] .  Quantification of ligand-receptor rupture force has 
been demonstrated for a large number of proteins, with one tethered to probe, and other 
to rigid substrate.  Ligand-receptor interactions were initially required “blindly”, meaning 
many ligand receptor force responses were gathered at individual, randomly selected or 
topographically interesting sites, or by acquisition of single force responses at each of 
many pixels comprising an image.  The drawback of this approach is that it does not 
allow mapping of ligand-receptor interactions with molecular-scale spatial resolution.  
The direct binding approach (termed recognition imaging) provides the potential to image 
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receptor distribution and gather ligand-receptor force distributions of cell surfaces.  
Cantilever deflection during oscillation of a ligand or anti-body functionalized probe can 
be deconvolved into a recognition image (image contrast is a function of probe-surface 
binding), and a topography image. By adhering whole cells to AFM cantilevers, the 
ligand-receptor interactions governing adhesion can be explored at the single-cell level.  
Such experiments are technically complex, and do not quantify receptor distribution or 
binding kinetics between individual ligand-receptor pairs, but this can be useful in the 
study of cell adhesion [150].  
 
Contact Mechanics for Biological Problems 
 
The origins of forces between colloid particles and surfaces can be distinguished 
between surface and bulk properties [148].  Surface forces result from Van der Waals 
forces (forces which arise from the polarization of molecules into dipoles ) and 
electrostatic forces, and can vary significantly with surface topography, bulk viscoelastic 
properties, and conductivity [148].  Bulk properties are determined by such 
characteristics as elastic modulus and Poisson’s ratio [148].  In actuality, contact between 
the two bodies occurs over many small areas, each a single asperity [152].  At smaller 
deformations, adhesive forces may potentially play a significant role in deformation, 
while at large deformations mechanical forces are the main determinants of deformation 
behavior.  A spherical indenter geometry will minimize stress concentrations in soft 
polymers and tissues [137]. The Hertz model described above has been shown to be 
experimentally valid for small deformations by a non-adhesive elastic sphere against 
planes and other particles [148].  Solutions for Hertz contact remain valid until applied 
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load is sufficiently large so as to initiate plastic deformation, at which point yielding will 
initiate in the material with the lower yield strength [152]. For adhesive spherical solid 
particles, the influence of the surface forces, which was not incorporated in the original 
Hertz theory, must be taken into account.  Johnson-Kendall-Roberts (JKR) and 
Derjaguin-Muller-Toporov (DMT) contact theories have been widely used to correct 
behavior of Hertzian contact in presence of surface forces.  JKR assumes that adhesive 
forces are confined to the contact area, while DMT assumes adhesive forces act outside 
the contact area [152].  They modify Hertz theory for two adhering smooth, elastic 
spheres by including thermodynamic work of adhesion, Δγ.  Simulated results indicate 
that JKR theory is generally applicable to systems with large, soft bodies and high 
surface energies, while DMT provides a better description of small, hard solid particles 
with low surface energies [148].  JKR method may be more applicable in cases where 
there is significant adhesion, and an obvious “snap to contact” point is visible between 
the AFM probe and sample [137]. It should be +also noted that both JKR and DMT are 
limited to cases of small contact area (contact radius is generally less than 10% of 
particle’s radius) [148]. 
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CHAPTER TWO 
 
RESEARCH AIMS 
 
Aim 1:  Characterization of  VSMC Mechanical Changes Associated  With Phenotypic 
Shifts 
 
 
The phenotypic state of VSMCs can be affected by numerous different stimuli, 
including humoral factors, cell-cell interactions, and mechanical forces [4].  Smooth 
muscle cells are unique among the three major types of muscle cells (skeletal, cardiac, 
smooth) in their retention of phenotypic plasticity, where as both skeletal and cardiac 
muscle cells are terminally differentiated [4, 29] . Although present as a reparative 
mechanism, this plasticity can often give rise to the development of atherosclerotic 
lesions.   In certain cases, such as during vascular development, and in disease states such 
as atherosclerosis and restenosis, a shift from a contractile to a synthetic phenotypic takes 
place.  This shift from the normal contractile state to a synthetic state, known as 
modulation,  is associated with a decrease in contractile protein content, as well as 
increased rates of proliferation, migration, and matrix production [29].  Changes to 
intrinsic VSMC mechanical properties could alter the cell’s response to mechanical 
stimuli, thereby disrupting vital signaling pathways and contributing to the positive 
feedback phenomenon that is characteristic of atherosclerotic lesion development [153].   
By inducing phenotypic changes in vitro via serum deprivation, we are able to 
create a model system for studying the cellular mechanical consequences of such 
changes.   Employing AFM indentation, along with data analysis using the Hertz model, 
 60 
 
we have the ability to determine what, if any, mechanical differences emerge from 
VSMC phenotypic shifts. 
 
Aim 2:  Measurement and Modeling of VSMC Stress Relaxation  
 
 Until recently, the majority of AFM cell mechanics research has focused on 
simple indentation curves, whereby cantilever deflection (force) is related to indentation 
depth, and an apparent elastic modulus is calculated, often employing Hertzian contact 
equations.  While this technique has been useful for comparative purposes, linear elastic 
models greatly oversimplify the true mechanical behavior of a living cell.  More recently, 
researchers have begun to explore the technique of using the AFM to measure stress 
relaxation behavior [149, 154, 155].  In doing so, the power of the AFM to extract 
cellular viscoelastic properties has been greatly enhanced.  However, In order to 
maximize the potential of this technique, appropriate mechanical models need to be 
employed.  
The theory of quasilinear viscoelasticity (QLV) was originally developed by Fung 
in order to model the viscoelastic behavior of biological tissues[132].  While it has been 
extensively utilized in that capacity, it has yet to be applied to cells.  As such, QLV 
modeling is a candidate for potential improvement over existing AFM relaxation models.  
Additionally, while the role of various cytoskeletal constituents (e.g. actin & 
microtubules) has been investigated in regards to AFM indentation experiments and 
various forms of dynamic mechanical measurements, their role in governing relaxation 
behavior is not as well understood.   Numerous cytoskeletal agents, causing assembly, 
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disassembly, or stabilization of cytoskeletal components, are commercially available for 
studies of this nature.   In the present study, we attempt to determine the roles of both 
actin and microtubules in governing vascular smooth muscle cell relaxation behavior, and 
in the process, identify a suitable model for representing that behavior.  This is 
accomplished by developing novel methods and protocols for AFM relaxation 
experiments.   
 
Aim 3: Measurement and Characterization of VSMC Frictional Properties 
 
 
While significant steps have been made towards understanding the bulk 
mechanical properties of living cells, very little is known about their frictional or surface 
shear properties.   Understanding surface shear properties is of interest from a basic 
science viewpoint. For example, cellular frictional properties are of interest for the study 
of physiological phenomena including red blood cell flow [156] , cartilaginous tissues 
subject to articulation [157], and cell migration [158].   Cells lining the vascular lumen 
are subject to shear forces from blood flow, and it is believed that these forces play a 
significant role in the regulation of vascular health [159].  In regards to the study of 
endovascular surgical procedures, increased knowledge of these properties could also be 
of great clinical value.  Deployment of endovascular devices results in significant shear 
forces on underlying vascular cells [160].   Complex lesions are of particular interest, as 
reduction of friction has been shown to ease delivery of endovascular devices in such 
cases [161].  Stent struts remain in constant contact with underlying vascular smooth 
muscle cells following stent deployment.  Any stent migration or micro-motion that 
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occurs will therefore result in shear forces at stent strut/cell interfaces.  Along these same 
lines, a better understanding of the frictional properties of vascular cells would allow 
more accurate computer modeling of in vivo stent behavior [160, 162] . Finite element 
models of AFM cell mechanics experiments have thus far relied on assumptions of slip or 
no-slip conditions, due to the lack of much hard data in support of either scenario [163, 
164].  Atomic force microscopy has been utilized extensively to measure frictional 
properties of various materials [141].  However, no such measurements have performed 
using intact living cells.   By functionalized the AFM probe with self-assembled 
monolayers (SAMs) of various known properties (e.g. hydrophobic or hydrophilic) we 
will be able to quantify surface shear forces between the cell and probe, and in doing so, 
develop a new method with further potential biological applications.  Our working 
hypothesis is that the primary friction-reducing component at the cell surface is the 
glycocalyx, a layer of glycoproteins and proteoglycans, which in VSMCs, is composed 
mostly of chondroitin sulfate and heparin sulfate, and is believed to play a role in 
mechanotransduction.[165]  In vascular endothelial cells, the glycocalyx is believed to 
play a major role in lubrication [156], raising the possibility that the same function is 
served in VSMCs. 
 
 
Aim 4: Effects of OxLDL on VSMC Viscoelastic and Frictional Properties 
 
 
The links between oxidized low-density lipoprotein (oxLDL) and atherosclerosis 
have been well-documented by numerous researchers [166, 167] . Oxidized LDL is 
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believed to be one of the most significant factors in vascular disease development [168].  
Among the numerous observed effects of oxLDL, has been the alteration of cytoskeletal 
structure in both endothelial [169] and vascular smooth muscle cells (VSMCs) [170, 
171].  In the case of endothelial cells,  cytoskeletal have been shown to result in cellular 
mechanical changes as well  [169].  To date, no such investigation of oxLD- associated 
VSMC mechanical changes has been performed.  Changes in cytoskeletal structure can 
have considerable effects on cellular function, particularly in terms of 
mechanotransduction [116].  Given that the cytoskeleton plays a dominant role in 
governing mechanical properties in most cell types, alterations to cytoskeletal 
composition can result in changes to cellular deformation in response to mechanical 
loading.  As a result, the subsequent mechanotransduced biochemical response can be 
altered as well.  Vascular smooth muscle cells can be subjected to mechanical loading 
from several sources, including blood pressure and endovascular devices such as stents 
and angioplasty balloons.  For these reasons, a better understanding of VSMC mechanical 
changes caused by clinically relevant stimuli, such as oxLDL, is important not only in 
terms of gaining a basic understanding of the underlying phenomena, but in 
understanding vascular disease progression as well.   
The atomic force microscope (AFM) is an extremely useful tool in the 
measurement of cellular mechanical properties [147, 172, 173].  Recently, techniques 
have been developed to measure stress relaxation behavior of living cells using an AFM 
[154, 155].   As cells typically exhibit viscoelastic behavior, the use of AFM stress 
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relaxation techniques can serve as a useful compliment to more widely used techniques 
such as cell indentation, which is commonly analyzed using Hertzian elastic models.   
 In the current study, it was hypothesized that oxLDL alters the viscoelastic 
properties of VSMCs through cytoskeletal and morphological changes.  To test this 
hypothesis, we examined the effects of oxLDL on cellular morphology, actin and 
microtubule distribution, and cellular viscoelasticity.   
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CHAPTER THREE 
 
EFFECTS OF SERUM DEPRIVATION ON THE MECHANICAL PROPERTIES OF 
VASCULAR SMOOTH MUSCLE CELLS 
 
Abstract: Vascular smooth muscle cell (VSMC) function plays a key role in regulating 
the development and progression of vascular lesions.   Among the more significant 
phenomena that occur during the development of these lesions is the phenotypic 
switching of VSMCs from a contractile to a synthetic state.  A better understanding of the 
concurrent changes to VSMC mechanical properties that occur with phenotypic shifts can 
help elucidate the role of VSMC mechanics in the development of vascular diseases.  In 
the current study, the mechanical properties of adherent cultured rat aortic VSMCs were 
assessed by atomic force microscopy (AFM).  Serum starvation was used to induce a 
phenotypic shift in vitro.  It was concluded that serum starvation led to a statistically 
significant increase in apparent elastic modulus after 5 days, as well a statistically 
significant decrease in hysteresis after 3 days in culture.  If this trend of VSMC 
mechanical properties changing concurrently with phenotypic shifts were to hold true in 
vivo, such changes could affect the processes of mechanotransduction and/or arterial 
mechanical properties, thereby contributing to the progression of vascular disease.    
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Introduction 
 
Vascular smooth muscle cells (VSMCs) are one of the main constituents of the 
arterial medial layer and therefore are continuously exposed to mechanical stresses from 
arterial blood pressure.  It is known that alterations in a cell’s mechanical properties can 
have profound effects on the response to such external mechanical forces [115].   For this 
reason, the study of single cell mechanical properties has become an increasingly 
valuable research area in recent years [146, 174] as investigators have begun uncovering 
the importance of mechanical cues in numerous disease pathologies [115, 134, 175]. Any 
disease that affects the cytoskeleton may, in turn, affect cellular mechanical properties. 
Furthermore, the mechanical behavior of individual cells often shares many 
characteristics with macroscopic tissues [134]. Given the relationship between vascular 
disease and mechanical stimuli, a better understanding of VSMC mechanical properties 
would provide valuable data to our knowledge of the complex atherosclerotic and 
restenotic disease processes.   
Vascular SMCs typically take on a synthetic phenotype after a short time in 
culture, but a shift towards a contractile phenotype has been shown to be possible in vitro 
through serum starvation and reversible through the subsequent re-addition of serum 
[176].  Serum starvation can have numerous affects on VSMCs in culture, including 
upregulation of cytoskeletal and contractile proteins [176-179], alterations in growth 
factor receptor expression [180], changes in integrin binding characteristics [181], altered 
Ca2+ response and chemotaxic behavior [179], decreased attachment and proliferation 
[182], decreased cell volume [183], and increased collagen expression [184]. It has been 
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demonstrated that in vitro VSMC serum starvation for 3 or more days results in 
restoration of contractility and significant upregulation of intracellular proteins 
characteristic of the contractile phenotype [176, 177]. Although serum starvation has not 
always been shown to induce complete restoration of the contractile phenotype [185], it 
has consistently been found to upregulate expression of the cytoskeletal and contractile 
proteins, which would contribute to cellular mechanical properties [176-179].  It is 
unlikely that VSMCs in culture would ever precisely mimic the mechanical behavior of 
VSMCs in vivo due to factors such as a lack of exposure to an in vivo physiological 
mechanical environment, differences in ECM composition, and the effects of a 2-D rather 
than a 3-D environment.  However, serum deprivation has consistently been shown to 
result in a shift along the phenotypic continuum [32]. This makes this system a suitable 
model for the purpose of this study, which addresses mechanical properties of different 
phenotypes of VSMCs.   
Previous studies have been performed examining the tensile elastic properties of 
VSMCs using a custom-designed micro-pipette system, with the data indicating that 
synthetic VSMCs have a lower tensile elastic modulus than contractile VSMCs [125-
127].  Nagayama and collaborators also reported that tensile properties of VSMCs were 
affected by the quantity, organization, and distribution of α-actin filaments [127]. These 
previous studies however, were performed using trypsinized non-adherent VSMCs, and 
only elastic properties were measured, despite cellular mechanical behavior being 
viscoelastic in nature [112]. Nonetheless, this previous research has provided some 
insight into the mechanical properties of VSMCs, which could be expanded upon by 
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additional characterization of the mechanical properties of adherent VSMC utilizing 
nanoindentation with an atomic force microscope (AFM).      
The major objective of the present study was to assess the differences in 
mechanical properties between serum-fed and serum-starved VSMCs using AFM 
nanoindentation.  As measures of elastic and viscous properties, VSMC apparent elastic 
modulus was quantified, along with the degree of hysteresis between indentation and 
retraction curves at different indentation speeds.  It was hypothesized that serum-starved 
VSMCs would exhibit greater elastic moduli due to their increased cytoskeletal and 
contractile protein content.   A secondary objective was to quantify intracellular 
variations in VSMC elastic modulus. 
 
Materials and Methods 
Cell Culture 
 Rat aortic VSMCs (Vectechnologies, Rensselaer, NY) from an established cell 
line were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Mediatech, 
Herndon, VA) with fetal bovine serum (FBS) (10%) (Sigma, St. Louis, MO) and 
antibiotic/antimycotic solution (1%) (Sigma).  Cells were maintained in T-75 polystyrene 
flasks in an incubator at 37ºC with 5% CO2, and fresh media was exchanged every 48 
hours.  Cells were utilized between passages 5 and 8.  For all AFM force measurements, 
cells were allowed to grow to ~80% confluency in the flasks then trypsinized with 0.25% 
trypsin  (Mediatech) / 0.02% EDTA (Sigma) and seeded in a sub-confluent layer onto 22 
x 22 mm glass coverslips (VWR, West Chester, PA).  Coverslips had each been coated 
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with 40 μl of 50 μg/ml monomeric type I collagen (Vitrogen 100, Cohesion 
Technologies, Palo Alto, CA) 24 hours prior to cell seeding.  Cells were seeded sub-
confluently in order to minimize overlapping and to control for the mechanical stiffening 
effects known to be imparted upon cells once they reach confluency in culture [174]. For 
each experiment, the seeded cells were divided into two groups, serum-starved and 
serum-fed.  Seeded coverslips in the serum-starved groups were maintained in serum-free 
(0% FBS) DMEM for 3 or 5-days, while the serum-fed groups were concurrently 
maintained in DMEM with 10% FBS.  Serum-starved cells were washed with phosphate 
buffered saline (PBS) (Mediatech) prior to switching to serum-free media.  All of the 
cell-seeded coverslips were maintained in 6-well plates at 37ºC with 5% CO2, and media 
was exchanged every 48 hours prior to AFM experimentation.   
 
AFM Indentation 
Atomic force microscopy (AFM) experiments were performed 3 or 5 days after the cells 
were seeded onto the coverslips, depending upon the designated number of days of serum 
starvation for each group.  For all AFM experiments, a Digital Instruments Dimension 
3000 AFM with a Nanoscope IV controller (Veeco Metrology, Santa Barbara, CA) was 
operated in contact mode with a fluid cell.  During AFM experiments, cells were kept on 
the coverslips in their respective culture media, which was exchanged approximately 
every 30 minutes with warm 37ºC media throughout the course of the AFM experiments, 
each lasting for approximately 2 h in total.  For each experiment, representative cells 
(n=15) were chosen based on their appearance as being either “spread” for the serum-fed 
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group, or “spindle-shaped” for the serum-starved group.  This was based on previous 
reports of morphological changes of serum-starved VSMCs [176, 177] and ensured that 
only cells that had responded to serum starvation were chosen for analysis.  The AFM 
probe was positioned over the central region of each cell body, avoiding the thin cell 
edges, and the cell was indented 5 times consecutively at each of 3 different approach 
speeds (0.095 Hz (0.50 μm/s), 0.498 Hz (2.62 μm/s), 1.94 Hz (10 μm/s)) for a total of 15 
indentations per cell.  Approach speeds were randomized for some samples in order to 
control for any mechanical changes that may be caused by repeated indentation.  The 
approximate depth of each indentation was 500 to 600 nm, although the Hertz model was 
only applied at 150 to 200 nm of each force curve, as described below.  Indentation depth 
was regulated by adjusting the triggering force (~ 20 nN) as necessary.  A single 5 μm 
diameter borosilicate spherical-tipped AFM probe (BioForce Nanosciences, Ames, IA) 
on a silicon-nitride cantilever with a nominal spring constant of 0.58 N/m, was utilized 
throughout the study.  Prior to each experiment, deflection sensitivity (nm/V) was 
determined by indenting onto a clean glass coverslip in DMEM.   
Several cells were also imaged in contact mode using a 0.58 N/m pyramidal AFM 
probe (Veeco Metrology).  These images were then used to determine cell height and to 
construct 40 × 40 point force-curve maps — covering a total area of approximately 1600 
μm2 — by using the “point and shoot” function in the NanoScope v6.13R1 software 
(Veeco Metrology) for the purpose of quantifying spatial variations in intracellular elastic 
modulus.  In order to determine intracellular variations in elastic modulus, the indentation 
depth at 20 nN for each point in the force-curve matrices was calculated and mapped.  
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Additionally, the coefficient of variation (COV) for elastic modulus in the central region 
(~ 25 μm2 area) of the cell was calculated.  Intracellular modulus measurements were 
conducted as a means to gauge the intracellular variability of elastic modulus values and 
therefore the validity of reported measurements from single-point AFM indentation 
throughout the current study.   
 
Force Curve Analysis 
Following the AFM experiments, a MATLAB (MATLAB 7.0, The MathWorks, 
Inc., Natick, MA) script was used to normalize the force curves and shift them as needed 
to a common zero point.  Contact points were determined by visually identifying the 
region at which the slope of each curve shifted upwards. In addition, and as a 
comparison, other methods for determining the contact point were also employed. The 
first method calculates the contact as the point where the force increases above the level 
of noise [186]. In the second method, the contact point is calculated as the point where 
the slope of the curve changes by fitting the curve to a 2-region model [146]. These 
methods gave a contact point similar to the visual inspection of the curve and did not 
significantly affect the calculated moduli or trends observed. 
To obtain a measure of individual cell stiffness, the apparent elastic moduli of the 
cells were calculated using the Hertz model for a spherical indenter [173]:   
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where F is the measured force (N), δ is indentation depth (m), E is apparent elastic 
modulus (Pa), υ is Poisson’s ratio (0.5) [187], and R is the spherical indenter radius (2.5 
μm).  A “normalized indentation depth” was calculated for both serum-fed and serum-
starved VSMCs.  This was chosen to be approximately 10% of the cell height, as this is 
the depth at which the Hertz model remains accurate [188].  As average cell height was 
measured using contact mode AFM imaging as ~ 1.5 μm for serum-fed cells and ~ 2.0 
μm for serum-starved cells (Figure 3.1), the corresponding depths at which the Hertz 
model was applied were 150 and 200 nm respectively.  The “pointwise modulus” method 
of cellular mechanical analysis developed by Costa, et al.[145] was utilized in addition to, 
and as support usage of the Hertzian method described above.  This method illustrates 
variations in elastic modulus as a function of indenter depth and geometry.  Indentation 
force Fi is related to the pointwise apparent elastic modulus Êi by the equation: 
Fi = 2πΦ(Di) Êi 
 where Φ(D) is a function relating the contribution of indenter geometry to depth 
dependence of the indentation response [145].  In essence, this is a rearrangement of the 
Hertz model that allows for the determination of elastic modulus variations as a function 
of indentation depth.  Performing this calculation allows one to determine whether 
significant variations in elastic modulus values would be obtained should the Hertz model 
be applied at different depths. 
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Figure 3.1.  Serum-fed VSMC imaged in contact mode; (a) Height image illustrating 
variations in cell height in reference to underlying substrate, (b) 3D height image, (c) 
Deflection image illustrating cell surface details. 
 
 
In addition to the elastic modulus calculations, the degree of hysteresis exhibited 
by each cell was calculated by subtracting the area under the entirety of each retraction 
curve from the area under the entirety of its corresponding indentation curve and then 
normalizing by the area under the indentation curve in order to account for variations in 
indentation depth (Figure 3.2) [143]. This calculation of hysteresis, combined with the 
changes in modulus with indentation speed, provided a measurement of non-elastic 
behavior and viscous energy dissipation [189].  Calculating hysteresis in the force curves 
provided a measure of viscous contributions that is independent of any concerns that 
would arise regarding the validity of various existing viscoelastic models.  
 
 
(a) (b) (c) 
1.5 μm 
 
30 nm 
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Figure 3.2.   A force curve obtained using an AFM is comprised of both an indent and a 
retract curve.  The contact point was determined by visually identifying the region at 
which the slope of the indent curve turned upward.  Hysteresis can be calculated by 
finding the area between the two curves and normalizing by the indent curve in order to 
account for variations in indentation depth. 
 
Immunofluorescence 
Immunofluorescence staining of SM-α-actin, which is one of the most abundant 
proteins in VSMCs and is known to be downregulated during phenotypic modulation 
[176, 190], was used as a means of visualizing any changes in α-actin distribution or 
expression level.  Cells designated for immunofluorescence were fixed in 100% ethanol 
at room temperature for 30 minutes at the same time points as the cells for the 
corresponding AFM experiments.  The cells were then incubated with blocking solution 
consisting of PBS (90%) (Sigma), bovine serum albumin (3.8%) (Sigma), donkey serum 
 = hysteresis 
 75 
 
(3.0%) (Sigma), and Triton-X (0.2%) (Sigma) for 30 minutes, followed by incubation 
with rat SM-α-actin monoclonal primary antibody (Abcam, Inc., Cambridge, MA) 
overnight.    A FITC-conjugated secondary antibody (Invitrogen, Inc., Carlsbad, CA) was 
added the following day for 2 hours, followed by incubation with DAPI for 5 minutes 
(Invitrogen, Carlsbad, CA).  Immunostained cells were visualized on glass slides using a 
Nikon Eclipse TE2000-S fluorescence microscope (Nikon USA, Melville, NY) with a 
FITC-filter, and digital images were captured using QCapture 2.68 imaging software 
(QImaging, Inc., Burnaby, BC). 
 
Statistics 
Repeated measures ANOVA was used to determine any statistically significant 
differences in apparent elastic modulus or hysteresis within experimental groups at 
different probe speeds, while Student’s t-tests were used to determine any statistically 
significant differences in apparent elastic modulus or hysteresis between experimental 
groups at a given speed.  In cases where normality tests failed (P < 0.05), Friedman 
repeated measures ANOVA on ranks and Mann-Whitney rank sum tests were used in 
place of repeated measures ANOVA and Student’s t-tests respectively, due to their 
greater stringency.  All statistical analyses were performed using SigmaStat 3.1 software 
(Systat Software, Inc., Richmond, CA).  An alpha level of 0.05 was used for all 
performed tests.  Coefficients of variation (standard deviation / mean) were calculated 
within each experimental group as a measure of cell-to-cell variations in modulus, within 
each cell loading session as a measure of data repeatability on a single point of 
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indentation, and within the force-curve matrices to determine intracellular modulus 
variation. 
 
Results 
Hertzian Apparent Elastic Modulus 
Statistically significant increases in hysteresis were observed with the increase of 
approach speeds in all VSMC groups (p < 0.05).  Furthermore, increased approach speeds 
resulted in greater measured apparent elastic modulus values in all experimental groups, 
as is commonly observed in viscous materials including cells [189].  Accordingly, the 
lowest AFM approach speed used in this study (0.5 um/s) was used for all calculations of 
apparent elastic modulus in order to minimize any viscous effects on the calculated 
estimate of the elastic modulus.  Approach speed randomization revealed no temporal 
changes in modulus measurements throughout indentation cycles.  Serum starvation for 5 
days resulted in a statistically significant increase in apparent elastic modulus.  All 3-day 
serum-starved groups exhibited non-significant increases in apparent elastic modulus.  
The mean apparent elastic for VSMCs was 13.5 ± 2.8 and 15.1 ± 6.2 kPa for the serum-
fed and 3-day serum-starved groups respectively (p = 0.842, Fig 3).  For VSMCs serum-
starved for 5-days, the mean apparent elastic modulus was 15.3 ± 4.3 kPa, compared to 
11.1 ± 4.1 kPa for serum-fed cells (p = 0.010, Figure 3.3).   
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Indenter Speed: 
Black = 10 µm/s 
White = 0.5 µm/s  
 
3-day Fed    3-day Starved    5-day Fed     5-day Starved 
 
(p = 0.010) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 3.  Apparent elastic moduli of serum-fed and serum-starved (3 and 5-days) rat 
aortic VSMCs measured with a 5 μm diameter borosilicate spherical AFM probe at 
approach speeds of 0.5 (white) and 10.0 μm/s (black), with 10% indentation depths 
approximated at 150 and 200 nm for serum-fed and serum-starved groups respectively (n 
= 15 cells per group).  At greater indenter speeds, artificially inflated elastic modulus 
values are commonly observed in materials exhibiting significant hysteresis.  Therefore, 
data from 0.5 µm/s measurements were used for statistical comparisons of elastic 
modulus.  Data are presented as mean ± SE.   
 
Histograms were plotted from the 5-day group in order to more clearly illustrate the 
differences in elastic modulus distribution between treated and control groups (Figure 3. 
4).   
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Figure 3.4.   Histograms illustrate the distribution of apparent elastic modulus values for 
5-day serum-starved VSMCs and controls.  As is commonly found with cell mechanics 
measurements, there is a relatively high degree of deviation in mechanical properties.  
However, the serum-starved group clearly exhibits a greater proportion of high modulus 
samples as compared to the serum-fed group. 
 
Averaged indentation curves (Figure 3.5a) with the standard deviation, noted at the depth 
of Hertz model application, illustrate the observed difference between treated and control 
groups.   Additionally, representative force curves from both a serum-fed and a serum-
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starved sample (Figure 3.5b&c) with the Hertz model overlaid at the fitted region visually 
represent the fit of the model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5.   Averaged force curves of serum-fed (solid) and serum-starved (hashed) 
VSMCs with respective points of Hertz fit (± SE) denoted by vertical bars (a).  
Representative force curves from 5-day serum-starved (b) and serum-fed (c) groups, 
overlaid by corresponding Hertz model fits. 
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The cell-to-cell apparent elastic modulus COV had a mean of 32.0 ± 9.5%.  The mean 
COV for moduli measured at a single point was 6.0 ± 5.3%.  Cell-to-cell apparent elastic 
modulus COVs and repeated indentation COVs for each experimental group are 
summarized in Table 3.1.   
 
 
 
Table 3.1.    Cell-to-cell and repeated point elastic modulus COVs  
 Cell-to-Cell COV 
(%) 
Repeated Point COV 
(%) 
3- day Serum-fed 20.6 4.1 
3-day Serum-starved 42.3 4.2 
5-day Serum-fed 36.8 10.3 
5-day Serum-starved 28.4 5.3 
All (mean ± SD) 32.0 ± 9.5 6.0 ± 5.3 
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Pointwise Elastic Modulus 
Averaged pointwise elastic modulus normalized to the Hertz model was plotted 
for both 5-day serum-starved cells and controls (Figure 3.6 a&b).  For the relevant 
regions of these plots, which includes the first 200 nm of indentation, both the serum-
starved and control groups appear relatively flat, providing evidence that the Hertz model 
is suitable in this region [145].  Beyond 200 nm, the plots do begin to exhibit increasing 
nonlinearity (Figure 3.6 c&d).  However, these larger indentation depths were not taken 
into account for modulus calculations and are therefore irrelevant to the current 
discussion.   
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Figure 3. 6.   Pointwise modulus normalized to Hertz model modulus of 5 day serum-fed 
(a&c) and serum-starved (b&d) groups shown to 200 nm depth (a&b) and to 500 nm 
depth (c&d).  Up to 200 nm, the plots are relatively linear and centered around a value of 
1, indicating applicability of the Hertz model.  However, beyond that depth, nonlinearity 
increases (particularly for the serum-starved cells). 
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Intracellular Elastic Modulus Variation 
Spatial intracellular variations in apparent elastic modulus for 3 mapped cells 
were found to be similar to cell-to-cell variations (COVs of ~ 35 to 40%).  The 
indentation depth at 20nN varied from approximately 100 nm to 1 µm over the entire cell 
(Figure 3.7).  However, in the more relevant central region, with an area of approximately 
25 µm2, which was probed for elastic modulus measurements, indentation depth at 20 nN 
varied only between ~ 500 to 600 nm.  Since only these inner regions of the cells were 
targeted for indentation throughout this study, the thinner peripheral regions are of lesser 
relevance.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7.   Indentation depth at 20 nN (left) and height image (right) from a 
representative serum-starved VSMC.  Lighter pixels represent greater indentation depth 
(lower elastic modulus).  The soft region in the upper-left quadrant of the indentation 
depth image is most likely due to a region of overlapping cells which was noticed during 
the imaging experiment. 
 84 
 
Hysteresis 
Hysteresis was statistically significantly greater at higher AFM probe approach 
speeds for all experimental groups in this study (p < 0.05).  It was therefore determined 
that the maximum probe approach speed that was used, 10 μm/s, would be utilized for all 
calculations of hysteresis in order to accentuate any differences in viscous contributions 
between cell phenotypes.  Hysteresis was statistically significantly lower for early 
passage 3-day serum-starved VSMCs (0.41 ± 0.08 and 0.32 ± 0.09 for serum-fed and 
serum-starved respectively, p = 0.007) (Figure 3.8).  Hysteresis was also statistically 
significantly lower in 5-day serum-starved than in serum-fed VSMCs (p < 0.001) (Figure 
3.8).     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 8 .  Hysteresis of VSMCs, serum-fed or serum-starved for three or five days, 
measured at an approach speed of 10.0 μm/s.  Data are presented as mean ± SE.  
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Immunofluorescence 
Serum starvation resulted in decreased cell spreading at both 3 and 5 day 
timepoints.  Immunofluorescence staining revealed that both serum-fed and serum-
starved VSMCs were positive for SM-α-actin.  In the majority of serum-fed VSMCs, 
SM-α-actin was randomly distributed; however, many cells did appear to stain darker 
around the cellular periphery.  Actin filaments were typically thin in appearance and were 
randomly oriented.  Serum-starved VSMCs exhibited a more heterogeneous staining 
profile, as some cells appeared to be very similar to the serum-fed cells while others had 
become elongated, with thicker actin filaments that were more evenly distributed, and ran 
parallel to the major axis.  Given that these elongated VSMCs were selected for 
indentation, the actin filament distribution within them is of greater relevance to the 
current study.  No obvious differences were noted in SM-α-actin content between 3 and 
5-day serum-starved cells.  Representative SM-α-actin images are shown in Fig. 9. 
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Figure 3.9.  Representative smooth muscle alpha-actin immunofluorescence images of an 
elongated serum-starved VSMC (left) and spread serum-fed VSMC (right) at 40x. 
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Discussion 
 
 
 
The present study was designed to model a phenotypic shift of VSMCs in vitro 
through the use of serum-starved and serum-fed VSMCs and to identify any trends in 
cellular mechanical property changes that occur during such a phenotypic shift.  
Differences in cell height between serum-fed and serum-starved VSMCs were accounted 
for by using a “normalized indentation depth” of ~10%.  This parameter is closely related 
to other factors, namely indenter radius and layer thickness. Recent computational 
research suggests that modulus values are not significantly in error with a 2.5 µm radius 
indenter when the ratio of indentation depth to sample thickness is at or below 0.1, as in 
the current study [191].  Support of the Hertz model using the pointwise modulus method 
was also undertaken.  Plots of pointwise elastic modulus were relatively flat for the first 
200 nm.  Therefore, as stated by Costa, et al.[145] the Hertz model is reasonably 
appropriate for modeling this region (~ 200 nm).  Regions beyond 200 nm in depth 
exhibiting increasing nonlinearity were not modeled and are therefore of lesser relevance.  
It is well-documented that the Hertz model has significant deficiencies when it comes to 
cell mechanical modeling, resulting in part from the fact that cells and tissues do not meet 
several assumptions of the Hertz model, e.g. linearity and isotropicity.  However, as a 
means of comparative analysis, Hertzian modeling does provide a quantitative measure 
relating to cellular mechanical properties, which can be useful under certain conditions.  
The validity of Hertzian analysis under the conditions of the current study was 
strengthened through the use of Costa’s pointwise modulus method.  This does not mean, 
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however, that use of the Hertz model is appropriate under all conditions and for all cell 
types.  Indeed, as demonstrated by Costa, there are scenarios in which significant 
nonlinearities are evident following pointwise analysis, and it is in these cases that the 
Hertz model should be deemed less appropriate.    
To the best of our knowledge, this is the first AFM study examining the changes 
in mechanical properties of VSMCs adhered to an arterial ECM constituent.  In addition 
to the basic science motivations behind this research, it also carries clinical significance, 
as it is known that elastic and/or viscous properties of single cells can be altered during 
many different diseases states and that these cellular mechanical properties can have 
significant effects on the process of mechanotransduction [115, 134]. In the case of 
vascular lesion development, VSMC mechanical changes may indeed have detrimental 
effects. 
In the current study, in vitro serum starvation of VSMCs resulted in statistically 
significantly increased apparent elastic modulus and statistically significantly decreased 
hysteresis.  The observed differences in elastic modulus are likely due, in part, to changes 
in expression level, organization, and orientation of cytoskeletal and contractile proteins 
[190]. However, two factors that have not yet been taken into account to explain the 
differences in mechanical properties between the serum-fed and serum-starved groups are 
cell adhesion and cell morphology (spreading).  There is evidence that increased cell 
adhesion [192] and increased cell spreading [193] both correlate with increased stiffness.    
In the present study, the serum-fed groups consistently displayed stronger adhesion and 
greater spreading, which may have offset cytoskeletal changes brought about through 
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serum starvation.   One possible limitation of measuring “elongated” serum-starved cells 
and “spread” serum-fed cells is that in actuality one would be assessing the mechanical 
differences associated with these two distinct morphologies.  However, it should be noted 
that such morphological differences are one of the key distinguishing features used to 
define VSMC phenotype [194].  Furthermore, under the conditions used in the current 
study very few (less than 5%) elongated cells were observed in serum-supplemented 
media.  Nevertheless, a potential means to address this limitation in future studies would 
be the addition of a contractile agent to the media, and the subsequent mechanical 
measurement of responsive versus non-responsive cells. 
Previous studies relating VSMC mechanical changes to phenotype utilized tensile 
strains of unattached, freshly isolated contractile and synthetic VSMCs, while the current 
study utilized indentation of attached serum-starved and serum-fed VSMCs in culture.  
Despite the differences in study protocols, data from the current study are in agreement in 
finding that a shift towards the synthetic phenotype results in a decrease in elastic 
modulus.   In terms of cell-to-cell elastic modulus variation, the present study yielded a  
mean COV of 32.0 ± 9.5%, which is towards the lower end of previously reported COVs 
from AFM cell indentations studies [174].  
The relatively low spatial intracellular variations in elastic modulus exhibited by 
the VSMCs in the current study provide evidence that indenting a single point near the 
center region of the cell serves as an adequate measure of cellular elastic modulus.  
Although a few previous studies have found differences in stiffness in a localized center 
of the cell due to contributions from the nucleus [142, 189], this was not observed in our 
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measurements. In this study, indentations of 10% of the total cell height were used to 
obtain modulus values, and the full-force indentation curves themselves were typically in 
the range of 500-600nm. At these small indentations, it is likely that any effect on 
stiffness due to the underlying nucleus is negligible.  Additionally, cell-to-cell elastic 
modulus variability was found to be in the same range as intracellular variability.  
Repeated indentations at a single point did not appear to affect measured modulus values, 
nor damage the cell in any significant manner.  The mean COV for moduli measured at a 
single point was 6.0 ± 5.3% in the present study.   
Fluorescent microscopic images of FITC-labeled SM-α-actin revealed that both 
serum-fed and serum-starved VSMCs were SM-α-actin positive.  However, a larger 
percentage (~ 25%) of serum-starved cells appeared to be elongated, with SM-α-actin 
distributed uniformly throughout the cells, while most (~ 95%) of the serum-fed cells 
exhibited random orientation of thinner SM-α-actin filaments.  Given the previous data 
regarding changes in SM-α-actin during modulation [176, 190, 195]  and its relationship 
to mechanical properties [127], it is hypothesized that such changes, along with 
morphological and adhesive alterations, contributed to the altered mechanical properties 
reported here.     
The extent to which serum starvation in culture can accurately replicate in vivo 
phenotypic changes is arguable.  Nonetheless, most available evidence does suggest that 
serum starvation in culture serves to mimic in vivo phenotypic changes through altered 
morphology, upregulation of intracellular cytoskeletal and contractile proteins, inhibition 
of proliferation and migration, and restored contractility [176, 177, 196]. Furthermore, 
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use of the current protocol can be justified by the fact that populations of VSMCs within 
even a single blood vessel in vivo are known to be highly heterogeneous [4], and the 
process of phenotypic shift itself occurs along a continuum [32].   It was demonstrated 
that a shift along this continuum significantly affects VSMC viscoelastic properties.   
 
Conclusions 
 
 
In vitro 5-day serum-starved VSMCs exhibit statistically significantly greater 
apparent elastic moduli and statistically significantly lower hysteresis than serum-fed 
VSMCs.  Further study is required to determine whether the observed in vitro trends 
accurately reflect an in vivo pathological scenario, and if so, how significant an impact 
such mechanical changes may have on mechanotransduction and vascular lesion 
development. 
 92 
 
 
CHAPTER FOUR 
 
ROLE OF CYTOSKELETAL COMPONENTS IN STRESS RELAXATION 
BEHAVIOR OF ADHERENT VASCULAR SMOOTH MUSCLE CELLS 
 
Abstract: A number of recent studies have demonstrated the effectiveness of atomic force 
microscopy (AFM) for characterization of cellular stress relaxation behavior.  However, 
this technique’s recent development creates considerable need for exploration of 
appropriate mechanical models for analysis of the resultant data and of the roles of 
various cytoskeletal components responsible for governing stress relaxation behavior.  
The viscoelastic properties of vascular smooth muscle cells (VSMCs) are of particular 
interest due to their role in the development of vascular diseases, including 
atherosclerosis and restenosis.  Various cytoskeletal agents, including cytochalasin D, 
jasplakinolide, paclitaxel, and nocodazole, were used to alter the cytoskeletal architecture 
of the VSMCs.  Stress relaxation experiments were performed on the VSMCs using 
AFM.  The quasilinear viscoelastic (QLV) reduced  relaxation function, as well as a 
simple power-law model, and the standard linear solid (SLS) model, were fit to the 
resultant stress relaxation data.   Actin depolymerization via cytochalasin D resulted in 
significant increases in both rate of relaxation and percentage of relaxation; actin 
stabilization via jasplakinolide did not affect stress relaxation behavior.  Microtubule 
depolymerization via nocodazole resulted in nonsignificant increases in rate and 
percentage of relaxation, while microtubule stabilization via paclitaxel caused significant 
decreases in both rate and percentage of relaxation.  Both the QLV reduced relaxation 
function and the power-law model provided excellent fits to the data (R2 = 0.98), while 
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the SLS model was less adequate (R2 = 0.91).   Data from the current study indicate the 
important role of not only actin, but also microtubules, in governing VSMC viscoelastic 
behavior.  Excellent fits to the data show potential for future use of both the QLV 
reduced relaxation function and power-law models in conjunction with AFM stress 
relaxation experiments.   
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Introduction 
 
 
The importance of mechanotransduction in regulating numerous physiological 
processes has become increasingly evident in recent years [115].  Mechanical stimuli 
have been found to play a significant role in the cellular pathology of numerous diseases, 
including atherosclerosis [197], cancer [198], and arthritis [199].  Thus, the behavior of a 
cell in reaction to mechanical stimuli appears to affect the cell’s subsequent biochemical 
response to those stimuli.  These findings have prompted development of improved 
techniques to further elucidate the complex mechanical behavior of cells and tissues 
[129].  One commonly used tool for the study of cell mechanics is the atomic force 
microscope (AFM) [134].  Until recently, the majority of AFM cell-mechanics research 
focused on simple indentation curves, whereby cantilever deflection (force) is related to 
indentation depth, and an apparent elastic modulus is calculated (often employing 
Hertzian contact equations) [143, 200].  The AFM, however, has also been used to 
quantify viscoelastic properties of living, adherent cells via stress-relaxation [149, 154, 
155] and cyclic-loading measurements [187].  While previous AFM stress relaxation 
work demonstrated the technique’s potential, it did not explore cytoskeletal roles in 
governing stress relaxation, and it relied on linear viscoelastic models [149, 154, 155, 
187].  Thus,  understanding the overall process of mechanotransduction requires 
identification of the contributions of cytoskeletal components and development of 
appropriate viscoelastic models [110].    
The mechanical behavior of vascular smooth muscle cells (VSMCs) is particularly 
important from a clinical perspective.  Because these cells have been implicated in the 
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pathogenesis of various vascular diseases (e.g., hypertension, atherosclerosis, and 
restenosis) [197], elucidating their intrinsic mechanical properties is essential to 
understanding the role of mechanotransduction in these disease processes. The role of 
VSMCs in the regulation of hemodynamics and their exposure to a range of mechanical 
stimuli (from sources including shear blood flow, blood pressure, and endovascular 
devices) underscore the value of characterizing their mechanical behavior.  Although 
stress relaxation of individual VSMCs has been  measured  [201, 202], the cells used in 
these studies were not adherent to a substrate, and custom tensile testers were used to 
obtain the data.     
The goal of the present study was to determine the roles of both actin and 
microtubules in governing VSMC viscoelastic behavior.  Thus, we measured the stress 
relaxation response of VSMCs via AFM and compared three existing models to analyze 
that behavior.   
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Materials and Methods 
 
 
Smooth muscle cells isolated from adult male Sprague-Dawley rat aortal explants 
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Mediatech, Herndon, 
VA) supplemented with fetal bovine serum (FBS) (10 %) (Sigma, St. Louis, MO) and 
antibiotic/antimycotic (1 %) (Sigma).  Cells were maintained in a humidified, 37 ºC, 5% 
CO2,  95% air environment.  Prior to AFM experiments, cells were seeded onto 22 x 22 
mm glass coverslips coated with type I collagen (Vitrogen 100, Cohesion Technologies, 
Palo Alto, CA) at a density of 150,000 cells per coverslip.  Seeded coverslips were 
incubated in 6-well plates with DMEM (10% FBS) at 37 ºC with 5% CO2 for 3 to 5 days 
prior to AFM experimentation.  Cells were used in experiments between passages 5 and 
8.   
AFM Stress Relaxation Experiments 
For all AFM experiments, a Veeco Dimension 3000 AFM with a Nanoscope IV 
controller (Veeco Metrology, Santa Barbara, CA) and hybrid x-y-z head was operated in 
contact mode with a fluid cell.  A single borosilicate spherical-tipped AFM probe (5 μm 
diameter) (NovaScan, Ames, IA) on a silicon-nitride cantilever with a nominal spring 
constant of 0.12 N/m was used throughout the study.  AFM experiments were performed 
after VSMCs had formed a confluent layer.  Following the identification of a target cell, 
the AFM probe was positioned over the central region of the cell body.  Relaxation tests 
were controlled using the strip-chart feature within the PicoForce mode of the NanoScope 
v6.13R1 software (Veeco Metrology).  Channel 1 was set to record cantilever deflection, 
while channel 2 was set to record Z-piezo movement.  Before each relaxation test was 
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run, the approximate separation distance between probe and cell was determined by 
visually inspecting a single force/displacement curve, Figure 4.1.    
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Figure  4.1.  Sample indentation curve illustrating approximate probe-cell separation 
distance. 
 
The estimated Z-separation gap was then minimized by lowering the probe in 
appropriate submicron increments using the step motor.   This method provided a good 
approximation for starting each ramp at or near the cell surface.  During AFM 
experiments, cell-culture media was changed approximately every 30 minutes; each 
experiment lasted no longer than 2 hrs in total.   
For each relaxation test, a ramp speed of 50 µm/s was used during both the approach 
and the retract phase.  This strain rate allowed for a reasonable approximation of a step 
strain while staying well below the Z-piezo’s maximum programmable velocity (~200 
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µm/s) to assure accuracy of measurement and reduce the presence of fluid-related 
artifacts.  To evaluate strain dependence, VSMCs were subjected to step indentations of 
0.5, 1.0, and 1.5 µm for 120 seconds (Figure 4.2) consecutively; to allow time for 
mechanical recovery, approximately one minute was allowed to elapse between tests.   
 
 
 
 
 
 
 
 
 
 
              
 
 
 
 
Figure  4.2.  Top, cantilever deflection force vs. time; Bottom, Z-piezo movement vs. 
time.  
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The order in which the three ramp distances were used was randomized for each cell.  For 
all experiments evaluating the effects of various cytoskeletal agents, a ramp distance of 1 
µm was chosen.  During the 120-second holding period, the fluctuation in strain in most 
cases was found to be on the order of 1% (5 to 15 nm), which was considered negligible.  
At the conclusion of all relaxation tests, the probe was retracted 2 µm to ensure probe/cell 
detachment in case any adhesion occurred during the relaxation phase.  Data were 
collected at a sampling rate of 100 Hz for the duration of each relaxation test.   
 
Cytoskeletal Agents 
  To assess the role of actin filaments in VSMC stress relaxation behavior, cells were 
treated with either 1 µM cytochalasin D (Sigma, St. Louis, MO) or 0.1 µm jasplakinolide 
(Fisher Scientific, Pittsburgh, PA) at 37 °C for 1 hour prior to tests.  Cytochalasin D is an 
actin depolymerizing agent that caps the barbed end of F-actin, while jasplakinolide is an 
actin stabilizing agent that binds to both ends of actin filaments, preventing 
depolymerization.  Likewise, to determine the role of microtubules in stress relaxation 
behavior, groups of cells were treated with either 20 µm nocodazole or 10 µM paclitaxel 
(both from Sigma) at 37 °C for 1 hour to induce microtubule depolymerization or 
hyperpolymerization, respectively.  Both nocodazole and paclitaxel bind to β-tubulin; 
however, the former disrupts and the latter stabilizes microtubules.  Concentrations of all 
cytoskeletal agents were chosen based on published research [143, 147, 203] or based on 
our own experience, as in the case of cytochalasin D, where we chose the maximum 
concentration that can be used without inducing cell detachment.  Control groups for each 
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experiment consisted of cells treated only with the equivalent amount of vehicle (DMSO) 
for these cyoskeletal agent treatments. 
 
Relaxation Data Analysis 
Following data collection, all stress relaxation curves were shifted to give a baseline 
force value of 0 and were then normalized by their respective t=0.01 s force values to 
obtain a starting (maximum) force value of 1.0 for each relaxation curve.   The 0.01 s 
time point was used for normalization due to the usage of logarithmic time spacing and 
the 100 Hz initial sampling rate.  Following normalization, data were resampled using 
logarithmic spacing with 100 data points from the start to the finish of each test.  The 
percentage of relaxation was calculated for each relaxation curve, with the parameter 
G(120), denoting G at t=120 s, representing 1 – % relaxation. Custom MATLAB scripts 
(MATLAB 7.0, The MathWorks, Inc., Natick, MA) were written to fit each curve using 
three different relaxation models: quasilinear viscoelastic (QLV) reduced relaxation 
function, Eq. (1); power-law, Eq. (2); and standard linear solid (SLS), Eq. (3).  The 
reduced relaxation function, G(t), Eq. (1) contains 3 parameters, c, τ1, and τ2, with a 
continuous relaxation spectrum, S(τ ) = c/τ,  between τ1 and τ2, which are time constants 
governing short and long term relaxation behavior, respectively.    
 
        (1) 
 
 
2 -t/
1
2
1
e1
( )
11
c d
G t
c d
ττ
τ
ττ
τ
τ
ττ
+
=
+
∫
∫
 102 
 
The constant, c, is unitless, and represents a relative measure of viscous energy 
dissipation (damping).   
The power law relaxation model used was of the form  
                (2) 
where A and α are constants governing the rate of decay. 
The relaxation behavior of a standard linear solid is defined by the equation: 
                                       (3)
 
 
where ER is the reduced relaxation modulus, and τε and τσ are the relaxation times for 
constant strain and constant stress, respectively [132].  
 
Immunofluorescence 
  Immunofluorescence staining was used to visualize actin filaments and 
microtubules.  Cells were fixed in 4% paraformaldedyde at room temperature for 30 
minutes following cytoskeletal-agent treatments at the same time points as the cells for 
the corresponding AFM experiments.  The cells were then incubated with blocking 
solution consisting of PBS (90%) (Sigma), bovine serum albumin (3.8%) (Sigma), 
donkey serum (3.0%) (Sigma), and Triton-X (0.2%) (Sigma) for 30 minutes.  This was 
followed by incubation with either alexa fluor 488 conjugated phalloidin (Sigma) at room 
temperature for 15 minutes for actin staining or alpha- and beta-tubulin primary 
antibodies (Hybridoma Bank, U. of Iowa) at 4°C overnight for microtubule staining.  The 
microtubule-stained cells were further incubated with a TRITC-conjugated secondary 
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antibody (Invitrogen, Inc., Carlsbad, CA) the following day for 2 hours and then with 
DAPI for 5 minutes (Invitrogen, Carlsbad, CA).   All samples were viewed using an 
Olympus IX71 inverted microscope (Olympus, Tokyo, Japan); images were subsequently 
collected and processed using HCImage software (Hamamatsu Corp., Bridgewater, NJ).   
 
Statistical Analyses 
  Coefficients of determination (R2) were determined for each individual curve fit for 
all 3 models.  Constants derived from each model are presented as a mean ± standard 
deviation.  Values of G(120) and α for respective treatment and control groups were 
compared using Student’s t-tests.  The effect of indentation depth (strain dependence) 
was evaluated using a Repeated Measures one-way ANOVA (on ranks when normality 
tests failed), followed by Tukey tests for pairwise comparison.  P-values < 0.05 were 
considered statistically significant for all tests.  
 
Results 
 
 
Vascular smooth muscle cells pretreated with cytochalasin D exhibited significantly 
(p=0.033) greater relaxation percentage, G(120) , and relaxation rate, α, (p = 0.002) than 
controls (Table 4.1).  In contrast, similar stress relaxation was observed between 
jasplakinolide-treated cells and controls, G(120) and α (p=0.931 and 0.436, respectively) 
(Table 4.1).  Paclitaxel-treated cells exhibited significantly lower relaxation percentage 
(p=0.008) and relaxation rate (p=0.011) compared to controls (Table 4.1).  Nocodazole-
treated cells exhibited nonsignificant decreases in relaxation percentage (p=0.220) and 
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relaxation rate (p=0.091) compared to controls (Table 4.1).  Averaged relaxation curves 
for each cytoskeletal agent were plotted vs. respective control groups on a logarithmic 
time scale, Figure 4.3.   
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Table 4.1.  G(120) values for each cell treatment and corresponding control group. 
 (* Denotes p < 0.05). 
  G(120) α  
Cytochalasin D (n=9) 0.11±0.12* -0.29±0.06* 
Control (n=5) 0.29±0.09 -0.16±0.06 
Jasplakinolide (n=12) 0.41±0.09 -0.09±0.02 
Control (n=12) 0.41±0.08 -0.09±0.02 
Paclitaxel (n=12) 0.44±0.08* -0.08±0.02* 
Control (n=12) 0.32±0.11 -0.11±0.03 
Nocodazole (n=23) 0.44±0.13 -0.09±0.03 
Control (n=15) 0.38±0.14 -0.11±0.03 
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Figure  4.3.   Averaged normalized VSMC relaxation curves plotted vs. logarithmic time 
from (a) Cytochalasin D, (b) Jasplakinolide, (c) Paclitaxel, (d) Nocodazole.  Arrows 
indicate the direction that curves of treated cells are shifted relative to controls.  Due to 
the usage of logarithmic spacing and the 100 Hz initial sampling rate, the initial time 
point of each curve is 0.01 seconds. 
 
 
The power-law exponent, α, and the normalized percentage of relaxation at the 
conclusion of each test , G(120), were used as statistical measures of strain dependence to 
examine the validity of the reduced relaxation function under current study conditions.    
Mean power-law exponents were similar for 0.5, 1.0 and 1.5 µm indentations (p=0.499) 
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(Table 4.2).  Repeated measures ANOVA indicated that the mean G(120) values also did 
not statistically vary with strain level (p=0.062) (Table 4.2).  Consecutive relaxation tests 
at 1 um depth revealed no statistically significant changes with each successive trial (data 
not shown).   
 
Table 4.2.  Mean G(120)  and power-law exponent (α) vs. indentation depth for untreated 
VSMCs. (n=24 cells ± SD). 
 Indentation Depth 
(µm)     G(120)  α  
0.5     0.39 ± 0.14  -0.10 ± 0.03  
1     0.42 ± 0.11  -0.10 ± 0.03  
1.5     0.44 ± 0.12  -0.10 ± 0.03  
 
 
The effects of the cytoskeletal agents used in this study are also reflected in the 
constants derived from the QLV reduced relaxation function.  In general, increased 
relaxation percentage and rate were observed to correspond to greater C values, lower τ2, 
and greater α values, while the short-term time constant, τ1, appeared to be unaffected 
(Table 4.3).   Due to the relatively poor fit of the SLS model, these parameters were not 
included in any further analysis.  
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Table 4.3.  QLV parameters from VSMCs treated with cytoskeletal agents and respective 
controls.  C is a unitless measure of damping; τ1 and τ2, short and long-term QLV time 
constants, respectively, serve as the bounds for the continuous spectrum of relaxation.   
  C τ1 (s) τ2 (s) 
Cytochalasin D (n=9) 3.4±3.7 0.06±0.02 76±130 
Control (n=5) 0.34±0.17 0.07±0.02 96±50 
 Jasplakinolide (n=12) 0.17 ± 0.06 0.09 ±  0.04 240 ± 310 
Control (n=12) 0.15 ± 0.03 0.08 ±  0.05 270 ± 290 
Paclitaxel (n=12) 0.16±0.06 0.09±0.04 400±310 
Control (n=12) 0.23±0.17 0.08±0.02 190±200 
Nocodazole (n=23) 0.14±0.06 0.08±0.03 230±250 
Control (n=15) 0.20±0.08 0.08±0.04 320±320 
 
 
Relaxation curves were fit very well by both the QLV reduced relaxation function, (R2 
= 0.98 +/- 0.02, n=120), Figure 4.4(a), and the power-law relaxation model, (R2 = 0.98 
+/- 0.03, n=125), Figure 4.4(b).  The standard linear solid model, however, provided a 
less adequate fit, (R2 = 0.91 +/- 0.03, n=117), Figure 4.4(c). 
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Figure  4.4.  Representative examples of normalized VSMC relaxation curves plotted vs. 
logarithmic time with curve fits of (a) QLV reduced relaxation, (b) power-law, and (c) SLS 
models.  Due to the usage of logarithmic spacing and the 100 Hz initial sampling rate, the initial 
time point of each curve is 0.01 seconds.     
 
   
 Untreated VSMCs exhibited normal actin (Figure 4.5(a)) and microtubule structure 
(Figure  4.5(b)).  Immunofluorescence imaging of actin (Figure 4.5(c)) and microtubules 
(Figure 4.5(d)) in cytochalasin D-treated VSMCs revealed significant disruption of actin 
stress fibers and no identifiable changes to microtubule structure.    Nocodazole-treated 
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VSMCs showed significant microtubule disruption (Figure 4.5(f)) without any changes to 
actin structure (Figure 4.5(e)).   No consistent visual differences were observed with actin 
or microtubule structure in paclitaxel-treated VSMCs (Figure 4.5(g) and 4.5(h)), although 
some cells did appear to exhibit denser microtubule content with less free tubulin.  No 
visual differences were observed in actin or microtubules (Figure 4.5(i) and  4.5(j)) of 
jasplakinolide-treated VSMCs.   
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Figure  4.5.  Immunofluorescence images of untreated VSMC (a ) actin and (b) 
microtubules; cytochalasin D-treated VSMC (c) actin and (d) microtubules; nocodazole-
treated VSMC (e)  actin and (f) microtubules; paclitaxel-treated VSMC (g) actin and (h) 
microtubules; jasplakinolide-treated VSMC (i) actin and (j) microtubules.  Scalebars 
represent 50 µm. 
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Discussion 
 
 
Mechanotransduction, the process by which mechanical stimuli are converted into 
physiological responses, is important in regulating a wide array of biological processes.  
Major human diseases, including atherosclerosis [197], cancer [198], and arthritis [199], 
are affected by mechanobiological phenomena.   At the cellular level, mechanical stimuli 
and resultant deformations are converted into physiological responses that affect growth, 
migration, differentiation, and protein processing.  Detailed knowledge of the role 
cytoskeletal components play in governing cellular mechanics is necessary for 
comprehensive understanding of mechanotransduction in disease development.  
Acquiring this knowledge requires development of techniques to better quantify cellular 
viscoelastic behavior using commercially available equipment and identification of 
simple yet accurate models for the description of the resultant data.  In this study, the 
effects of four cytoskeletal agents on the viscoelastic properties of VSMCs were 
evaluated.  Subsequently, three distinct viscoelastic models were applied to the collected 
AFM stress relaxation data, and the strengths and weaknesses of each were evaluated.   
Data from this study provided evidence that actin disruption with cytochalasin D greatly 
altered the viscoelastic behavior of cultured vascular smooth muscle cells.  In agreement with 
previous cellular viscoelastic research [187], actin disruption increased damping behavior and 
decreased viscosity.   With the actin cytoskeleton largely disassembled, the more fluid-like 
cytoplasm dominates viscoelastic behavior, so the observed increases in relaxation and damping 
are unsurprising.  In contrast to cytochalasin D, 0.1 µM jasplakinolide had no significant effects 
on relaxation behavior.  Jasplakinolide has been shown to have little effect on the relaxation 
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behavior of protoplasts at 10 µM [204]; in another study, however, it increased storage and loss 
moduli of airway smooth muscle cells as measured via magnetic twisting cytometry at 0.07 µM 
[205].  In the current study, pretreatment with 1 µM concentrations of jasplakinolide resulted in 
cell death and detachment from the cover slip within approximately 30 minutes.  It has been 
suggested that stabilizing actin (and thereby inhibiting the dynamic nature of actin filaments) 
disturbs the actin cytoskeleton in a manner similar to that observed in actin depolymerization 
[206] with cytochalasin D.  This effect may be what was observed when the VSMCs treated with 
1µM jasplakinolide detached from the substrate.  Given the complex effects of jasplakinolide that 
were seen when it was used under other conditions [203, 207] and the lack of reported use due to 
its relatively recent discovery, differences in the reported data are not surprising.  The variety of 
results among studies pertaining to effects of jasplakinolide on cellular viscoelasticity may 
warrant further investigation.   
The role of microtubules in cellular mechanical behavior is more controversial than 
that of actin and can depend greatly on factors such as the degree of cell spreading [113].  
For example, previous studies have demonstrated an increase in cellular stiffness from 
microtubule disruption [123, 208],  while others have found the opposite effect [209].  In 
the present study, microtubule disruption via nocodazole resulted in statistically 
nonsignificant decreases in the percentage and rate of relaxation.  A possible explanation 
for these observations is that microtubule disrupting agents, including nocodazole, have 
been found to induce the formation of actin stress fibers via a Rho signaling mechanism 
[210].  In the present study, evidence of increased actin stress fiber content was not 
observed from immunofluorescence images (Fig. 6), and further analysis of gene 
expression or actin protein content was not conducted.  An alternative explanation for the 
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effects of nocodazole observed here is that microtubule disruption resulted in a decrease 
in the level of prestress balanced by the microtubules [113].   Although elastic shear 
modulus (normally associated with prestress) is a parameter that is distinct from the stress 
relaxation data obtained in the current study, a comparison between the two might 
provide a framework for understanding the effects of cytoskeletal treatments on stress 
relaxation behavior.  This is because cellular prestress has been found to positively 
correlate with both storage and loss moduli [211].  The precise physical mechanisms 
behind this correlation are not yet known.       
Given that microtubule disruption with nocodazole resulted in decreased relaxation 
rate and percentage in the current study, it would seem counterintuitive that microtubule 
stabilization with paclitaxel resulted in statistically significant decreases in both 
parameters.  However, previous researchers have also observed increased viscosity as a 
result of paclitaxel treatment in cardiomyocytes [212, 213], endothelial cells [209],  and 
isolated sections of cardiac muscle [214].  In addition to stabilizing microtubules, 
paclitaxel has been found to decrease microtubule flexural rigidity [215, 216], induce 
microtubule bundling [217], cause internal protofilament sliding [218], and increase 
microtubule relaxation time [216].  Each of these secondary effects resulting from 
paclitaxel treatment could conceivably affect whole-cell viscoelastic properties.  
Although the exact mechanisms involved in these changes are not well understood, the 
viscoelastic effects observed in the current and in past studies may be due to one or a 
combination of several factors: internal microtubule friction (i.e., viscous sliding of 
protofilaments); frictional interactions among microtubule bundles; frictional interactions 
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between microtubules and cytoplasmic constituents; and intrinsically altered relaxation 
behavior of the microtubule filaments.  In the context of the mechanical-testing protocol 
used in the current study, a proposed hypothetical scenario could involve rapid 
displacement of flexible paclitaxel-stabilized microtubules and cytoplasm caused by the 
high-velocity impact of the AFM probe.  The high-viscosity flow of microtubules caused 
by these displacements could cause friction that could then lead to decreased rate of 
relaxation and relaxation percentage.  Therefore, the apparently similar viscoelastic 
effects of nocodazole and paclitaxel on VSMCs may be the result of two distinct 
phenomena.  The findings related to paclitaxel reported here are particularly interesting 
from a clinical perspective because paclitaxel is used in some drug-eluting stents to 
prevent VSMC hyperplasia.   
The theory of quasilinear viscoelasticity (QLV) was originally developed by Fung to 
model the viscoelastic behavior of biological tissues [132].  The QLV model contains the 
reduced relaxation function, G(t), describing stress relaxation behavior.   Although 
numerous studies have dealt with the successful application of the QLV model to whole 
tissues, including blood vessels [219], heart valves [220], and ligaments [221], the model 
has yet to be applied to isolated cells.   For the QLV reduced relaxation function to be 
valid for the cells used in the current study, strain independence had to be demonstrated; 
i.e., relaxation should be a function of time only.  To test this relationship between strain 
and relaxation, we compared both the rate of relaxation, α, and the total percentage of 
relaxation, G(120), at varying strains.  Both rate of relaxation and total percentage of 
relaxation were found to be independent of initial strain, a finding that could be viewed as 
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supportive of the validity of the reduced relaxation function under the conditions of the 
current study [222].  The reduced relaxation function exhibited an excellent fit (R2 = 
0.98) for AFM stress relaxation data of VSMCs.  When applied to cellular viscoelastic 
research, the reduced relaxation function provides the ability to compare data to previous 
studies on whole tissues.  Tanaka and Fung found C parameter values an order of 
magnitude lower for circumferential and longitudinal mechanical testing of intact aortas 
[219].   Cytochalasin D-treated VSMCs were the lone exception to this trend: Their 
significantly increased damping behavior was reflected in C values two orders of 
magnitude greater than those of intact aortas.   Short-term time constants (τ1) in the 
current study did not vary significantly with the various cytoskeletal treatments. 
However, they were found to be on the same order as those of the abdominal aorta and 
lower than those of the thoracic aorta [219].  A possible explanation for this finding could  
be the higher collagen and elastin content of the thoracic aorta compared to the 
abdominal aorta [223], which result in larger contributions of those ECM components to 
viscoelastic behavior.  The long-term time constant (τ2) values in the current study were 
of the same order as intact aortas [219], although standard deviations were exceptionally 
large, and many values were greater than the 120-second duration of the stress relaxation 
tests.  However, long-term QLV time constants vary widely in the literature and within 
given test protocols [224].  Future AFM stress relaxation studies utilizing the QLV 
reduced relaxation function could perhaps specify longer relaxation protocols; these 
would more accurately capture long-term relaxation behavior.  The viscoelastic 
differences between whole aortas and isolated VSMCs are unsurprising since the 
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comparatively stiffer and less viscous ECM plays a large role in governing mechanical 
behavior of whole tissues.   
The attention that power-law behavior of cells has lately received is in part due to 
recent experiments examining the behavior of cells under cyclic loading conditions [225].  
Creep behavior of cells has also been modeled using a power-law function, J(t) = Atα 
[226].  In the present study, stress relaxation data of VSMCs were fit very well (R2 = 
0.98) using the power-law model.  It has been suggested that power-law behavior is an 
intrinsic cellular feature that is independent of measuring technique [226]. This issue, to 
which the current data may be relevant, warrants continued investigation.  Power-law 
fitting complements the QLV model, as it can be used to validate or invalidate use of the 
latter, as it was in this study.  A simple power-law stress relaxation fit provides a 
numerical gauge of the rate of decay, but no other information is provided, i.e. there are 
no time constants, etc.   Nonetheless, the data reported here add to a growing body of 
literature pertaining to power-law behavior of cells mainly from dynamic mechanical 
analyses, but also from creep measurement [226, 227], and now AFM stress relaxation.  
Future AFM stress relaxation studies may employ the power-law equation used herein or 
perhaps variations thereof.   
The SLS model has previously been applied to cells [228] and tissues [229].  Previous 
indentation tests and analyses of the intimal vessel wall of healthy human arteries using 
an AFM-based technique and the SLS model [229] found SLS parameters τε & τσ with 
values of 16.9 and 29.3, respectively.  These SLS parameters are an order of magnitude 
greater than typical SLS parameter values measured in the current study for untreated 
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attached VSMCs, though the SLS model fit was unsatisfactory for VSMCs.  Additional 
elements (springs and dashpots) could possibly be added to the SLS model to improve the 
fit; however this would require extra fitting parameters and more complex analyses.  
Extracellular matrix contributions to whole tissue mechanics possibly explain the 
differences in SLS parameters between whole tissues and the current VSMCs.  In 
summary, although the SLS model has been used to successfully for tissue relaxation data 
in the past, it did not provide an adequate fit to the current VSMC data.      
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Conclusions 
 
 
To our knowledge, the data presented herein are the first describing the role of actin 
and microtubules in governing stress relaxation behavior of adherent VSMCs.  This 
information adds to previous work pertaining to the role of cytoskeletal components in 
governing the viscoelastic behavior of cells under dynamic conditions [123, 187].  While 
it is generally agreed that actin stress fibers play the primary role in governing cellular 
viscoelastic properties, these data indicate the relevance of the contributions of 
microtubules.  This relevance underscores a major limitation of relying solely upon 
elastic modulus measurements to describe the mechanical properties of viscoelastic 
materials such as cells.    
In the current study, the QLV reduced relaxation function was applied to isolated cells 
rather than to whole tissues.  Validity of the QLV reduced relaxation function under the 
current conditions was checked by testing the strain dependence of both rate and 
percentage of relaxation [222].  It must be recognized that applicability here does not 
indicate that the QLV reduced relaxation function will be universally valid for cell 
mechanics studies.    For AFM stress relaxation studies, the use of the QLV reduced 
relaxation function in combination with a power-law model may serve as a simple 
method of describing the viscoelastic behavior of cells under various treatment 
conditions.  The reduced relaxation function will permit comparisons to data from whole 
tissue. With the power-law model, comparisons of AFM stress relaxation data with 
power-law data collected using other techniques will be possible.  As previous studies 
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have suggested, when modeling whole tissues, it may be desirable to model the 
viscoelastic contributions of the cellular and ECM components separately [230].  Thus, 
data from the current study may aid future AFM-based analyses of arterial mechanics.   
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CHAPTER FIVE 
 
FRICTIONAL PROPERTY MEASUREMENT OF INDIVIDUAL VASCULAR 
SMOOTH MUSCLE CELLS 
 
Abstract: With the advancement of the field of biotribology, considerable interest has 
arisen in the study of cell and tissue frictional properties.   From the perspective of 
medical device development, the frictional properties between a rigid surface and 
underlying cells and tissues is of a particular clinical interest.   As with many bearing 
surfaces, it is likely that contact asperities exist at the size scale of single cells and below.  
Thus, a technique to measure cellular frictional properties would be beneficial from both 
a clinical and a basic science perspective.  In the current study, an atomic force 
microscope with a 5 µm diameter borosilicate spherical probe was used to measure the 
surface frictional properties of vascular smooth muscle cells (VSMCs).    Various 
treatments were used to alter cell structure, in order to better understand the cellular 
components and mechanisms responsible for governing frictional properties.  It was 
found that untreated VSMCs had a frictional coefficient of approximately 0.06.  The 
friction coefficient has been shown to be greatly affected by cellular rigidity.    
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Introduction 
 
While significant steps have been made towards understanding the bulk 
mechanical properties of living cells, comparatively little is known about their surface 
frictional properties.  The study of cellular frictional properties is of interest for a variety 
of reasons.   For example, numerous physiological processes including blood flow [156] , 
articulating cartilaginous tissues [157],  respiration [231], cell adhesion [232], and cell 
migration [158], are all affected in some manner by cellular and tissue frictional 
properties.   In regards to endovascular surgical procedures, increased knowledge of 
cellular frictional properties could also be of a significant clinical value.  The deployment 
of endovascular devices results in the exertion of mechanical shear forces on underlying 
vascular endothelial and vascular smooth muscle cells  (VSMCs) [160].  In cases of 
complex or tortuous vascular lesions, a reduction of friction has been shown to ease 
delivery of endovascular devices [161].  The process of stent placement typically results 
in endothelial denudation [233].  As a result, stent struts are in direct contact with 
underlying VSMCs.  More accurate computer modeling of in vivo stent behavior could be 
accomplished if the frictional properties of vascular cells were elucidated [160, 162].  
Similarly, finite element models of atomic force microscope (AFM) cell mechanics 
experiments have thus far relied on assumptions of frictional conditions, due to a lack of 
experimental data [163, 164].   
Numerous cellular constituents may play a role in governing frictional properties.  
The glycocalyx, an extracellular matrix of proteglycans and glycoproteins is believed to 
play a role in the lubrication of red blood cells [156] and endothelial cells [234].  
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Additionally, the glycocalyx is involved in mechanical signal transduction in both 
endothelial cells and VSMCs [165].  In the case of VSMCs, the glycocalyx is composed 
primarily of chondroitin sulphate and heparan sulphate [235].  Located beneath the 
glycocalyx, the cell membrane is composed of a lipid bilayer containing a wide array of 
transmembrane proteins.  Lipid bilayers alone have complex frictional and viscous 
properties [236], and in the case of intact living cells, these properties are likely made 
even more complex by the presence of transmembrane molecules and surface charge 
distribution.  Finite element research on the frictional properties of soft biological tissues 
has shown a positive correlation between the friction coefficient and the modulus of 
elasticity [231].  It is quite possible that this same relationship would exist for individual 
cells, in which case the cytoskeleton, the main determinant of cellular elastic modulus, 
would also play a significant role in governing cellular frictional properties.  In many cell 
types, actin and microtubules are the cytoskeletal components primarily responsible for 
determining cellular mechanical properties [237].  All of these cellular constituents 
(glycocalyx, cell membrane, cytoskeleton) are of course physically linked with one 
another, making it rather difficult to fully separate the effects of each on whole-cell 
frictional properties. 
The atomic force microscope (AFM) is a useful tool for the measurement of 
frictional forces at the nano- and micro- scales [141], a technique often referred to as 
lateral force microscopy.  Numerous studies have examined frictional properties on a 
range of materials, including various polymers, films, and lipid bilayers [141].  Currently 
however, very little data exist relating to the frictional properties of living cells or tissues 
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at the micro-scale.  However, recent studies have examined macro-scale frictional 
properties of vascular endothelial cells [160] and corneal epithelial cells [238, 239].  The 
AFM technique described herein is capable of providing microscale frictional data to 
complement the available macroscale data.  A significant advantage of AFM-based 
cellular friction measurements is the use of considerably lower normal loading forces as 
compared to macro-scale, reducing the chances of any cell damage occurring during the 
experimental procedure.   
The main goal of the current study was the development of an AFM-based 
technique for micro-scale measurement of individual cell surface frictional properties, as 
well as elucidation of the cellular physical constituents responsible for governing 
frictional behavior.  Vascular smooth muscle cells were chosen for this research due to 
the clinical relevance of their frictional properties with respect to endovascular surgical 
procedures. 
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Materials and Methods 
Cell Culture 
Rat aortic VSMCs were isolated from adult male Sprague-Dawley rats and 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Mediatech, Herndon, VA) 
with fetal bovine serum (FBS) (10 %) (Sigma, St. Louis, MO) and antibiotic/antimycotic 
solution (1 %) (Sigma).  Cells were maintained in T-75 polystyrene flasks in an incubator 
at 37 ºC, with 5% CO2, and fresh media was exchanged every 48 hours.   Cells were 
allowed to grow to ~80% confluency in the flasks, then trypsinized with 0.25% trypsin  
(Mediatech) / 0.02% EDTA (Sigma) and seeded onto 22 x 22 mm glass coverslips 
(VWR, West Chester, PA) at a density of 150,000 cells per coverslip   Seeded coverslips 
were incubated in 6-well plates with DMEM (10% FBS) at 37 ºC with 5% CO2, and 
media was exchanged every 48 hours prior to AFM experimentation.  Cells were utilized 
between passages 5 and 8. 
 
AFM Friction Experiments 
Atomic force microscopy (AFM) experiments were performed once cells had 
formed a confluent monolayer on coverslips, typically between 5 to 6 days.  For all AFM 
experiments, a Veeco Dimension 3000 AFM with a Nanoscope IV controller (Veeco 
Metrology, Santa Barbara, CA) was operated in contact scanning mode. A borosilicate 
spherical-tipped AFM probe (5 μm diameter) (NovaScan, Ames, IA) on a silicon-nitride 
cantilever with a nominal spring constant of 0.12 N/m, was used throughout the study.  A 
5 µm AFM probe was chosen, in part, due to its proximity in size to that of asperities 
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previously observed on the surface of endovascular stents in our laboratory, Fig 1.  
During AFM experiments, cells were kept on the coverslips in their culture media 
(DMEM w/ 10% FBS), which was exchanged approximately every 30 minutes with 
warm 37 ºC media throughout the course of the AFM experiments, each lasting for 
approximately 1 hr in total.   
 
 
 
Figure  5.1.  Scanning electron micrograph of a stainless steel stent, illustrating size and 
prevalence of surface asperities. 
 
 
Cells received one of the following treatments prior to AFM friction experiments; 
fixation with 3% glutaraldehyde overnight at room temperature, incubation with 0.2 U/ml 
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of chondroitinase ABC and 0.2 U/ml heparinase III (Sigma, St. Louis, MO) for 30 min. at 
37 °C, incubation with 5µM cytochalasin D (Sigma) for 30 min. at 37 °C.   Each of these 
agents was chosen due to their known effects on cellular structure.  Glutaraldehyde is a 
commonly used fixative for cells and tissues that induces significant crosslinking.  
Cytochalasin D is an agent known to disrupt the actin network of living cells.  
Chondroitinase ABC and heparinase III are responsible for the enzymatic degradation of 
the glycocalyx constituents chondroitin sulphate and heparan sulphate, respectively.  
Untreated VSMCs were used as controls.  
 Following the identification of a target cell, the AFM probe was positioned over 
the central region of the cell body. Elongated cells were chosen for friction testing, with 
the AFM probe reciprocating along the major axis of each test cell as in Figure 5.2, thus 
preventing the probe from coming into contact with adjacent cells or substrate.  Friction 
measurements were performed at a 90° scan angle with a scan size (reciprocating cutoff 
length) of 10 µm. 
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Figure 5.2.  Screen capture of AFM probe positioned over an elongated VSMC, with 
reciprocation along the major axis of the cell.   
 
 
Most measurements were performed at tip velocity of 20 µm/s, however for some 
experiments a velocity of 2 µm/s was used in order to evaluate velocity-dependence.  
Normal forces were incrementally increased by adjusting the deflection setpoint from -2 
to +8 volts, or approximately 0 to 100 nN, in 0.25 to 0.5 volt increments.  For each 
deflection setpoint on a given cell, 16 lines of trace and retrace frictional data were 
recorded, with 512 data points recorded per line (Figure 5.3).    
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Figure 5.3.  Representative raw trace and retrace curves from a VSMC.  512 data points 
were collected on each line.  Recording trace and retrace data allows one to distinguish 
frictional from topographical effects on the lateral signal. 
 
 
 
The maximum normal force exerted on each cell was in the range of 100 nN, with 
the exact value dependent upon deflection sensitivity and cantilever spring constant.   At 
the start and finish of each experiment, frictional force data were also collected on a clean 
glass coverslip in media.  The resulting friction coefficients could then be compared to 
existing data on the coefficient of friction between 2 glass surfaces under lubricated 
conditions, revealing whether the values determined for cells were reasonably accurate.  
The lateral sensitivity of the cantilever was determined using the previously 
published “modified wedge method” for calibration of micro-sized tips [240, 241].  
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Briefly, the probe was used to collect frictional force data on a flat mica surface, as well 
as a mica surface positioned at a known angle of incline.  The resulting voltage vs. 
normal force plots are used to determine the lateral sensitivity, α, of the cantilever.  This 
lateral sensitivity value is then used to convert all lateral deflection signals (V) into lateral 
force values (nN).  Cell surface frictional coefficients (µ) were then calculated based on 
the equation:  
FL = µ × FN, 
where  FL is the lateral force acting on the AFM probe, and FN is the normal force.  The 
normal force applied at each deflection setpoint was determined by the product of the 
deflection setpoint (V), deflection sensitivity (nm/V), and cantilever spring constant 
(N/m).   For untreated and glutaraldehyde-treated VSMCs, a Stribeck curve was plotted 
using data from 5 separate cells, with an approximation of the Sommerfeld number 
calculated as: 
               (η  ×  v)/FN, 
where η is the dynamic viscosity of DMEM (0.00078 Pa·s)[242], v is probe velocity (20 
µm/s), and FN is normal force (N),.   
Data Analysis 
Following each experiment, data were processed using custom MATLAB (The 
Mathworks,Inc., Natick, MA) scripts.  Excessive noise was filtered from the data by 
eliminating all data points greater than 2 standard deviations away from the mean lateral 
signal value at a given normal force.  The net lateral signal from each pair of trace and 
retrace lines is calculated as half of the difference between the two of them.   Laser drift 
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that occurred during frictional measurements was accounted for by recording the lateral 
voltage on the photodiode at the start and finish of each cell, and correcting using a linear 
algebraic function.  Mean lateral forces and standard deviations were plotted vs. normal 
forces, from which a linear fit was used to determine the slope of each line, i.e., the 
coefficient of friction, µ.   
Statistical Analysis 
Coefficients of friction between groups were compared using one-way analysis of 
variance (ANOVA) tests with subsequent pairwise comparison using Students t-tests.  All 
tests were performed with an alpha of 0.05, and p-values less than 0.05 were considered 
statistically significant. 
 132 
 
Results 
 
 
For the AFM cantilever used in these experiments, the lateral sensitivity, α, was 
found to be approximately 68 nN/V, based on two separate calibration measurements.  In 
total, 16 data points were collected at each given normal force, for each individual cell, 
Figure 5.4.   
 
Figure 5.4.   Representative frictional data (lateral force vs. normal force) from each 
VSMC group in the current  study.  Each curve corresponds to an individual cell chosen 
as a representative example due to its proximity to its respective VSMC group mean 
frictional coefficient.  Each data point within a curve represents the mean ± SD for a 
particular normal force.    
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One-way ANOVA comparison of friction coefficients indicated a statistically 
significant difference between groups, p<0.001.  Subsequent pairwise comparisons 
indicated significantly greater friction coefficients for glutaraldehyde treated VSMCs 
(µ=0.21 ± 0.04) vs. controls (µ=0.06 ± 0.02), p = 7.8 x 10-6, and significantly lower 
friction coefficients for cytochalasin D treated VSMCs (µ = 0.01 ± 0.01) vs. controls, p = 
3.4 x 10-6.  No significant difference was found between chondroitinase/heparinase 
treated VSMCs (µ = 0.06 ± 0.01) and controls (p = 0.41).  There was no significant 
difference between untreated VSMCs measured at 20 or 2 µm/s (µ = 0.05±0.001), p = 
0.17.  The mean coefficient of friction on glass coverslips in media was 0.18 ± 0.09, 
which is in the range of the coefficient of friction for glass on glass under lubricated 
conditions (0.1 to 0.6) [243].  Measured coefficient of friction values for all VSMC 
groups are compared in Figure 5.5.    
 
 
 
 
 
 
 
 
 
Figure 5.5.  VSMC coefficients of friction.  Data are presented as mean ± SD. 
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A linear fit to data in the approximated Stribeck curve for untreated VSMCs, revealed a 
positive slope with increasing (η  ×  v)/FN  ratio, Figure 5.6. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6.  Coefficient of friction for untreated VSMCs plotted versus an approximated 
Sommerfeld number.  The data points are from 5 separate VSMCs, and were fit with a 
linear trendline, R2 = 0.539. 
 
 
 
In contrast, the approximated Stribeck curve for glutaraldehyde-treated VSMCs revealed 
a relatively flat relationship between friction coefficient and (η  ×  v)/FN, Figure 5.7. 
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Figure 5.7.  Coefficient of friction for glutaraldehyde-treated VSMCs plotted versus an 
approximated Sommerfeld number.  The data points are from 5 separate VSMCs, and 
were fit with an exponential trendline, R2 = 0.0002. 
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Discussion 
 
The principal goal of the current study was to investigate the development of an 
AFM-based method for measurement of cell surface frictional properties on the micro-
scale, with a specific interest in vascular smooth muscle cells.  Secondly, an attempt was 
made to elucidate which cellular structural components are responsible for governing 
frictional behavior.  To the best of the authors’ knowledge, the current data represent the 
first reporting of cellular surface frictional coefficients obtained via AFM.  The mean 
coefficient of friction for untreated VSMCs found in the current study (0.06 ± 0.02) is 
similar to macroscale values previously reported for endothelial cells (μ = 0.03–0.06) 
[160] and corneal epithelial cells (μ = 0.05± 0.02) [239].  It should be noted that not only 
were these previous cellular friction studies conducted on different cell types on the 
macroscale, but probe speed, diameter, and velocity were all substantially different than 
the current study.  Each of these studies was carried out in media with 10% serum, 
meaning there was undoubtedly significant protein adhesion to the probe.  Such protein 
adhesion however, is precisely what one would expect from almost any implant material 
once it comes in contact with blood.  Protein adsorption has been found to increase 
friction on polymer surfaces [244], and  it may very well have had an effect under the 
current conditions, although this was not investigated.  No detachment or noticeable 
displacement of cells was observed in any of the VSMC sample groups during friction 
testing, indicating that the cells were firmly adhered to the substrate.  The lone exception 
to this was the observation that cytochalasin D treated VSMCs underwent a noticeable 
bulk reciprocating motion in phase with probe motion.  Through microscopic 
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observation, cells did not appear to be physically damaged as a result of AFM probe 
contact.  Furthermore, the use of spherical as opposed to pyramidal AFM probes, greatly 
reduces contact stresses at a given normal force and lessens the chances of cell damage 
[245].   
The observation that glutaraldehdye (a crossklinking agent) and cytochalasin D 
(an actin depolymerizing agent) caused significant increases and decreases in frictional 
coefficients, respectively, serves as evidence that bulk cellular modulus does correlate 
positively with frictional coefficient, as it does with whole tissue [231].  Although VSMC 
exposure to the glycocalyx degrading enzymes for chondroitin sulphate and heparin 
sulphate did not significantly affect frictional coefficients in the current study, this does 
not mean that the glycocalyx should be ruled out as a source of VSMC lubrication.  It is 
unlikely that the glycocalyx would be completely removed from enzymatic treatment at 
the concentrations used in this study [165]. Consequently, further investigation is 
warranted.  It has been suggested that fluid film lubrication, and in particular 
elastohydrodynamic lubrication, is a common  lubricating mechanism in biological 
systems [246].  Certainly, vascular smooth muscle cells such as those used in the current 
study are soft enough to be subject to deformation under most loading regimes.   
However, given that fluid film coefficients of friction are typically in the range of 0.001 
to 0.01, while boundary lubrication yields friction coefficients closer to 0.1, it is also 
possible that the intermediate values found for untreated VSMCs are indicative of a 
mixed  lubrication regime [247] for the contact and tribological conditions used in this 
study.  The Stribeck curve for untreated VSMCs plotted in the current study revealed a 
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positive correlation between frictional coefficient and the approximated Sommerfeld 
number.   This behavior is representative of fluid film lubrication.  This is in agreement 
with previously a published finite element simulation of elastohydrodynamic lubrication, 
showing decreasing frictional coefficients with increased pressure in soft biological 
tissues [231]. It is possible that glutaraldehyde-fixed VSMCs exhibited a different 
lubrication profile either due to mechanical changes (increased stiffness) or chemical 
changes at the cell surface.  If the former cause is true, and VSMC  mechanical  and 
frictional properties also varied in vivo, this could result in intrinsic variable contact 
stresses within the tissue, and a variable frictional profile over the surface, leading to 
disturbed contact stresses [248].    
 Future mechanistic studies examining VSMC lubrication regimes are indeed 
warranted, especially to further determine the effects of velocity, load, and lubricant 
viscosity.  One potential benefit of an AFM-based cellular friction technique is the ability 
to modify the AFM probes with any number of different surface chemistries, for instance 
based on charge or hydrophilicity.  In combination with treatments altering the physical 
chemistry and makeup of the underlying cells, such experiments could help reveal the 
underlying mechanisms of cellular and tissue lubrication.  The technique described  in the 
current study could be used to gather valuable information in the area of biotribology.  
Given the mechanical and material complexity of living cells, innovative and accurate 
frictional measurement techniques will be needed to determine the underlying 
mechanism(s) of friction and lubrication.  
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Conclusions 
 
Measurement of cellular surface frictional properties via AFM is a viable, albeit 
complex technique.  In the current study, frictional coefficients of untreated VSMCs were 
found to be approximately 0.06.  Frictional coefficients were increased by cellular 
crosslinking, and decreased by cytoskeletal depolymerization.  Further study using this 
technique is needed to determine the precise mechanisms underlying cellular lubrication.    
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CHAPTER SIX 
 
THE EFFECTS OF OXLDL ON MECHANICAL PROPERTIES OF VASCULAR 
SMOOTH MUSCLE CELLS 
 
 
Abstract:  The study of single cell mechanics has gained considerable interest recently, 
due in part to the recognition that mechanical properties can greatly affect physiologic 
behavior.  Vascular smooth muscle cells (VSMCs) and oxidized low density lipoprotein 
(oxLDL) are two of the key players in the development of vascular disorders, including 
atherosclerosis and restenosis.  Recently, it has been observed that oxLDL can affect the 
cytoskeleton of vascular smooth muscle cells.  In light of this evidence, it was 
hypothesized in the current study that oxLDL-associated cytoskeletal changes would 
have effects on VSMC mechanical properties.  This hypothesis was tested using atomic 
force microsopy based elastic and viscoelastic measuring techniques.  It was found that in 
vitro, oxLDL at a concentration of 50 µg/ml induced cytoskeletal and morphological 
changes in VSMCs similar to those associated with a transition towards a synthetic 
phenotype.   After 5 days of exposure, oxLDL caused significant reductions in apparent 
elastic modulus, and significantly increased rate and percentage of stress relaxation, when 
compared to controls.  These findings raise the possibility that similar VSMC mechanical 
changes may result from oxLDL exposure in vivo. 
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Introduction 
 
 
Oxidized low-density lipoprotein (oxLDL) is believed to be one of the most 
significant factors in vascular disease development [168], and the links between oxLDL 
and atherosclerosis have been well-documented by numerous researchers. [166, 167]  
Among the observed effects of oxLDL, is the alteration of cytoskeletal structure in both 
endothelial [169] and vascular smooth muscle cells (VSMCs) [170, 171].  Changes in 
cytoskeletal structure can have considerable effects on cellular biochemical responses to 
mechanical loading [116], given that the cytoskeleton plays a dominant role in governing 
mechanical properties of most cell types.  In endothelial cells, oxLDL-related 
cytoskeletal changes have been shown to result in cellular mechanical changes [169].  
However, no such investigation of oxLDL-associated VSMC mechanical changes has yet 
been performed. Vascular smooth muscle cells are subjected to mechanical loading from 
several sources, including blood pressure, blood flow, and in some cases, endovascular 
devices such as stents and angioplasty balloons.  For these reasons, a better understanding 
of VSMC mechanical changes associated with clinically relevant biochemical stimuli, 
such as oxLDL, is important not only in terms of gaining a basic understanding of the 
underlying phenomena, but in understanding vascular disease progression, and 
potentially developing targeted treatments.   
The atomic force microscope (AFM) is an extremely useful tool in the 
measurement of cellular mechanical properties, allowing for experimentation on living 
cells in aqueous media [147, 172, 173].  Recently, techniques have been developed to 
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analyze stress relaxation behavior of living cells using an AFM [154, 155, 249].  As cells 
typically exhibit viscoelastic behavior, AFM stress relaxation techniques can serve as a 
useful compliment to other AFM-based mechanical techniques such as cell indentation, 
which assume elastic behavior. 
 In the current study, it was hypothesized that oxLDL alters the viscoelastic 
properties of VSMCs through cytoskeletal and morphological changes.  To test this 
hypothesis, we examined the effects of oxLDL on cellular morphology, actin and 
microtubule distribution, as well as cellular viscoelastic and surface shear properties.   
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Materials and Methods 
 
Cell Culture 
Rat aortic VSMCs previously isolated from adult male Sprague-Dawley rats were 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Mediatech, Herndon, VA) 
with fetal bovine serum (FBS) (10 %) (Sigma, St. Louis, MO) and antibiotic/antimycotic 
solution (1 %) (Sigma).  Cells were maintained in T-75 polystyrene flasks in an incubator 
at 37 ºC, with 5% CO2, and fresh media was exchanged every 48 hours.   Cells were 
allowed to grow to no greater than ~70% confluency in the flasks, then trypsinized with 
0.25% trypsin  (Mediatech) / 0.02% EDTA (Sigma) and seeded onto 22 x 22 mm glass 
coverslips (VWR, West Chester, PA) at a density of 10,000 cells per coverslip.  Seeded 
coverslips were incubated in 6-well plates with DMEM (10% FBS) at 37 ºC with 5% 
CO2, for 24 hours.  After 24 hours,  FBS-supplemented DMEM was replaced with serum-
free DMEM supplemented with insulin-transferrin-selenium (ITS) media supplement 
(Sigma, St. Louis, MO) at a concentration of 5 µg/ml insulin, 5 µg/ml transferrin, and 5 
ng/ml sodium selenite.  Cells were kept in ITS-supplemented serum-free media for 72 
hours prior to addition of lipoproteins.    All cells in the current study were used between 
passages 4 and 6. 
 
Lipoprotein Supplementation 
 
Native LDL and OxLDL were obtained from Biomedical Technologies,Inc 
(Stoughton, MA).   The oxidation level of OxLDL was 17.7  nmoles of MDA/mg protein, 
as determined by the supplier.   Following 72 hours in ITS-supplemented DMEM, 
VSMCs were exposed to either native LDL or OxLDL at a concentration of 0.05 mg/ml 
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for periods of 1,3, and 5 days.  Control VSMCs remained in media only for the same time 
periods.  Media was exchanged every 24 hours, along with fresh aliquots of LDL and 
OxLDL.   
 
Immunofluorescence 
Immunofluorescence staining was used to visualize actin filaments and 
microtubules.  At each timepoint, VSMCs were fixed in 4% paraformaldedyde at room 
temperature for 30 minutes.  The cells were then incubated with blocking solution 
consisting of PBS (90%) (Sigma), bovine serum albumin (3.8%) (Sigma), donkey serum 
(3.0%) (Sigma), and Triton-X (0.2%) (Sigma) for 30 minutes.  This was followed by 
incubation with a beta-tubulin primary antibody (Invitrogen, Inc. Carlsbad, CA) at 4°C 
overnight for microtubule staining.  The cells were then incubated the following day with 
a TRITC-conjugated secondary antibody (Invitrogen, Inc., Carlsbad, CA) for 2 hours, 
followed by alexa fluor 488 conjugated phalloidin (Sigma) at room temperature for 15 
minutes for actin staining, and DAPI nuclear staining for 5 minutes (Invitrogen, Carlsbad, 
CA).   All samples were viewed using an Olympus IX71 inverted microscope (Olympus, 
Tokyo, Japan); images were collected and processed using HCImage software 
(Hamamatsu Corp., Bridgewater, NJ).  Cells from the 5 day treatment group were 
measured along their major and minor axes using HCImage software (Hamamatsu Corp., 
Bridgewater, NJ), as an approximate measure of any changes to cell size and shape that 
resulted from oxLDL treatment.  For each group, 25 randomly selected cells were used 
for measurements.  
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Confocal Microscopy 
Confocal microscopy was performed using a Zeiss LSM 510 (Carl Zeiss 
MicroImaging, Inc., Thornwood, NY).  As with the conventional fluorescence 
microscopy, cells were fixed on glass coverslips with 4% paraformaldehyde, and F- actin 
was labeled with alexa fluor 488 conjugated phalloidin, while beta-tubulin was labeled 
with anti-beta tubulin and a TRITC-conjugated secondary antibody (Invitrogen).  Some 
samples were also stained with amphipathic Cellmask™ Deep Red, a Membrane Stain 
(Invitrogen), both prior to and after plasma membrane permeabilization in order to 
visualize cell shape.  Coverslips containing labeled cells were mounted on glass slides 
along with SlowFade Gold antifade reagent (Invitrogen).  Confocal images were 
processed using Zeiss LSM Image Browser software (Carl Zeiss Microimaging). 
 
AFM Mechanical Measurements 
Cellular indentation and stress relaxation tests were performed on VSMCs in 
succession.  Briefly, the AFM probe was first positioned over the center of a target cell.  
Three consecutive indentation curves were taken at an approach speed of 500 nm/s.  The 
quasi-static loading was then followed by a 120 sec stress relaxation  test, with an 
indentation distance of 1 µm at 50 µm/s approach speed, as previously described [249].  
At 3 and 5 day timepoints, 11 cells were subjected to indentation and stress relaxation 
testing for both control and oxLDL groups, while 6 cells were tested for each group at 1 
day.  Lateral force microscopy measurements were also performed on some cells, during 
which the AFM probe was reciprocated at a 90° angle  along a 10 µm path length at 20 
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µm/s, with incremental increases in normal force up to approximately 100 nN.    For all 
measurements, a 5 µm diameter borosilicate probe with a spring constant of 0.12 N/m 
was used.  
 
Modeling  
 
Following AFM experiments, indentation curves were fit using the modified 
Hertz model for a spherical indenter [250] 
 
 
 
where F is the measured force (N), δ is indentation depth (m), E is apparent elastic 
modulus (Pa), υ is Poisson’s ratio (0.5) [187], and R is the spherical indenter radius (2.5 
μm).  The Hertz model was fit to an indentation depth of 300 µm, which is approximately 
10% of VSMC height on the glass substrates used in the current study.  Apparent elastic 
moduli were calculated by averaging the three indentation curves from each cell.  
Hysteresis exhibited by each indentation loop was calculated by subtracting the area 
under the entirety of each retraction curve from the area under the entirety of its 
corresponding indentation curve, and then normalizing by the area under the indentation 
curve in order to account for variations in indentation depth.  Nonspecific adhesion 
between VSMCs and the AFM probe was quantified by measuring the maximum 
separation force from each retraction curve. 
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Stress relaxation curves were fit using  the QLV reduced relaxation function, 
 
 
 
 
 
 
where  τ1 and τ2 are time  constants governing short and long term relaxation behavior, 
respectively,  and c  is a unitless constant, representing a relative measure of viscous 
energy dissipation (damping). 
Relaxation curves were also fit with a power-law relaxation model, 
 
 
where A and α are constants governing the rate of decay.   
All stress relaxation curves were shifted to give a baseline force value of 0 and 
were then normalized by their respective force values at time, t=0.01 s  to obtain a 
starting (maximum) force value of 1.0 for each relaxation curve.   The 0.01 s time point 
was used as the initial time point for normalization due to the usage of logarithmic time 
spacing and the 100 Hz initial sampling rate.  Following normalization, data were 
resampled using logarithmic spacing with 100 data points from the start to the finish of 
each test.  The degree of relaxation was quantified for each relaxation curve using the 
parameter G(120), denoting G at t=120 s.  Nonspecific adhesion during relaxation tests 
was quantified using the breakaway force during tip retraction. 
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For lateral force data, excessive noise was first filtered from the data by 
eliminating any data points greater than 2 standard deviations away from the mean lateral 
signal value at a given normal force.  The net lateral signal from each pair of trace and 
retrace lines was calculated as half of the difference between the two lines.   Laser drift 
that occurred during lateral force measurements was accounted for by recording the 
lateral voltage on the photodiode at the start and finish of each cell, and correcting using 
a linear algebraic function.  Mean lateral voltage and standard deviations were plotted 
against normal forces, and a linear fit was used to determine the slope of each line, µ, 
which represents the magnitude of lateral probe deflection from shear forces at the cell 
surface.  All numerical data were processed using custom MATLAB (The Mathworks, 
Natick, MA) scripts. 
 
Statistical Analyses 
Two-way analysis of variance (ANOVA), with time and LDL treatment as 
factors, was used for comparison of Hertzian apparent elastic moduli, hysteresis, G(120), 
and the power-law exponent, α.  Post-hoc pairwise analyses were performed using the 
Holm-Sidak method.  In addition, correlations between measured variables were 
compared using coefficients of correlation.  Coefficients of determination (R2) were 
calculated for each individual curve fit for both stress relaxation models.  Constants 
derived from each model are presented as a mean ± standard deviation.  P-values < 0.05 
were considered statistically significant for all tests.   
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Results 
 
 
Immunostaining and fluorescence imaging revealed no changes to cell 
morphology, actin, or microtubule structure, for native LDL-treated VSMCs at any 
timepoint in the current study, Figure 6.1.   However, treatment with oxLDL led to 
changes in VSMC morphology and cytoskeletal structure were noted at both 3 and 5 
days.  More specifically, at 3 days oxLDL-treated VSMCs exhibited elongated processes 
extending from the cell body, and greater dispersion of microtubules when compared to 
untreated VSMCs, Figure 6.2.   
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Figure 6.1.  LDL-treated VSMC actin stained with phalloidin at 1,3, and 5 days (a,c,e) 
and LDL-treated VSMC microtubules stained with anti-alpha tubulin at 1,3, and 5 days 
(b,d,f).  Images were captured using a fluorescent microscope at 20x magnification, and 
processed using HCImage software. 
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Figure 6.2  (a) OxLDL-treated VSMC microtubules stained with anti-alpha tubulin at day 
3 (b) Control VSMC microtubules stained with anti-alpha tubulin at day 3 
 
 
 
At 5 days, the oxLDL group displayed fewer actin stress fibers in the central cell regions, 
along with continued microtubule dispersion. In contrast,  control VSMCs exhibited 
greater actin fiber content, and a concentrated microtubule aster in the perinuclear region 
with longer microtubules radiating from it, Figure 6.3.   
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Figure 6.3.  (a&b) Control VSMCs at day 5, green regions are F-actin, red regions are 
microtubules ; (c&d) OxLDL-treated VSMCs at day 5, green regions are F-actin, red 
regions are microtubules. 
 
Staining of oxLDL-treated VSMCs with CellMaskTM revealed substantial lipid 
staining throughout the cytoplasm, particularly in dense microtubule regions, in both 
permeabilized and unpermeabilized VSMCs at day 5, Figure 6.4, d,e,f.    In contrast, 
control VSMCs stained with CellMask exhibited lipid staining only in the perinuclear 
region, again colocalized with dense microtubule structure, Figure 6.4, a,b,c.   
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Figure 6.4.   Confocal microscopy images of (a) membrane permeabilized control 
VSMCs stained with CellMask (white) and anti-beta tubulin (red), showing staining 
predominantly in the central region of each cell, and colocalization of CellMask staining 
with microtubules, (b) Membrane permeabilized control VSMCs stained with CellMask 
(white), (c) unpermeabilized control VSMCs fixed and stained with CellMask (red), (d) 
membrane permeabilized oxLDL-treated VSMCs stained with CellMask (white) and 
anti-beta tubulin (red), showing staining throughout  each cell, and colocalization of 
CellMask staining with microtubules, (e) Membrane permeabilized oxLDL-treated 
VSMCs stained with CellMask (white), and (f) unpermeabilized oxLDL-treated VSMCs 
fixed and stained with CellMask (red). 
 
 
The mean cell dimensions were similar in oxLDL-treated VSMCs (140 and 50 
µm along the major and minor axes, respectively), and control VSMCs (120 and 50 µm 
along the major and minor axes, respectively), n=25.   
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OxLDL-treated VSMCs had mean elastic moduli of (4.4 ± 3.1, 1.6 ± 0.7, and 1.6 
± 0.8 kPa at 1, 3, and 5 days, respectively), Figure 6.5.  A mean elastic modulus of (3.1 ± 
1.4, 2.9 ± 1.6, and 3.6 ± 1.4 kPa at 1, 3, and 5 days, respectively) was determined for 
control VSMCs, Figure 6.5.  Two-way ANOVA revealed a statistically significant effect 
of time after allowing for the effects of treatment (p=0.029) and a statistically significant 
interaction between time and treatment (p=0.012).  Subsequent pairwise analyses 
revealed a significant difference between oxLDL and control at day 5 (p=0.003) and 
significant differences within the oxLDL group when comparing days 1 vs. 3 and 1 vs. 5, 
(p=0.001) for each.   
 
 
 
 
 
 
Figure 6.5.  Apparent elastic moduli of oxLDL-treated VSMCs (black) and controls 
(white) at 1,3, and 5 days.  Data represent means ± SD. 
 
p= 0.003 
p= 0.001
p= 0.001
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Analysis of indentation loop hysteresis, showed a significant effect of time after 
allowing for the effects of treatment (p=0.012), treatment after allowing for the effects of 
time (p=0.026), and significant interaction between time and treatment (p<0.001).  
Subsequent pairwise analyses revealed a significant difference between oxLDL and 
control (p<0.001) at day 5 and significant differences within the oxLDL group when 
comparing days 1 vs. 5 and 3 vs. 5, (p<0.001 for each), Figure 6.6.  OxLDL-treated 
VSMCs had mean hysteresis values of (0.24 ± 0.1, 0.31 ± 0.2, and 0.64 ± 0.3 at 1, 3, and 
5 days, respectively), Figure 6.6.  Control VSMCs   had mean hysteresis values of (0.3 ± 
0.1, 0.3 ± 0.2, and 0.25 ± 0.1 at 1, 3, and 5 days, respectively), Figure 6.6 
 
 
 
 
 
 
 
 
 
 
 
 Figure 6.6.  Indentation loop hysteresis of oxLDL-treated VSMCs (black) and controls 
(white) at 1,3, and 5 days.  Data represent means ± SD. 
 
p <  0.001 
p <  0.001 
p <  0.001 
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Nonspecific adhesion between VSMCs and the AFM probe was significantly greater (p 
<0.001) at 5 days for oxLDL-treated VSMCs compared to controls, (2.3 ± 0.9 pN vs. 0.9 
± 0.4 pN, respectively).   
In quantifying stress relaxation via the parameter G(120), there was a significant 
interaction between time and treatment (p=0.008).  Subsequent pairwise analysis revealed 
a significant difference between oxLDL and control at day 5 (p=0.001), Figure 6.7.  
OxLDL-treated VSMCs had mean G(120) values of (0.25 ± 0.1, 0.31 ± 0.1, and 0.18 ± 
0.1 at 1, 3, and 5 days, respectively), Figure 6.7.  Control VSMCs had mean G(120)  
values of (0.18 ± 0.2, 0.31 ± 0.1, and 0.4 ± 0.1 at 1, 3, and 5 days, respectively), Figure 
6.7. 
  
 
 
 
 
 
 
 
 
 
Figure  6.7.  G(120) of oxLDL-treated VSMCs (black) and controls (white) at 1,3, and 5 
days.  Data represent means ± SD. 
p =  0.001 
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For the power-law relaxation exponent, α, there was a significant interaction 
between time and treatment (p=0.005), with subsequent pairwise analysis revealing a 
significant difference between oxLDL and control at day 5 (p<0.001), Figure 6.8.  
OxLDL-treated VSMCs had mean α values of (-0.12 ± 0.1, -0.12 ± 0.1, and -0.17 ± 0.1 at 
1, 3, and 5 days, respectively), Figure 6.8.  Control VSMCs had mean α values of (-0.14 
± 0.04, -0.13± 0.06, and -0.08 ± 0.02 at 1, 3, and 5 days, respectively), Figure 6.8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  6.8.  Power-law exponent, α, of oxLDL-treated VSMCs (black) and controls 
(white) at 1,3, and 5 days.  Data represent means ± SD. 
 
 
p <  0.001 
 158 
 
 Both the QLV reduced relaxation function and the power-law model fit the stress 
relaxation data well (R2 = 0.98 ± 0.02 and 0.96 ± 0.05, respectively).  OxLDL-treated 
VSMCs had greater C values, and lower τ1 values at all three timepoints, while τ1 was 
greater in the oxLDL group at 1 and 3 days, but lower at day 5, Table 5.1. 
 
Table 5.1.  QLV reduced relaxation function parameters. 
 
 
 
 
 
 
 
No significant difference in cell adhesion was observed between oxLDL and control 
VSMCs following stress relaxation tests at day 5, (1.34 vs. 1.87 nN, respectively, 
p=0.20). 
Day Group C τ1 τ2 
1 Control        0.45±0.21 0.16±0.12 150±160 oxLDL 0.73±1.2 0.09±0.04 380±290 
     
3 Control 0.33±0.32 0.13±0.21 170±260 oxLDL 0.70±1.2 0.06±0.02 300±310 
     
5 Control 0.15±0.06 0.09±0.07 480±390 oxLDL 1.0±1.7 0.05±0.03 220±250 
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Strong correlations were found between the different measures of viscous energy 
dissipation, G(120), α, C, and to a lesser extent, indentation hysteresis, used in the current 
study (gray shaded cells in Table 5.2).  Apparent elastic modulus showed moderate 
correlations with viscous measures (green shaded cells in Table 5.2).  Lateral force 
measurements were strongly correlated with measures of viscous dissipation (yellow 
shaded cells in Table 5.2).   
 
Table 5.2  Correlation coefficients of VSMC mechanical parameters. 
  E G120 C α Hys µ 
E 1.00      
G120 0.20 1.00     
C -0.29 -0.61 1.00    
α 0.41 0.76 -0.61 1.00   
Hys -0.46 -0.49 0.41 -0.76 1.00  
µ -0.25 -0.66 0.86 -0.72 0.58 1.00 
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Discussion 
 
 
The study of single cell mechanics has gained considerable interest in recent 
years, as researchers have begun to recognize the importance of cellular mechanical 
properties in regulating many physiological processes.  Among the key tasks within this 
field of study is the determination of what stimuli, either mechanical or chemical, affect 
cellular mechanical properties.  With regard to vascular function and disease progression, 
oxLDL is known to have numerous effects, including the potential to alter cytoskeletal 
structure in both ECs and VSMCs.  Based upon these prior observations, the purpose of 
the current study was to determine whether oxLDL caused mechanical changes to 
VSMCs in an in vitro environment  
After 5 days of exposure, oxLDL-treated VSMCs displayed fewer actin stress 
fibers, increased cytoplasmic organelle content, and lamellopoid-like protrusions.  All of 
these observations are characteristic of cell cycle and phenotypic changes  [45, 251].  It 
has been proposed that oxLDL causes a shift towards a synthetic phenotype via the 
induction of cell cycle proteins [252], with involvement of MAPK pathways [253].  The 
decreased cell stiffness of  VSMCs observed in this study, due to a reduction in actin 
stress fiber content, would agree with previous VSMC mechanical measurements relating 
to phenotype [126, 250].  The reduced actin stress fibers in the oxLDL-treated cells 
would also mean an increased role of the viscous cytoplasm in governing viscoelastic 
behavior, providing a possible explanation for the reduced viscosity and more fluid-like 
behavior of the oxLDL group in the present study.   
 161 
 
The precise effects of microtubule dispersion in the mechanical behavior of 
oxLDL-treated VSMCs are unclear.  However, it is possible that the highly organized 
microtubule asters found in the central region of control VSMCs contributed to the 
greater stiffness and viscosity.  Previous research in our laboratory demonstrated that 
VSMCs treated with the microtubule stabilizing agent paclitaxel, showed significantly 
increased viscosity[249].  .  The microtubule dispersion observed in the oxLDL group 
may be a result of their role in cell motility, cell cycle changes, or intracellular organelle 
transport [254, 255], which rely on the dynamic instability of microtubules.  Together, it 
can be speculated that relative stability or instability of the microtubular network may 
play a key role in cellular viscoelastic behavior.   
The CellMask stain used in this study is amphipathic, that is, it is largely 
hydrophobic, but includes a hydrophilic moiety at one end in order to anchor onto 
phospholipid membranes.  It is for this reason, that the observed staining patterns likely 
reflect the presence of cytoplasmic organelles, which are surrounded by phospholipid 
membranes.  Increased synthetic organelle content within oxLDL-treated VSMCs may 
actually serve to increase cytoplasmic viscosity [256].  It is not known what effect, if  
any, this may have had in the current study, but nonetheless this provides an interesting 
question for further investigation.  The increased nonspecific adhesion for oxLDL-treated 
cells at 5 days between the AFM probe and cell, may relate to previous observations that 
oxLDL upregulates adhesion receptors, and that VSMCs isolated from atherosclerotic 
arteries have been found to exhibit greater levels of adhesion to underlying substrates 
[257, 258].  
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Cytoskeletal and morphological changes of VSMCs in response to oxLDL 
treatment have been observed previously [171, 259].  Both minimally modified LDL 
(mmLDL) and more highly oxidized oxLDL were shown to induce actin disruption in 
VSMCs, with the former binding to LDL receptors, while the latter binds to scavenger 
receptors [260].   Previous studies have shown that VSMCs treated with 50ug/ml of 
oxLDL in the presence of ITS-supplemented media show significantly increased cell 
proliferation [252]. However, oxLDL has been shown to have dramatically varying 
effects on VSMCs, ranging from increased proliferation at concentrations of 35 and 50 
µg/ml, to apoptosis at concentrations over 100 µg/ml.[252, 261]  In vivo, VSMCs 
contribute to the development of atherosclerotic plaques in several different ways, 
including cell proliferation, migration, and apoptosis.  In light of this and the varying in 
vitro results reported in the literature, it is clear that the effects of oxLDL on VSMCs are 
highly dependent on numerous variables, including concentration, extent of LDL 
oxidation, and exposure time.   
In the current study, changes to actin an microtubule structure were associated 
with significant changes in viscoelastic mechanical measurements.  Based upon the 
immunfluorescence staining results, oxldl-treated and control VSMCs were mechanically 
tested at 1, 3, and 5 day timepoints.  LDL-treated VSMCs were not mechanically tested, 
due to the lack of observed cytoskeletal or morphological effects. When compared to 
controls, oxLDL-treated VSMCs showed significantly increased relaxation rate and 
percentage (alpha and G(120)) at 5 days.  Indentation loop hysteresis was significantly 
greater for oxLDL compared to controls at 5 days, with an increasing trend over time.  
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Together with apparent elastic modulus also being significantly lower in the oxLDL 
group compared to controls at 5 days, these data suggest increasing fluid-like behavior of 
VSMCs when subjected to prolonged oxLDL treatment, with the opposite occurring in 
control cells, most likely due to serum withdrawal and contractile protein upregulation 
[250]. 
Both the QLV reduced relaxation function and the power-law model used in this 
study provided very good fits to the data (R2=0.96 and 0.98, respectively).  For the 
reduced relaxation function, the mean short term time constant, τ1, was lower for oxLDL-
treated VSMCs compared to controls at each timepoint, and in both groups, decreased at 
each successive timepoint.  In viscoelastic materials, relaxation time constants generally 
decrease with lower viscosity or greater elasticity.  When approached from this 
perspective, the decrease in τ1 in the oxLDL cells can be viewed as resulting from 
decreased viscosity, in light of the decreased elastic behavior, as quantified via apparent 
elastic modulus.  However, in control VSMCs, decreasing τ1 more likely resulted from 
increasing contribution from elastic elements (e.g. actin fibers).  The mean long term time 
constant, τ2, consistently increased with time for control groups, while it consistently 
decreased for ox-LDL groups.  Recent evidence suggests that actin stress fibers are 
viscoelastic in their behavior, with retraction behavior after severing characterized by a 
viscoelastic element with a spring and dashpot in parallel [262].  In the current study, an 
increasing long term time constant in the control group, τ2, may reflect the viscous 
behavior of the actin stress fibers over longer time periods, while the decreasing τ2 in 
oxldl-treated cells reflects the disappearance of these fibers, and a heightened role of 
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other cellular constituents in determining viscoelastic behavior.   It should be noted that 
too much weight should not be assigned to the precise values found for the short and long 
term time constants, as QLV time constants, especially τ2, can vary greatly [224].   
The range of power-law exponents describing VSMC relaxation behavior in the 
current study demonstrate a weak frequency dependence in agreement with previous 
studies examining power-law behavior of other cell types [263].  The power-law 
exponent, α, while not an indicator of physical mechanisms governing relaxation 
behavior, does provide a simple means of comparing the physical rates of relaxation 
between different materials.  Values of the power-law exponent in the current study 
indicate that after 5 days, oxLDL-treated VSMCs display more fluid-like behavior (i.e., 
stronger frequency dependence), when compared to controls, in agreement with the 
reduced relaxation function damping constant, C.   
When comparing the mechanical parameters calculated from the experiments in 
this study, strong correlations emerged between the different measures of viscous 
behavior, which provides further support for the validity of each.  The relatively lower 
correlation between apparent modulus and viscous measures underscores the idea that 
indentation measurements do not capture all relevant viscoelastic properties, and cannot 
be solely relied upon to quantify cellular mechanical behavior.  Lateral force 
measurements were found to correlate positively with measures of viscous energy 
dissipation, although the sample size was relatively small (n=10) and variations within 
lateral force measurements were minute as well.  Nonetheless, this observation may result 
 165 
 
from greater contact area between cell and probe during lateral force measurements in 
less viscous (more fluid-like) cells.   
Plasma oxLDL levels are a strong predictor of acute coronary heart disease 
events[264] and restenosis after stent placement[265].  The lipoprotein concentration 
used in this study was close to that found in serum of human subjects with coronary 
artery disease [266].  However, oxLDL levels found within subendothelial space in 
vascular lesions are likely to have much higher levels of oxLDL than those found in 
blood, due to antioxidation defenses within the bloodstream [267].  Further investigation 
is necessary to determine any physiological changes that may result from oxLDL-
associated mechanical changes.  From the perspective of arterial mechanics, oxLDL-
induced cellular phenotypic shifts, as hypothesized to have occurred in the current 
research, would likely cause a drop in cell stiffness.  However, there would also likely be 
increased ECM deposition, thereby explaining the previously observed correlation 
between oxLDL levels and decreasing arterial compliance [268, 269]. 
 
Conclusions 
 
 
Data from the current study indicate that oxLDL can induce significant changes to 
the viscoelastic properties of VSMCs in vitro, including decreased stiffness and viscosity.  
The potential clinical implications of this finding warrant further research. 
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CHAPTER SEVEN 
CONCLUSIONS AND RECOMMENDATIONS 
Conclusions 
 
The current research was motivated by the desire to gain a better understanding of 
VSMC mechanical and frictional behavior at the single cell level, and to develop useful 
techniques to quantify that behavior and its responses to clinically relevant conditions and 
stimuli.  The atomic force microscope was chosen as a platform for this research due to 
the ability to perform measurements on living cells in media, versatility in mechanical 
and frictional measurement, imaging capabilities, and commercial availability.   
The first aim of this research was to determine whether or not VSMC phenotypic 
shifts resulted in cellular mechanical changes.   A better understanding of the concurrent 
changes to VSMC mechanical properties that occur with phenotypic shifts can help 
elucidate the role of VSMC mechanics in the development of vascular diseases.  In the 
current study, the mechanical properties of adherent cultured rat aortic VSMCs were 
assessed by atomic force microscopy (AFM).  Serum starvation  in DMEM was used to 
induce a phenotypic shift toward a contractile state in vitro, while control groups were 
kept in DMEM with 10% FBS.  Cellular indentation with the AFM was conducted, and 
the resulting force curves were fit using the Hertz model.  The Hertz model allows for 
computation of an apparent elastic modulus for each cell.  In addition, viscous energy 
dissipation (hysteresis) was calculated for each indentation curve.  It was concluded that 
serum starvation caused a statistically significant increase in apparent elastic modulus 
 167 
 
after 5 days, as well a statistically significant decrease in hysteresis after 3 days in 
culture.  Furthermore, serum starved VSMCs became more elongated than controls, 
which exhibited more spreading.  Use of the Hertz model was validated by calculating 
apparent elastic modulus as a function of indentation depth, over the range of depths used 
in this study.  This demonstrated sufficient linearity in elastic modulus, one of the key 
assumptions of the Hertz model.  Indentation force maps over the surface of the cells 
revealed relatively small variations in elastic modulus over the central region of the cell, 
validating the usage of a single indentation point with a sufficiently large probe.  The 
current mechanical data are in agreement with previously published research dealing with 
the relationship between phenotypic state and mechanical properties of non-adherent 
VSMCs.  If these observed trends in VSMC mechanical property alterations were to hold 
true in vivo, such changes could affect the processes of mechanotransduction and/or 
arterial mechanical properties, thereby contributing to the progression of vascular disease.  
As proliferative VSMCs are typically associated with a disease state, this study served as 
proof of concept that significant mechanical differences exist between “healthy” and 
diseased VSMCs.    
The second aim was to determine the role of specific cytoskeletal components in 
determing VSMC stress relaxation behavior.  Given that the first phase of research 
showed that significant mechanical changes can occur during phenotypic changes, an 
understanding of the roles of specific cytoskeletal components responsible for such 
changes was needed.  Furthermore, given the viscoelastic behavior of living cells, the 
Hertzian elastic modeling commonly used for AFM cell mechanics research was deemed 
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inadequate on its own.  As a means to quantify viscoelastic properties,  a novel method of 
AFM stress relaxation experimentation and modeling was developed.  Various 
cytoskeletal agents with known effects on actin or microtubules, including cytochalasin 
D, jasplakinolide, paclitaxel, and nocodazole, were used to alter the cytoskeletal 
architecture of the VSMCs.  Stress relaxation experiments were performed on the 
VSMCs using AFM.  Indentation was performed with a 5 µm  spherical probe at 50 µm/s 
in order to approximate a step strain.  The quasilinear viscoelastic (QLV) reduced  
relaxation function, as well as a simple power-law model, and the standard linear solid 
(SLS) model, were fit to the AFM stress relaxation data.  As a necessary condition for use 
of the reduced relaxation function, strain independence was investigated and confirmed.  
Statistical comparisons of stress relaxation behavior were performed  using the 
percentage of relaxation (G(120) and rate of relaxation (power-law exponent, α).  In 
addition, the reduced relaxation function yields two time constants, and a unitless 
measures of damping, while the SLS model yields two time constants as well.  Actin 
depolymerization via cytochalasin D resulted in significant increases in both rate of 
relaxation and percentage of relaxation, while actin stabilization via jasplakinolide did 
not affect stress relaxation behavior.  Microtubule depolymerization via nocodazole 
resulted in nonsignificant increases in rate and percentage of relaxation, while 
microtubule stabilization via paclitaxel caused significant decreases in both rate and 
percentage of relaxation.  Both the QLV reduced relaxation function and the power-law 
model provided excellent fits to the data (R2 = 0.98), while the SLS model was less 
adequate (R2 = 0.91).   Failure of the SLS model to properly fit the data, illustrate the 
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divergence in mechanical characteristics of living cells from many common viscoelastic 
materials.  Data from the current study indicate the important role of not only actin, but 
also microtubules, in governing VSMC viscoelastic behavior.  Depolymerizatin of actin 
leads to more fluid-like behavior of the cell.  Based upon these data, as well as  
previously published  research, the role of microtubules in  governing cellular 
viscoelastic behavior appears to be highly dependent on specific experimental conditions, 
and more complex than that of actin.  From a clinical perspective, the significant 
mechanical changes induced by paclitaxel are relevant, due to its usage in drug eluting 
stents that are already available on the market.  Further research into potential adverse 
physiological effects of these mechanical changes is necessary.  Additionally, this 
research underscores the need and benefit of characterizing cell mechanics using 
viscoelastic, rather than purely elastic models.   
The third aim was to develop a method to measure surface cellular frictional 
properties.  With the advancement of the field of biotribology, considerable interest has 
arisen in the study of cell and tissue frictional properties.   Much interest exists in the 
determination of how cells crawl, migrate, and flow through narrow spaces in vivo.  From 
the perspective of medical device development, the frictional properties between a rigid 
surface and underlying cells and tissues is of a particular clinical interest.   As with many 
bearing surfaces, it is likely that contact asperities exist at the size scale of single cells 
and below.  Thus, a technique to measure cellular frictional properties would be 
beneficial from both a clinical and a basic science perspective.  In the current study, an 
atomic force microscope with a 5 µm diameter borosilicate spherical probe was used to 
 170 
 
measure the surface frictional properties of vascular smooth muscle cells (VSMCs).  A 
technique commonly used for frictional measurement of synthetic materials, known as 
lateral force microscopy (LFM), was adapted for use with VSMCs in media.  A 5 µm 
borosilicate spherical probe,  a 10 µm reciprocating path length over the major axis of 
single cells, speeds of 2 and 20 µm/s, and normal forces up to approximately 100 nN 
were used for experimental parameters.  All experiments were performed in DMEM. 
Various treatments were used to alter cell structure, in order to better understand the 
cellular components and mechanisms responsible for governing frictional properties.  
Actin depolymerization, and therefore cell softening, was induced using cytochalasin D, 
while crosslinking (cell stiffening) was achieved using paraformaldehyde fixation.  In 
addition, the main constituents of the VSMC glycocalyx, chondroitin sulfate and heparan 
sulfate, were partially degraded via enzymatic treatment with the enzymes chondroitinase 
and heparinase, respectively.  In some experiments, the AFM probe was chemically 
modified via SAMs, to make the surface hydrophobic or hydrophilic, or else give a 
positive or negative charge.  It was found that untreated VSMCs had a frictional 
coefficient of approximately 0.06.  This frictional coefficient also appears to be greatly 
affected by cellular rigidity, with softer cells treated with cytochalasin D having a lower 
coefficient of friction than paraformaldehyde treated cells.  This positive correlation 
between cell stiffness and frictional coefficient is also what has been found for whole 
tissues.   No changes to frictional properties resulted from glycocalyx degradation, and 
data from chemically modified probes were inconclusive.  The technique of measuring 
frictional properties at the surface of cells using lateral force microscopy appears to be a 
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viable one, with potential for investigation of various probe chemistries in the future.  
However, further research is required to determine the exact nature of the interactions 
between the AFM probe and cell surface, as well as the sensitivity of this technique.  This 
includes treatment to manipulate the cell surface and/or AFM probe.  Investigation into 
the mode of lubrication is also warranted. Data from the current study indicate the 
possibility of an elastohydrodynamic or mixed lubrication regime, but further research is 
needed before any definitive conclusions can be drawn.    
The fourth and final research aim was the application of the elastic, viscoelastic, 
and frictional measurement techniques developed in the prior 3 aims, toward the 
investigation of frictional and mechanical effects resulting from clinically relevant 
VSMC stimuli.   For this purpose, the lipoproteins LDL and oxLDL were chosen.  Both 
LDL and oxLDL are well known to be associated with vascular disease development.  
Past studies have shown that oxLDL in particular can cause cytoskeletal changes to 
VSMCs in vitro.  In light of this evidence, it was hypothesized in the current study that 
oxLDL-associated cytoskeletal changes would have also effect VSMC mechanical 
properties.  This hypothesis was tested using AFM-based elastic and viscoelastic 
measuring techniques, including stress relaxation, Hertz indentation, and hysteresis 
measurement.  In addition to these mechanical measurements, imaging of cytoskeletal 
components (actin and microtubules) was carried out using fluorescent and confocal 
microscopy.  VSMCs were serum deprived (with the addition of ITS media supplement) 
for 72 hours prior to lipoprotein supplementation   It was found that in vitro, oxLDL at 50 
µg/ml induced cytoskeletal and morphological changes in VSMCs similar to those 
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associated with a transition towards a synthetic phenotype.  Specifically, oxLDL 
treatment was associated with a reduction in actin stress fiber content, as well as  
increased microtubule and organelle dispersion.  No changes were observed in LDL or 
control VSMCs, and as  a result, LDL groups were not mechanically tested.  After 5 days 
of exposure, oxLDL caused significant reductions in apparent elastic modulus, and 
significantly increased rate and percentage of stress relaxation, when compared to 
untreated controls.  These findings raise the possibility that similar VSMC mechanical 
changes may result from oxLDL exposure in vivo.  Strong correlations were found among 
the different measures of viscous energy dissipation, supporting the validity of their 
usage.  Furthermore, there was a strong positive correlation between cellular frictional 
coefficients, and mechanical damping.   This finding seems to contradict the results from 
aim 3, however it should be noted that different chemical treatments were used in the two 
studies, and their effects on cellular surface chemistry and frictional behavior are as yet 
unknown.  Data pertaining to frictional effects of oxLDL were inconclusive.  The results 
from this aim represent the collective and successful usage of the AFM-based 
measurement techniques developed over the course of the prior aims.  Using these 
techniques, it was demonstrated that oxLDL causes significant changes in both elastic 
and viscoelastic behavior.  As such, these measurement techniques or variations thereof, 
can serve as an in vitro test bed for evaluation of the effects of various stimuli on cellular 
mechanics in future studies.  One of the most important points raised by this study, is the 
need to use several mechanical measurement techniques in combination, when evaluating 
the effects of a stimulus, as no single measure captures al l pertinent data. 
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Based upon the results of this research, it can be concluded that numerous 
clinically relevant stimuli, including oxLDL (aim 4) and paclitaxel (aim2) exposure, 
affect VSMC mechanical properties in a significant manner.    In addition the role of 
various cytoskeletal components in governing mechanical behavior has been further 
elucidated.  In both aims 1 and 4 of this study, evidence was found that VSMC 
phenotypic shifts are associated with mechanical changes, the physiological effects of 
which require further exploration.  Perhaps most importantly, AFM-based techniques and 
associated mechanical models have been identified that will allow for easily repeatable 
assessment of any number of clinically relevant stimuli related to vascular disease.  It is 
believed that a test platform such as this will allow for the evaluation of not only 
pharmaceutical and biological agents, but also of mechanical contact from different 
materials and surface chemistries with potential applications for endovascular devices.  
From a mechanical standpoint, implantation of vascular devices represents a complex 
system with numerous variables and components.  Using these AFM techniques, it will 
be possible to provide data for the creation of better computational and experimental 
models of the mechanical interactions between endovascular devices and underlying 
cells. 
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Recommendations 
 
1. Simultaneous AFM mechanical testing and live cell fluorescence imaging.  
One of the most significant drawbacks of the AFM cell techniques described in 
this research, is the reliance on the investigator on conventional light microscopy 
for identification of target cells and probe positioning.  Development of reliable 
methods for fluorescent staining of live cell cytoskeletal components would not 
only make cell identification far less difficult, but would also allow the correlation 
of cytoskeletal structure within specific cells with the mechanical properties of 
that cell.  This would represent a vast improvement over the current methodology, 
in which cell populations exposed to a given treatment are heterogeneous in their 
response, creating great difficulty in discerning if and how a given cell has 
responded, and how that response is manifested mechanically. 
 
2. AFM dynamic mechanical analyses. The AFM has been used in the past to 
conduct dynamical mechanical tests on living cells, as have various other 
techniques, such as magnetic twisting cytometry .  Utilization of such techniques 
would allow comparison with the stress relaxation data from the current research, 
as viscoelastic behavior over a certain frequency spectrum could be compared and 
validated using the separate techniques.  If necessary, refinement of the current 
mechanical models and identification of better models could be accomplished.   
 
 175 
 
3. In vitro screening of biomaterials and biomolecules.  The current AFM 
techniques carry great potential for use as an in vitro tool to screen clinically 
relevant biomolecules (e.g.   pharmaceuticals,  cytokines, lipoproteins) and 
biomaterials (e.g. stent materials and coatings) for mechanical effects and 
frictional behavior on VSMCs.  In particular, further exploration of lipoproteins, 
and their effects on cytoskeletal structure and cell mechanics is warranted, in light 
of the current research findings.  Attention should be focused on the identification 
of agents that inhibit any observed changes to cellular structure and mechanics, 
with the eventual goal being the identification of targeted therapies that block 
mechanical changes.  Such an approach  may help bring some of the clinical 
benefits of cellular mechanics research to fruition. 
 
4. Investigate the roles of intermediate filaments, focal adhesions, cytoplasmic 
properties, and cell contractility on cellular mechanical behavior.  The current 
research focused primarily on the mechanical effects actin and microtubules.  
However, these components are by no means the only factors in governing 
cellular mechanical behavior.  Strength of attachment (via focal adhesions), 
intermediate filaments (typically effecting large strain behavior), cytoplasmic 
content, and especially in the case of vascular smooth muscle cells, contractility, 
all warrant future investigation.  In each of these areas, existing methods and 
techniques exist that could be employed for investigation of their role in overall 
cell mechanics.  Doing so will provide a more comprehensive picture of VSMC 
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mechanical behavior than that provided by the current research.   
 
5. Mechanical investigation of different cell types.  The only cell type investigated 
in the current research was VSMCs.  However, the usefulness of these AFM 
techniques should be investigated using other cell types as well.  It is not known 
whether the specific techniques and models employed in the current research will 
be applicable over a wide range of cell types, or if they are VSMC specific.  From 
the perspective of a vascular researcher, the most obvious candidate would be 
vascular endothelial cells, given their large role in vascular disease development.    
 
6. 2.5-D or 3-D cell culture for mechanical analysis.  Another significant 
drawback of the current AFM techniques, is the fact that the cells were adherent 
to a flat substrate (2-D culture).  Although this is usually preferable to non-
adherent cells (for instance tested using micropipette techniques) it still leaves a 
great deal to be desired in terms of replicating the in vivo cell environment.   One 
possible solution to this is the fabrication of 2.5-D cell culture wells, in which 
cells are seeded within a depressed region of a substrate, allowing for attachment 
on all sides with the exception of the top plane, which would then be accessible to 
an AFM probe.  Mechanical testing of cells in a full 3-D environment would most 
likely necessitate the use of techniques other than AFM, but this is certainly a 
research goal worth pursuing.   
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7. Comparison with whole tissue (arterial) mechanics.  In the current research, 
the effects of various treatments on VSMC mechanical properties have been 
investigated.  Utilizing these data, an interesting avenue of investigation would be 
quantifying the effects of these same treatments (e.g. paclitaxel, oxLDL) on whole 
arterial tissue, whether in vivo or ex vivo.  Doing so will provide insight into the 
role of VSMC mechanics in the behavior of the artery as a whole.    
 
8. Frictional measurements using modified probes/cell modifications.  Although 
frictional measurements using chemically modified AFM probes were thus far 
unsuccessful, this is still an area that warrants further investigation.  Building of 
SAMs on AFM probes is a relatively easy and reproducible process, and further 
investigation to better understand probe/cell interactions in the context of lateral 
force microscopy is warranted.  Different probe materials could also be examined, 
in addition to chemical modification similar to that done in the current research.  
This is of particular importance when dealing with the effect of different stent 
materials on underlying cells.   Varying probe speeds and mechanical loads will 
also yield useful data pertaining to cellular lubrication mechanisms.  Lastly, 
modification of the cell surface could be looked at as an alternative to probe 
modification.  Careful selection of chemical treatments that alter either the 
glycocalyx or plasma membrane will also provide insight into these areas.   
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9. Use of primary cells.  In the current study, cells were generally utilized between 
passages 4 and 8.  Although this is within the commonly accepted passage range 
for VSMC in vitro work, there is still the possibility of substantial changes taking 
place in between the time of  isolation, and passage 4.  As soon as cells are 
removed from their in vivo environment, certain changes will be irreversible.  So, 
in addition to the use of earlier passage cells, this fact makes development of a 2.5 
or 3D mechanical testing scaffold  all the more important. 
(as suggested in #6 above) in order to replicate the in vivo environment as closely 
as possible. 
 
10. Quantitative analysis of cytoskeletal structure.  In the current research,  
descriptions of cytoskeletal architecture were largely qualitative.  Future work 
should focus on the development of methods to quantitatively characterize the 
amount and orientation of cytoskeletal difference cytoskeletal components, and 
the correlation of those variables with viscoelastic measurements. 
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Appendix A 
 
Additional AFM Indentation Data 
 
To obtain a measure of individual cell stiffness, the apparent elastic moduli of the cells 
were calculated using the modified Hertz models for a pyramidal indenter [173]:   
 
 
 
where F is the measured force (N), δ is indentation depth (m), E is apparent 
elastic modulus (Pa), υ is Poisson’s ratio (0.5) [187], and α is cone angle of the pyramidal 
indenter (35°).  The mean apparent elastic moduli of early passage VSMCs measured 
using a pyramidal probe were 72.0 ± 24.9 and 80.5 ± 18.3 kPa for serum-fed and 3-day 
serum-starved groups respectively (p = 0.207).  For late-passage VSMCs measured using 
a pyramidal probe, the mean apparent elastic moduli were 60.2 ± 14.2 and 70.0 ± 21.4 
kPa for the serum-fed and 3-day serum-starved groups respectively (p = 0.161), Figure 
A.1.  Based on these data from the pyramidal AFM probes, there were no statistically 
significant differences in apparent elastic modulus between early-passage and late-
passage serum-fed VSMCs (p = 0.197), or early- and late-passage 3-day serum-starved 
VSMCs (p = 0.163).  However, late passage VSMCs did exhibit non-significant 
decreases in modulus.   
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Figure A.1.  VSMC apparent elastic moduli measured using a pyramidal probe.  E=Early 
passage, L=Late passage, F=Serum fed, S=Serum starved.  Data represent mean ± SE. 
 
 
Elastic modulus values were significantly greater than those obtained with spherical 
probes for both early-passage serum-fed VSMCs (p < 0.001) and early-passage 3-day 
serum-starved VSMCs (p < 0.001).  The cell-to-cell apparent elastic modulus COV had a 
mean of 28.1 ± 5.9% and 32.0 ± 9.5% for pyramidal and spherical AFM probe groups 
respectively.  The mean COV for moduli measured at a single point were 12.9 ± 12.0% 
and 6.0 ± 5.3% for pyramidal tips and spherical tips respectively.  Cell-to-cell apparent 
elastic modulus COVs and repeated indentation COVs for each experimental group are 
summarized in Table A.1.   
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Table A.1.    Cell-to-Cell and Repeated Point Elastic Modulus COVs  
pyr=pyramidal tip, sphere=spherical tip 
 
 
 Cell-to-Cell COV  
(%) 
Repeated Point COV 
(%) 
Early Passage (Serum-fed, pyr) 35.2 24.3 
Early Passage (3-day Serum-starved, 
pyr) 
22.7 8.2 
Early Passage (Serum-fed, sphere) 20.6 4.1 
Early Passage (3-day Serum-starved, 
sphere) 
42.3 4.2 
Early Passage (5-day Serum-fed, sphere) 36.8 10.3 
Early Passage (5-day Serum-starved, 
sphere) 
28.4 5.3 
Late Passage (Serum-fed, pyr) 23.7 8.1 
Late Passage (Serum-starved, pyr) 30.6 11.3 
All Pyramidal (mean ± SD) 28.0 ± 5.9 12.9 ± 12.0 
All Spherical (mean ± SD) 32.0 ± 9.5 6.0 ± 5.3 
All Serum-fed (mean ± SD) 29.0 ± 8.1 12.5 ± 12.4 
All Serum-starved (mean ± SD) 31.0 ± 8.2   6.1 ± 4.1 
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Hysteresis was statistically significantly lower for early passage 3-day serum-
starved VSMCs in both the pyramidal probe groups (0.62 ± 0.20 and 0.30 ± 0.10 for 
serum-fed and serum-starved respectively, p < 0.001) and the spherical probe groups 
(0.41 ± 0.08 and 0.32 ± 0.09 for serum-fed and serum-starved respectively, p = 0.007).  
Hysteresis was also statistically significantly lower in 5-day serum-starved than in serum-
fed VSMCs (p < 0.001). There was a non-statistically significant decrease in hysteresis 
for late-passage serum-starved VSMCs compared to late-passage serum-fed VSMCs (p = 
0.181).  Serum-fed early-passage VSMCs exhibited statistically significantly greater 
levels of hysteresis than serum-fed late passage VSMCs (p<0.001), while no statistical 
difference was observed between serum-starved late- and early-passage VSMCs (p = 
0.469).  Hysteresis data are compared in Figure A.2.   
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Figure A.2.   Hysteresis of early (E) and late passage (L) serum fed (F) and serum starved 
(S) rat aortic SMCs measured with pyramidal (p) and spherical (s) AFM probes at an 
approach speed of 10.0 μm/s.  Data are presented as mean ± SE.     
 
 
There has recently been discussion in the literature regarding the efficacy of 
various AFM probe geometries in determining cellular mechanical properties [173].   It 
has been reported that mean modulus values yielded from a pyramidal AFM probe are 
greater than those yielded from a spherical probe [173]. Data from the current study are 
in agreement on this matter.  It is likely that modulus data from spherical probes are more 
accurate, due to the relative ease of characterizing spherical contact geometry compared 
to pyramidal geometry, as well as the larger contact area, lesser strains at lower 
indentation depths, and lower COVs on a repeated point of indentation.  In terms of cell-
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to-cell elastic modulus variation, the present study yielded mean COVs of 28.0 ± 5.9 and 
32.0 ± 9.5% for pyramidal and spherical AFM probe groups respectively, which are both 
towards the lower end of previously reported COVs from AFM cell indentations studies 
[174].   
The effect of probe speed on measured elastic modulus values was investigated 
using a spherical indenter.   Single cells were indented 5 times consecutively at both 10 
µm/s and 0.5 µm/s.  Apparent elastic modulus was non-significantly greater at 10 µm/s 
for each group tested, Figure A.3. 
 
 
 
 
 
 
 
 
 
 
 
Figure A.3.  VSMC apparent elastic moduli measured at indentation speeds of 10 µm/s 
(black) and 0.5 µm/s (white).  F = Serum-fed, S=Serum-starved.  Data presented as mean 
± SD. 
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The mean COV for moduli measured at a single point were 12.9 ± 12.0% and 6.0 ± 5.3% 
for pyramidal tips and spherical tips respectively in the present study.  Pyramidal AFM 
probes do however retain the advantage of enabling the user to easily switch between 
force and imaging mode without a change of tips and thus allow the creation of 
intracellular force maps and measurements of localized nanoscale mechanical property 
variations. The larger spherical probes are more suitable for providing “averaged” values 
for whole-cell mechanical behavior [146].   
In vitro aging has previously been used as a model for examining changes in 
mechanical properties of epithelial cells in an AFM study, with the finding that in vitro 
aging led to increased cell stiffness [144]. However, in the present study, cells were 
found to have a slightly decreased modulus after in vitro aging (~ 15 passages).  This 
discrepancy may be accounted for by the fact that in the current study the “early passage” 
cells were from passages 5 to 8, perhaps beyond the point of initial in vitro phenotypic 
changes.  Data from the current study indicate that late-passage VSMCs did not respond 
in as significant a manner to serum starvation as early-passage VSMCs, as there were no 
statistically significant changes in either modulus or hysteresis.  It is therefore likely, that 
past a certain length of time in culture, redifferentiation of VSMCs becomes increasingly 
difficult, and in vitro aging of cells renders them unusable for studies of this nature. 
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Appendix B 
 
IL-6 and HIL-6 Experiments 
 
Interleukin-6 (IL-6) and Hyper-IL-6 (HIL-6) treatment did not result in any 
significant changes to VSMC mechanical properties, as measured by AFM indentation 
and stress relaxation experiments.  HIL-6 is a “designer cytokine” produced and provided 
by the laboratory of Professor Stefan Rose-John at the Institute of Biochemistry at the 
Christian Albrechts Univerity Kiel.  It consists of IL-6 chemically joined to its soluble 
receptor, sIL-6R.  Il-6 was added at a concentration of 1000 ng/ml for a period of 24 
hours, while HIL-6 was added at a concentration of 10 ng/ml for 24 hours.   These 
concentrations were based on clinically relevant serum levels of IL-6, and upon the fact 
that HIL-6 is 100 to 1000 times more active than IL-6 alone.   Despite prior evidence that 
IL-6 substantially alters the cytoskeletal makeup of VSMCs, no significant effects were 
observed during the current research. 
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Appendix C 
Chemical Modification of AFM Probes 
 
Gold coated 5 um diameter spherical particle tips were utilized for the formation 
of self-assembled monolayers (SAMs), Figure A.4.  This technique enables the creation 
of an AFM probe with specified chemical properties (e.g. hydrophilic/phobic, charged).  
For these experiments, a hydrophilic surface was created using the hydroxyl (-OH) 
terminated alkanethiol 11-hydroxy-1-undecanethiol (Asemblon, Redmond, WA), and a 
hydrophobic surface was created using the methyl (-CH3) terminated alkanethiol 1-
Dodecanethiol (Asemblon).  In addition, a positively charged surface was created using 
the amine-terminated alakenthiol 11-Amino-1-undecanethiol, and a negatively charged 
surface was created using the carboxyl-terminated alkanethiol, 11-Mercaptoundecanoic 
Acid (Both from Asemblon). Briefly, 1 mmol ethanol solutions of each respective 
alkanethiol were made, in which the 5 µm colloidal gold coated 0.12 N/m AFM probes 
(NovaScan) were submerged overnight.  Probes were left in the alkanethiol solution until 
usage.  
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Figure A.4.  Interactions between the SAM adhered to the AFM probe, and molecules at 
the cell surface, may allow for the elucidation of the molecular mechanisms affecting cell 
surface shear. 
 
 
The data yielded from these experiments was unusable, although it is not known whether 
this is a result of instrumentation (AFM) problems or methodological difficulties.  Using 
chemically modified AFM probes for the examination of cell surface frictional 
phenomena may be a viable technique for future research. 
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Appendix D 
 
Membrane Permeabilization 
 
Triton X-100 and Escin used for permeabilization of VSMC cell membrane.  
Triton-X resulted in complete skinning of cell, and was therefore ruled out.  Escin, used 
at concentrations of  1000, 100, and 10 uM, permeabilized cell membrane successfully.  
However, immunofluorescence imaging revealed significant changes to cytoskeletal 
structure at higher concentrations (1000 and 100 uM), when cells were placed in PBS, 
DMEM, or intracellular medium.  Lower escin concentrations did not alter cellular 
mechanical properties in any way.  After reviewing these data, this aim was dropped from 
the current research. 
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Appendix E 
            MATLAB Scripts 
 
Hertz Modeling Scripts:  
 
AFMConvertAvgCells.m (reads in text files of raw AFM force curves, and converts to 
for force-distance or force-indentation) 
 
function [Forces, M, FileNums]= AFMConvertAvgCells(Name, startnum, endnum, RampSize, spring, ds, 
type) 
  
%function [Forces, M, FileNums]= AFMConvertAvgCells(Name, startnum, endnum, RampSize, spring, 
ds, type) 
% 
% AFMConvertAvgCells.m reads in text files of the raw AFM force curves (in 
% Volt units) and converts it to force-distance or force-indentation 
% curves. Be sure to export the data in the AFM software by doing Save As 
% ASCII and make sure your do NOT export the header. 
%  
% Name is the basename of the files you are reading in (for example: if 
%       your files are called CellForces051106.000.txt to 
%       CellForces051106.099.txt then the basename is 'CellForces051106')   
% startnum is the smallest file number in the range you are reading in 
% endnum is the largest file number that you are reading in 
% RampSize is the length in nm of the Z piezo ramp 
% spring is the spring constant in N/m 
% ds is the deflection sensitivity in V/nm (if you input ds = 0 and type = 
%       'forces', the program will calculate the deflection sensitivity 
%       from the data in the first file) 
% type is either 'forces', for HRFS data, or 'indent', for nanoindentation 
%       data.  
%          
% Forces is the matrix of distances and forces of the converted data (i.e. 
%       [distApproach FApproach distRetract ForceRetract distApproach...]) 
% M is the raw data from each file 
% FileNums is the list of the file numbers that got converted 
  
FileNums = []; 
M = []; 
reply = 'y'; 
display('Commands:');  
display ('y = yes: include this curve,'); 
display ('n = no: do not include this curve,'); 
display ('p = pass: include this curve and just do the rest of the curves (stop prompting me!),'); 
display ('q = quit: do not include this curve and do only the curves up to this point'); 
display ('b = back: go back one curve'); 
display('if something goes wrong and you want to stop the program completely without saving anything 
type cntrl-C') 
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reply2 = input('Name of input file of numbers? [if none, just press enter] ', 's'); 
  
if isempty(reply2), 
    i = 0; 
    while i <(endnum-startnum+1), 
        i = i+1; 
        if startnum+i-1<10 
            FileName = strcat(Name,'.00', num2str(startnum+i-1),'.txt'); 
        elseif startnum+i-1<100 
            FileName = strcat(Name,'.0', num2str(startnum+i-1),'.txt'); 
        else 
            FileName = strcat(Name,'.', num2str(startnum+i-1),'.txt'); 
        end 
        FileName 
        fid=fopen(FileName,'r'); 
        if fid ~= -1 
            tline1=fgetl(fid); %Read-off first line containing titles 
            temp = fscanf(fid, '%f %f', [2 inf])'; 
            if reply ~= 'p', 
                plot([linspace(RampSize, 0, length(temp))' linspace(0, RampSize, length(temp))'], temp); 
                reply = input('Do you want to include this curve? y/n/p/q/b [y]: ', 's'); 
                if length(reply)>1, 
                    reply = input('            only one character please! y/n/p/q/b [y]: ', 's'); 
                end 
                if isempty(reply) 
                    reply = 'y'; 
                end 
            end 
            if reply == 'y' || reply =='p', 
                FileNums = [FileNums; startnum+i-1]; 
                M= [M temp]; 
            elseif reply == 'q' 
                break 
            elseif reply == 'b' 
                i = i-2; 
            end 
        end 
        fclose('all'); 
    end 
else 
    FileNums = load(reply2); 
    for i = 1:length(FileNums), 
        if FileNums(i)<10 
            FileName = strcat(Name,'.00', num2str(FileNums(i)),'.txt'); 
        elseif FileNums(i)<100 
            FileName = strcat(Name,'.0', num2str(FileNums(i)),'.txt'); 
        else 
            FileName = strcat(Name,'.', num2str(FileNums(i)),'.txt'); 
        end 
        FileName 
        fid=fopen(FileName,'r'); 
        tline1=fgetl(fid); %Read-off first line containing titles 
        temp = fscanf(fid, '%f %f', [2 inf])'; 
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        M= [M temp]; 
        fclose('all'); 
    end 
end 
[Rrows, Rcolumns]=size(M); 
NumSets=Rcolumns/2; 
Samples=Rrows; 
Data=M(:,:); 
Forces =zeros(Samples, 4*NumSets); 
  
for i = 1:NumSets, 
    Zext = linspace(RampSize, 0, Samples)'; 
    Zret = linspace(0, RampSize, Samples)'; 
%         Defext = UnSlopeBaseCells(Zext, Data(:, i*2-1), 20)*ds; 
%         Defret = UnSlopeBaseCells(Zret, Data(:, i*2), 20)*ds; 
%         Defext = UnSlopeBaseCells(Sepext, Defext, 100); 
%         Defret = UnSlopeBaseCells(Sepret, Defret, Samples-100); 
    if type == 'forces', 
        Data(:, i*2-1) = UnSlopeBaseCells2(Zext, Data(:, i*2-1), 50, 100); 
        Data(:, i*2) = UnSlopeBaseCells2(Zret, Data(:, i*2), Samples-150, Samples-50); 
        if ds ==0, 
            temp = polyfit(Data(Rrows-50:Rrows-20, i*2-1), Zext(Rrows-50:Rrows-20), 1); 
            ds = -temp(1) 
        end 
        Defext = (Data(:, i*2-1)-mean(Data(45:55, i*2-1)))*ds; 
        Defret = (Data(:, i*2)- mean(Data(Samples-55:Samples-45, 2*i)))*ds; 
    Sepext = Zext + Defext; 
    Sepret = Zret + Defret; 
    Defext = Defext -ones(Rrows, 1)*mean(Defext(50:100, :)); 
    Defret = Defret -ones(Rrows, 1)*mean(Defret(Rrows-30:Rrows-20, :)); 
    Sepext = Sepext -ones(Rrows, 1)*mean(Sepext(Rrows-30:Rrows-20, :)); 
    Sepret = Sepret -ones(Rrows, 1)*mean(Sepret(50:100, :)); 
  
     
    elseif type == 'indent', 
    
    Defext = (Data(:, i*2-1))*ds; 
    Defret = (Data(:, i*2))*ds; 
    Sepext = Zext + Defext; 
    Sepret = Zret + Defret; 
     
    Startbase = 40; 
    %Check for wacky up-down baseline from missing data during trigger mode 
    %measurements when the tip is a bit too close to the sample 
    while abs(Defext(Startbase)-Defext(Startbase+1))> 0.8*ds, 
        Startbase = Startbase + 2; 
    end 
    Endbase = Startbase+50; 
  
% If you have a lot of base line drift, then uncomment the next line to 
% take out the base line drift ( you might need to change region of points 
% you are fitting) 
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    [Defext Defret] = UnSlopeBaseCells3(Sepext, Defext, Startbase, Endbase, Sepret, Defret); 
    
% Smooth out the data for contact point finding methods. NOTE: this is only  
% used to find the 0 point. The actual data that is returned is not smoothed  
% out or processed. 
    DefextSmooth = Defext; 
    for j=51:Samples-50, 
        DefextSmooth(j) = mean(Defext(j-50:j+50)); 
    end 
  
% PICK YOUR CONTACT POINT FINDING METHOD! Uncomment out the part of code 
% for the the method you want to use... 
  
    % Threshold method for picking contact point 
    thresh = 2; %Threshold in nm for picking the 0 point. Change this depending on the noise level of your 
data 
    j = Startbase+50; 
    while min(DefextSmooth(j:Samples))< thresh+min(DefextSmooth(Startbase+50:Samples)) & j<Samples 
        j = j+1; 
    end  
    pt0val = Sepext(j); 
    [Defext Defret] = UnSlopeBaseCells3(Sepext, Defext, Startbase+20, j-50, Sepret, Defret); 
        DefextSmooth = Defext; 
    for j=51:Samples-50, 
        DefextSmooth(j) = mean(Defext(j-50:j+50)); 
    end 
  
    j = Startbase+50; 
    while min(DefextSmooth(j:Samples))< thresh+min(DefextSmooth(Startbase+50:Samples)) & j<Samples 
        j = j+1; 
    end  
    pt0val = Sepext(j); 
     
    % two region fit over whole data with moving break point. 
%     DefextDeriv = polyderiv(DefextSmooth(Startbase:Samples), Zext, 10)'; 
%     [point0 pt0val] = FindZeroPt(Zext(Startbase+50:Samples-30), DefextDeriv(50:length(DefextDeriv)-
30), 0, 1); 
%     point0= point0+Startbase+50; 
%     pt0val = Sepext(point0); 
%      
    % moving window with 2 region fit to find contact point 
%     DefextDeriv = polyderiv(DefextSmooth, Zext, 10)'; 
%     [point0 pt0val] = FindZeroPt2(Zext, DefextDeriv, 0, 1, 200, 100, 500); 
%     pt0val = Sepext(point0); 
     
    Sepext = -(Sepext-pt0val); 
    Sepret = -(Sepret-pt0val); 
    Defext = Defext ; 
    Defret = Defret ; 
  
    end 
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    Forces(:, i*4-3:i*4) = [Sepext Defext*spring Sepret Defret*spring]; 
end 
 
 
AVERAGELOTSFORCESCELLS.m (calculates elastic modulus and hysteresis from 
indentation curves) 
 
function [Averages, Stiffness, Eall, Hys, FilesRemoved] = AverageLotsForcesCells(Data, Files, 
NumPoints) 
% function [Averages, Stiffness, Eall, FilesRemoved] = AverageLotsForcesCells(Data, Files, NumPoints) 
% 
% AverageLotsForcesCells.m assumes Data is a matrix where the columns are 
% alternating distance vectors and force vectors of data. It basically 
% averages all the force curves in the matrix Data.  
% 
% Data is a matrix of force curves (i.e. [distances_1 Force_1 distances_2 
% Force_2...] where distances_i is the vector of distances at which the 
% forces in vector Force_i were taken)  
%           NOTE: it is therefore assumed that Data has an even number of 
%           columns 
% Files is the list of file numbers (from AFMConvertAvgCells.m output) 
% NumPoints is the number of points that you would like to resample at. 
%  
% Averages is the matrix of averaged data resampled so that it has 
% NumPoints points 
% Stiffness is the average and standard deviation of the elastic modulus 
% for each cell or group of curves. It is calculated using the Hertz model 
% Eall is the elastic modulus calculated for each individual curve 
% FilesRemoved is a list with any file number that was removed from the 
% averaging set by the user. 
  
[Rows Cols] = size(Data); 
Averages = []; 
Stiffness = []; 
CellNumber = 0; 
cell = -1; 
j = 1; 
Approach = []; 
Retract = []; 
Eall = []; 
Hys = []; 
FilesRemoved = []; 
reply2 = 'y'; 
InputFile = input('Input file name? [none]: ', 's'); 
if isempty(InputFile), 
    ManualMode = 1; 
else 
    InputList = load(InputFile); 
    SpeedNum = 1; 
    TotalCells = length(InputList)/SpeedNum; 
    ManualMode = 0; 
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end 
if ManualMode, 
    SpeedNum = str2num(input('How many different speeds did you use per cells? [3] ', 's')); 
    TotalCells = 0; 
end 
reply2 = input('Check curves individually? y/n [n]: ', 's'); 
if isempty(reply2) 
    reply2 = 'p'; 
elseif length(reply2)~= 1 
    reply2 = input('ERROR: please answer y or n: ', 's'); 
end 
if reply2 == 'n' || reply2 == 'p', 
    reply2 = 'p'; 
else 
    figure(1) 
    hold off 
end 
if isempty(SpeedNum), 
    SpeedNum = 3; 
end 
speed = 0; 
while j <=length(Files), 
    Approach = []; 
    Retract = []; 
    cell = cell +1; 
    CellNumber = floor(cell/SpeedNum)+1 
    if speed ==SpeedNum, 
        speed =0; 
    end 
    speed = speed+1 
    if ManualMode, 
        file1 = (input('        First File Number: ', 's')); 
        if file1 == 'q', 
            break 
        end 
        temp = 1; 
        if file1 ~= 's' 
            file2 = (input('        Second File Number: ', 's')); 
            if file2 == 'q', 
                break 
            end 
            file1 = str2num(file1); 
            file2 = str2num(file2); 
        end 
    elseif cell+1> TotalCells 
        break 
    else 
        file1 = InputList(cell+1, 1); 
        file2 = InputList(cell+1, 2); 
    end 
    temp =1; 
    if file1>file2, 
        display('ERROR: the first file number should be smaller than the second one') 
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        temp  =0; 
    end 
    while temp==1 & j<=length(Files) 
        if  Files(j)<file1, 
            j = j+1; 
        elseif Files(j)<=file2, 
            if reply2 ~= 'p', 
                hold off 
                plot(Data(:, j*4-3), Data(:, j*4-2)); 
                axis([-1000 1000 -5 20]); 
                reply2 = input('Is this curve ok? y/n/p [y]: ', 's'); 
                if isempty(reply2) 
                    reply2 = 'y'; 
                elseif length(reply2) ~= 1, 
                    reply2 = input('ERROR: please answer y, n, or p only... y/n/p? ', 's'); 
                end 
                if reply2 ~= 'n' 
                    Approach = [Approach Data(:, j*4-3:j*4-2)]; 
                    Retract = [Retract Data(Rows:-1:1, j*4-1:4*j)]; 
                    j = j+1; 
                else 
                    reply2 = input('Try to fix it? y/n [y]: ', 's'); 
                    if isempty(reply2) 
                        reply2 = 'y'; 
                    elseif length(reply2)~= 1, 
                        reply2 = input('ERROR: please answer y or n only... y/n? ', 's'); 
                    end 
                    if reply2 == 'n', 
                        FilesRemoved = [FilesRemoved; Files(j)]; 
                        j = j+1; 
                    else 
                        xoff = 0; 
                        yoff =0; 
                        reply2 = 'n'; 
                        while reply2 == 'n', 
                            reply2 = input('x offset: ', 's'); 
                            xoff = xoff+str2num(reply2); 
                            plot(Data(:, j*4-3)+xoff, Data(:, j*4-2)+yoff); 
                            axis([0 1000 0 20]); 
                            reply2 = input('y offset: ', 's'); 
                            yoff = yoff+str2num(reply2); 
                            plot(Data(:, j*4-3)+xoff, Data(:, j*4-2)+yoff); 
                            axis([0 1000 0 20]); 
                            reply2 = input('is it ok now? y/n/q [y]: ', 's'); 
                            if isempty(reply2) 
                                reply2 = 'y'; 
                            elseif length(reply2) ~= 1, 
                                reply2 = input('ERROR: please answer y, n, or q only... y/n/q? ', 's'); 
                            end 
                        end 
                        if reply2 == 'y', 
                            Approach = [Approach Data(:, j*4-3:j*4-2)]; 
                            Retract = [Retract Data(Rows:-1:1, j*4-1:4*j)]; 
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                            j = j+1; 
                            if j>=length(Files) 
                                temp = 2; 
                            end 
                        else 
                            FilesRemoved = [FilesRemoved; Files(j)]; 
                            j = j+1; 
                        end 
                    end 
                end 
  
            else 
                Approach = [Approach Data(:, j*4-3:j*4-2)]; 
                Retract = [Retract Data(Rows:-1:1, j*4-1:4*j)]; 
                j = j+1; 
                if j>length(Files) 
                temp = 2; 
                end 
            end 
        else 
            temp = 2; 
        end 
    end 
     
    if (isempty(Approach) ~=1) 
        [x F Fs E Estd Et] = AverageForces(Approach, NumPoints); 
        Averages = [Averages x F Fs]; 
        Stiffness = [Stiffness; E Estd]; 
        %         if Estd/E > 0.5, 
        %             [E Estd] 
        %             plot(x, F, '.') 
        %             hold on 
        %             [r c] = size(Approach); 
        %             plot(Approach(:, 1:2:c), Approach(:, 2:2:c)) 
        %             pause 
        %         end 
        Eall = [Eall; Et]; 
        dx = x(2)-x(1); 
        HysAp = sum(F(1:NumPoints))* dx; 
        [x F Fs] = AverageForces(Retract, NumPoints); 
        dx = x(2)-x(1); 
        Hys = [Hys; (HysAp-sum(F(1:NumPoints))*dx)/HysAp]; 
        Averages = [Averages x(NumPoints:-1:1) F(NumPoints:-1:1) Fs(NumPoints:-1:1)]; 
    else 
        display('I was supposed to average files: ') 
        file1 
        display('through ') 
        file2 
        display('but I''m at file') 
        Files(j) 
        display('Either none of those files were good or there is a problem with the script input file?'); 
        pause 
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        Averages = [Averages zeros(NumPoints, 3)]; 
        Stiffness = [Stiffness; 0 0]; 
    end 
end 
 
 
Stress Relaxation Scripts: 
 
HDRLOAD.m (reads in raw stress relaxation data) 
Script from The MATHWORKS (Natick, MA) 
http://www.mathworks.com/support/tech-notes/1400/1402.html 
 
 
function [data] = hdrload(file) 
  
  
% HDRLOAD Load data from an ASCII file containing a text header. 
%     [header, data] = HDRLOAD('filename.ext') reads a data file 
%     called 'filename.ext', which contains a text header.  There 
%     is no default extension; any extensions must be explicitly 
%     supplied. 
% 
%     The first output, HEADER, is the header information,  
%     returned as a text array. 
%     The second output, DATA, is the data matrix.  This data  
%     matrix has the same dimensions as the data in the file, one 
%     row per line of ASCII data in the file.  If the data is not 
%     regularly spaced (i.e., each line of ASCII data does not  
%     contain the same number of points), the data is returned as 
%     a column vector. 
% 
%     Limitations:  No line of the text header can begin with 
%     a number.  Only one header and data set will be read, 
%     and the header must come before the data. 
% 
%     See also LOAD, SAVE, SPCONVERT, FSCANF, FPRINTF, STR2MAT. 
%     See also the IOFUN directory. 
  
  
% check number and type of arguments 
if nargin < 1 
  error('Function requires one input argument'); 
elseif ~isstr(file) 
  error('Input must be a string representing a filename'); 
end 
  
  
% Open the file.  If this returns a -1, we did not open the file  
% successfully. 
fid = fopen(file); 
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if fid==-1 
  error('File not found or permission denied'); 
  end 
  
  
% Initialize loop variables 
% We store the number of lines in the header, and the maximum  
% length of any one line in the header.  These are used later  
% in assigning the 'header' output variable. 
no_lines = 0; 
max_line = 0; 
  
  
% We also store the number of columns in the data we read.  This  
% way we can compute the size of the output based on the number  
% of columns and the total number of data points. 
ncols = 0; 
  
  
% Finally, we initialize the data to []. 
data = []; 
  
  
% Start processing. 
line = fgetl(fid); 
if ~isstr(line) 
  disp('Warning: file contains no header and no data') 
  end; 
[data, ncols, errmsg, nxtindex] = sscanf(line, '%f'); 
  
  
% One slight problem, pointed out by Peter vanderWal: If the  
% first character of the line is 'e', then this will scan as  
% 0.00e+00. We can trap this case specifically by using the  
% 'next index' output: in the case of a stripped 'e' the next  
% index is one, indicating zero characters read.  See the help  
% entry for 'sscanf' for more information on this output  
% parameter. We loop through the file one line at a time until  
% we find some data.  After that point we stop checking for  
% header information. This part of the program takes most of the  
% processing time, because fgetl is relatively slow (compared to  
% fscanf, which we will use later). 
while isempty(data)|(nxtindex==1) 
  no_lines = no_lines+1; 
  max_line = max([max_line, length(line)]); 
  % Create unique variable to hold this line of text information. 
  % Store the last-read line in this variable. 
  eval(['line', num2str(no_lines), '=line;']); 
  line = fgetl(fid); 
  if ~isstr(line) 
    disp('Warning: file contains no data') 
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    break 
    end; 
  [data, ncols, errmsg, nxtindex] = sscanf(line, '%f'); 
  end % while 
  
  
% Now that we have read in the first line of data, we can skip  
% the processing that stores header information, and just read  
% in the rest of the data.  
data = [data; fscanf(fid, '%f')]; 
fclose(fid); 
  
  
% Create header output from line information. The number of lines 
% and the maximum line length are stored explicitly, and each  
% line is stored in a unique variable using the 'eval' statement  
% within the loop. Note that, if we knew a priori that the  
% headers were 10 lines or less, we could use the STR2MAT  
% function and save some work. First, initialize the header to an 
% array of spaces. 
header = setstr(' '*ones(no_lines, max_line)); 
for i = 1:no_lines 
  varname = ['line' num2str(i)]; 
  % Note that we only assign this line variable to a subset of  
  % this row of the header array.  We thus ensure that the matrix 
  % sizes in the assignment are equal. We also consider blank  
  % header lines using the following IF statement. 
  if eval(['length(' varname ')~=0']) 
    eval(['header(i, 1:length(' varname ')) = ' varname ';']); 
    end 
  end % for 
  
  
% Resize output data, based on the number of columns (as returned 
% from the sscanf of the first line of data) and the total number 
% of data elements. Since the data was read in row-wise, and  
% MATLAB stores data in columnwise format, we have to reverse the 
% size arguments and then transpose the data.  If we read in  
% irregularly spaced data, then the division we are about to do  
% will not work. Therefore, we will trap the error with an EVAL  
% call; if the reshape fails, we will just return the data as is. 
eval('data = reshape(data, ncols, length(data)/ncols)'';', ''); 
data(:,2) = []; 
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STRESSRELAX.m (normalizes and truncates stress relaxation data) 
 
% function [data_final, depth, delta_strain] = stressrelax(data, defsens, ramp) 
function [data_final] = stressrelax(data) 
  
  
lintime = linspace(0.01,120,12000)'; 
baseline_shift = mean(data(1:100)); 
data_shift = (data-baseline_shift); 
data_small = data_shift(1:1000); 
[y n] = max(data_small); 
data_norm = (data_shift(n+1)).\(data_shift(n+1:n+12000)); 
sum(data_norm); 
for i = 1:length(data_norm), 
    if data_norm(i) < 0 
        data_norm(i) = 0.01; 
    end 
end 
sum(data_norm); 
data_log = [log10(data_norm(1:12000))]; 
logtime = log10(lintime(1:12000)); 
time_resample = evenspc(logtime,logtime,100); 
sum(data_log); 
data_resample = evenspc(data_log,logtime,100); 
  
  
% data_final = [[1; 10.^data_resample] [0; 10.^time_resample]]; 
  
% sum(data_temp); 
% for i = 10:length(data_temp), 
%     if data_temp (i) > mean(data_temp(i-2):data_temp(i-1))+1*std(data_temp(i-2):data_temp(i-1))       
%         data_temp(i) = mean(data_temp(i-2):data_temp(i-1))+1*std(data_temp(i-2):data_temp(i-1));  
%     elseif data_temp(i) < mean(data_temp(i-2):data_temp(i-1))-1*std(data_temp(i-2):data_temp(i-1))         
%       data_temp(i) = mean(data_temp(i-2):data_temp(i-1))-1*std(data_temp(i-2):data_temp(i-1));  
%      
%     end    
% end 
%  
% sum(data_temp); 
data_final = [10.^data_resample 10.^time_resample]; 
% lintime2 = linspace(0,120,12000)'; 
% depth = [data_norm lintime2]; 
% delta_strain = (((defsens*y)-(defsens*data_norm(12000)))/depth)*100; 
G120=data_final(100) 
  
end 
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EVENSPC.m (called by stressrelax.m) 
 
 
function [F, x] = evenspc(f, d, N) 
% 
% [F, x] = evenspc(f, d, N) 
% 
% Creates an evenly-spaced force vector 
% 
% f = vector of forces 
% d = vector of distances 
% length(f) must be the same as length(d) 
% N = length of desired output force vector 
% 
% Example: 
% forces = [1000 300 600 150]; 
% dists  = [100 70 20 5]; 
% F = evenspc(forces, dists, 200); 
%  
% F will be a force vector with 200 components representing 
% forces at evenly-spaced distances from 100 down to 5. 
% x will be a vector with 200 components representing the distance at which 
% forces in F are done. 
% 
L = length(f); 
[m, n] = size(f); 
flag = 0; 
if d(L)>d(1), 
    d = d(L:-1:1); 
    f = f(L:-1:1); 
    flag =1; 
end 
increment = (d(L) - d(1)) / (N-1); 
if n==1, 
    F = zeros(N,1); 
    x = linspace(d(1), d(L), N)'; 
else 
    F = zeros(1,N); 
    x = linspace(d(1), d(L), N); 
end 
  
F(1) = f(1); 
F(N) = f(L); 
for i=2:N-1, 
   dist = d(1) + increment * (i-1); 
   j = 1; 
   if (i==N) 
       j = L-1; 
   else 
    while (d(j+1) > dist & j<L-1), 
          j = j + 1; 
    end 
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   end 
   % dist is now between d(1,j) and d(1,j+1) 
   % let lambda be equal to "how far between" on a  
   % scale of 0..1. 
   lambda = (dist - d(j)) / (d(j+1) - d(j)); 
   % linearly interpolate the force based on lambda 
   force = f(j+1) * lambda + f(j) * (1-lambda); 
   F(i) = force; 
end 
if flag ==1, 
    F = F(N:-1:1); 
    x = x(N:-1:1); 
end 
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THEGFUNCTION.m  (Used in conjunction with QLVFIT.m to fit QLV reduced 
relaxation function data to stress relaxation data). 
 
 
 
 
 function G = TheGFunction(a, t) 
G = 0*t; 
C = a(1); 
tau1 = a(2); 
tau2 = a(3); 
dtau = (tau2-tau1)/800; 
taus = linspace(tau1, tau2,800)'; 
for i = 1:length(t), 
%     fun1 = @(tau) (exp(t(i)/tau)/tau); 
%     fun2 = @(tau) (1/tau); 
%     int1 = quad(fun1, tau1, tau2); 
%     int2 = quad(fun2, tau1, tau2); 
    int1 = sum(exp(-t(i)./taus)./taus)*dtau; 
    int2 = sum(1./taus)*dtau; 
    G(i) = (1 + C.*int1)./(1+ C.*int2); 
end 
 
  
 
 
  
QLVFIT.m (Used in conjunction with THEGFUNCTION.m to fit QLV reduced 
relaxation function data to stress relaxation data). 
 
 
 
% QLVfun2 = @ (a,t) [1+a(1).*quad((exp(-t./a(2))./a(2)),a(3),a(4))] ./ [1+a(1).*quad((1./a(2)),a(3),a(4))]; 
  
%  
lintime = linspace(0.01,120,12000)'; 
logtime = log10(lintime); 
t = evenspc(logtime,logtime,100); 
  
% t=logspace(-2,2.079,100)'; 
StartingVals = [1 0.05 100]; 
coefEsts = nlinfit(meanjasp(:,2), meanjasp(:,1), @TheGFunction, StartingVals) 
xgrid = logspace(-2,2.079,100); 
plot(xgrid, meanjasp(:,1), '.') 
plot(xgrid, TheGFunction(coefEsts, xgrid), 'r'); 
hold on  
fit = TheGFunction(coefEsts, xgrid)'; 
R = corr2(fit, meanjasp(:,1)); 
  
R2 = R^2 
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EXPONENTIALFIT.m (Used to fit power-law model to stress relaxation data) 
 
 
t= logspace(-2,2.079,100)'; 
Expfun = @(a,t) a(1).*(t.^a(2)); 
StartingVals = [1 0]; 
coefEsts = nlinfit(t, CWilson5_final(:,1), Expfun, StartingVals) 
xgrid = logspace(-2,2.079,100); 
line(xgrid, Expfun(coefEsts, xgrid), 'Color','g'); 
fit = Expfun(coefEsts, xgrid)'; 
R = corr2(fit, CWilson5_final(:,1)); 
R2 = R^2 
  
 
 
 
SLSFIT.m (Fits standard linear solid model to stress relaxation data) 
 
 
t= logspace(-2,2.079,100)'; 
% a(1)=ER, a(2)=taustress, a(3)=taustrain 
SLSfun = @(a,t) a(1).*(1-(1-a(2)./a(3)).*exp(-t./a(3))); 
StartingVals = [1 1 1]; 
coefEsts = nlinfit(t, CWilson_final(:,1), SLSfun, StartingVals) 
xgrid = logspace(-2,2.079,100); 
line(xgrid, SLSfun(coefEsts, xgrid), 'Color','m'); 
fit = SLSfun(coefEsts, xgrid)'; 
R = corr2(fit, CWilson_final(:,1)); 
R2 = R^2 
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Friction Scripts: 
 
 
 
loadFRICFILES.m  (loads raw friction data) 
 
 
% loadForceFiles 
  
function [F]=loadForceFiles(pathName, baseName, ff, lf) 
iflag_main=0; 
  
  
%  
F = []; 
 num_datas=512; 
 num_lines=16; %aspect ratio 
% ff=51; %first file number 
% lf=78; %last file number 
% path='C:\Delphine''s Stuff\Lab Stuff\AFMData\10-19-04\102004_AggcolIS\'; %path for loading files 
  
numfiles = lf-ff+1; 
  
n=1; 
for j=ff:lf 
  
    if j<10, 
        S=strcat(pathName, baseName,'.00',num2str(j),'.txt'); 
    end 
     
    if j>=10, 
        S=strcat(pathName, baseName,'.0',num2str(j),'.txt'); 
    end 
     
    if j>=100, 
        S=strcat(pathName, baseName,'.',num2str(j),'.txt'); 
    end 
 S 
 fid=fopen(S,'r'); 
     tline1=fgetl(fid); %Read-off first line containing titles 
    for i=1:num_lines, 
        line = fgetl(fid); 
        stuff = sscanf(line, '%f', inf); 
        temp_m(i, :) = stuff; 
    end 
     F = [F; temp_m]; 
     tline1=fgetl(fid); %Read-off first line containing titles 
     tline1=fgetl(fid); 
    for i=1:num_lines, 
        line = fgetl(fid); 
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        stuff = sscanf(line, '%f', inf); 
        temp_m(i, :) = stuff; 
    end 
     F = [F; temp_m]; 
     tline1=fgetl(fid); %Read-off first line containing titles 
     tline1=fgetl(fid); 
    for i=1:num_lines, 
        line = fgetl(fid); 
        stuff = sscanf(line, '%f', inf); 
        temp_m(i, :) = stuff; 
    end 
     F = [F; temp_m]; 
    %for i=1:num_datas*num_lines 
    %    line=fgetl(fid); 
    %    stuff=sscanf(line,'%f %f %f'); 
    %    temp_m(:,i)=stuff; 
    %end 
    
%     if j == ff 
%         F = load(S); 
%     else 
%         F = [F; load(S)]; 
%     end 
     
    fclose('all'); 
end 
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AVERAGEHEIGHTFRICCELL.m  (calculates friction values) 
 
 
 
function [Friction, StDevFric, avFric, stdFric] = AverageHeightFricCell(Datas, lines) 
% [AvgHeight StDevHeight Height Friction StDevFric] =  
% AverageHeightFric(Datas, Positions, lines, stagg, endagg) 
% % Datas is the set of data with trace, retrace of the friction signal,  
% and height. 
% % Postitions is either 'midd' or 'side'. 'midd' is if your pattern is  
% in 
% % the middle of the image (so for example, if you have polymer in the 
% % middle and some SAM outside). 'side' assumes that your pattern takes  
% up 
% % one side of the image (so for example the polymer is on the left side  
% and 
% % the SAM is on the right side of the image) 
% lines is the number of lines per set of data (8, or 16 usually) 
% stagg is the index at which the pattern starts  
% endagg is the index at which the pattern ends (if you are using 
% 'side' position then endagg doesn't matter) 
% 
% see also AverageHeight (if you only have height data and no friction) 
  
[rows cols] = size(Datas); 
numData = rows/(3*lines); 
  
HeightDatas = zeros(lines, cols); 
StepHeights = zeros(lines, 1); 
TraceDatas = HeightDatas; 
ReTraceDatas = HeightDatas; 
Frics = zeros(lines,cols); 
  
blck = lines*3; 
  
Height = zeros(numData*lines,1); 
AvgHeight = zeros(numData,1); 
StDevHeight = AvgHeight; 
Friction = zeros(numData*lines,1); 
StDevFric = Friction; 
  
for i = 1:numData, 
    HeightDatas = Datas(i*blck-blck+1:i*blck, :); 
    TraceDatas = Datas(i*blck-blck+lines+1:i*blck-blck+2*lines, :); 
    ReTraceDatas = Datas(i*blck-blck+2*lines+1:i*blck-blck+3*lines, :); 
        Frics = (TraceDatas-ReTraceDatas)/2; 
            Friction((i-1)*lines+1: i*lines) = mean(Frics, 2); 
            StDevFric((i-1)*lines+1: i*lines) = std(Frics, 0, 2); 
            avFric(i) = mean(mean(Frics, 2)); 
            stdFric(i) = std(mean(Frics, 2)); 
            temp = []; 
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            for j = 1:lines 
                if Friction((i-1)*lines+j) < avFric(i)+2*stdFric(i) & Friction((i-1)*lines+j) > avFric(i)-
2*stdFric(i) 
                    temp = [temp; Friction((i-1)*lines+j)]; 
                else 
                    sprintf('deleted block %i line %i', i, j) 
                end 
            end 
            avFric(i) = mean(mean(temp, 2)); 
            stdFric(i) = std(mean(temp, 2)); 
             
%             Friction((i-1)*lines+j,1) = mean(Frics(stagg+20:cols-50),  
% 2); 
% %             Friction((i-1)*lines+j,2) = mean(Frics(50:stagg-20), 2); 
% %             StDevFric((i-1)*lines+j,1) = std(Frics(stagg+20:cols-50),  
% 2); 
%             StDevFric((i-1)*lines+j,2) = std(Frics(50:stagg-20), 2); 
          AvgHeight(i) = mean(Height((i-1)*lines+1:i*lines)); 
        StDevHeight(i) = std(Height((i-1)*lines+1:i*lines)); 
    end     
end 
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Appendix F 
 
Reagent Dilutions 
 
Cytochalasin D (Sigma): 
 
507.62 g/mol 
Start w/ 1 mg in powder form 
Dilute into 1 ml DMSO (1 mg/ml) 
Aliquot into 20 vials, each with 50 uL 
For 10 uM, add 25 uL from vial to 5 ml of media in well  
 
Nocodazole (Sigma): 
 
301 g/mol 
Start w/ 10 mg in powder form 
Dilute into 2 ml DMSO (5 mg/ml) 
Aliquot into 20 vials, each with 0.1 ml 
For 20 uM, add 6 uL from vial to 5 ml of media in well  
 
Paclitaxel (Sigma): 
 
853.9 g/mol 
Start w/ 5 mg in powder form 
Dilute into 1 ml DMSO (5 mg/ml) 
Aliquot into 10 vials, each with 100 uL 
For 10 uM, add 8.5 uL from vial to 5 ml media 
 
Jasplakinolide (Sigma): 
 
710 g/mol 
Start w/ 50 ug 
Dilute into 0.1 ml DMSO (0.5 mg/ml) 
Aliquot into 5 vials, each with 20 ul 
For 1 uM: dilute 7 ul from stock into 5 ml media 
 
Amine-Terminated SAM (11-Amino-1-undecanethiol) (Asemblon): 
 
1 mmol = 0.0024 g/ 10 ml 
 
Carboxyl-Terminated SAM (11-Mercaptoundecanoic Acid) (Asemblon): 
 
1 mmol = 0.0022 g/10 ml 
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Hydroxy-Terminated SAM (11-Hydroxy-1-undecanethiol) (Asemblon): 
 
1 mmol = 0.002 g / 10 ml 
 
Methyl-Terminated SAM (1-Dodecanethiol) (Asemblon): 
 
1 mmol = 0.002 g / 10 ml 
 
CellMask Plasma Membrane Stain (Invitrogen): 
 
Stock is 5 mg/ml in DMSO (total of 100 uL = 500 ug) 
Stock Conc. = 5 ug/uL 
Working Conc. = 5 ug/ml 
Dilute 1 ul stock per ml working solution, or 1.5 ul per ml for 7.5 ug/ml 
Incubate for 10 minutes @ 37 C 
 
OxLDL (Biomedical Technologies): 
 
(Comes in 1 ml vial with 2 mg per vial) for 0.05 mg/ml, add 0.025 ml per ml DMEM; for 
0.025 mg/ml, add 0.0125 ml per ml DMEM; for 0.01 mg/ml, add 0.005 ml per ml 
DMEM 
 
LDL (Biomedical Technologies): 
 
(Comes in 5 mg per 1.0 ml per vial); for 0.05 mg/ml, add 0.01 ml per ml DMEM; for 
0.025 mg/ml, add 0.005 ml per ml DMEM; for 0.01 mg/ml, add 0.002 ml per ml DMEM 
 
Chondroitinase ABC (Sigma): 
 
Reconstitute in a 0.01% aqueous bovine serum albumin 
solution. Subsequent dilutions can be made into a 
buffer containing 50 mM Tris, pH 8.0, 60 mM sodium 
acetate, and 0.02% bovine serum albumin. Solutions 
should be prepared fresh. 
Sodium acetate = 82.03 g/mol 
Sodium acetate (60mM) = 4.9 g/L = 0.005 g/ml = 0.05 g/10ml 
Tris = 121.1 g/mol 
Tris (50mM) = 6 g/L = 0.006 g/ml = 0.06 g/10ml 
0.01% BSA  = 0.0001 g/ml = 0.001 g/10ml 
 
Heparinase III (Sigma): 
 
This enzyme can be reconstituted in 20 mM Tris-HCl 
pH 7.5, containing 0.1mg/ml BSA and 4 mM CaCl2 
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CaCl2 = 111 g/mol 
CaCl2 (4mM) = 0.444 g/L = 0.0004 g/ml = 0.004 g/10ml 
Tris (20 mM) = 2.4 g/L = 0.002 g/ml = 0.02 g/10ml 
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